This is a Validated Antibody Database (VAD) review about mouse Foxp3, based on 560 published articles (read how Labome selects the articles), using Foxp3 antibody in all methods. It is aimed to help Labome visitors find the most suited Foxp3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Foxp3 synonym: JM2; scurfin; sf

Invitrogen
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:30; fig 4c
Invitrogen Foxp3 antibody (eBioscience, 12-5773-82) was used in flow cytometry on mouse samples at 1:30 (fig 4c). Nat Commun (2022) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...
Invitrogen Foxp3 antibody (Thermo Fisher Scientific, FJK-16s) was used in flow cytometry on mouse samples . J Exp Med (2022) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3a
Invitrogen Foxp3 antibody (Invitrogen, FJK-16s) was used in flow cytometry on mouse samples (fig 3a). Front Immunol (2022) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen Foxp3 antibody (eBioscience, 11-5773-82) was used in flow cytometry on mouse samples (fig 1b). Sci Adv (2022) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:50; loading ...; fig 6j
Invitrogen Foxp3 antibody (eBioscience, 12-5773-82) was used in flow cytometry on mouse samples at 1:50 (fig 6j). Nat Commun (2022) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:400; loading ...; fig 4b
Invitrogen Foxp3 antibody (Thermo Fisher Scientific, 17-5773-82) was used in flow cytometry on mouse samples at 1:400 (fig 4b). Heliyon (2022) ncbi
mouse monoclonal (150D/E4)
  • flow cytometry; mouse; loading ...; fig s1i
Invitrogen Foxp3 antibody (eBioscience, 12-4774-42) was used in flow cytometry on mouse samples (fig s1i). Front Immunol (2022) ncbi
rat monoclonal (NRRF-30)
  • flow cytometry; mouse; loading ...; fig 5a, 5c
Invitrogen Foxp3 antibody (eBioscience, 12-4771-82) was used in flow cytometry on mouse samples (fig 5a, 5c). PLoS Pathog (2022) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 5a, 5c
Invitrogen Foxp3 antibody (eBioscience, 17-5773-82) was used in flow cytometry on mouse samples (fig 5a, 5c). PLoS Pathog (2022) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 4g
Invitrogen Foxp3 antibody (Invitrogen, 14577380) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4g). Front Pharmacol (2022) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen Foxp3 antibody (eBioscience, 48-5773-82) was used in flow cytometry on mouse samples (fig 5d). Oncoimmunology (2022) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen Foxp3 antibody (Invitrogen (eBioscience), FJK-16s) was used in flow cytometry on mouse samples (fig 4b). Nature (2022) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry; mouse; fig 7a
Invitrogen Foxp3 antibody (Thermo Fisher, FJK-16s) was used in immunohistochemistry on mouse samples (fig 7a). Nat Commun (2022) ncbi
rat monoclonal (NRRF-30)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2f
  • flow cytometry; mouse; loading ...; fig s1i
Invitrogen Foxp3 antibody (eBioscience, 14-4771-80) was used in immunohistochemistry - frozen section on mouse samples (fig 2f) and in flow cytometry on mouse samples (fig s1i). Cell Rep (2022) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; human; loading ...; fig 7a
Invitrogen Foxp3 antibody (eBioscience, 11-5773-82) was used in flow cytometry on human samples (fig 7a). Cell Rep (2022) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig s6a
Invitrogen Foxp3 antibody (eBioscience, 14-5773-82) was used in immunohistochemistry on mouse samples at 1:1000 (fig s6a). Nat Commun (2022) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3a, s4a
Invitrogen Foxp3 antibody (Invitrogen, 56-5773-82) was used in flow cytometry on mouse samples (fig 3a, s4a). Environ Health Perspect (2022) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 5e
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 5e). Int J Mol Sci (2022) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; 1:20; loading ...; fig 5a
Invitrogen Foxp3 antibody (Thermo Fisher, FJK-16s) was used in immunohistochemistry - paraffin section on mouse samples at 1:20 (fig 5a). Sci Rep (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s2a
Invitrogen Foxp3 antibody (Invitrogen, 45-5773-82) was used in flow cytometry on mouse samples (fig s2a). iScience (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen Foxp3 antibody (eBioscience, FJK-16S) was used in flow cytometry on mouse samples (fig 1b). Nat Commun (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...
Invitrogen Foxp3 antibody (Thermo Fisher Scientific, FJK-16s) was used in flow cytometry on mouse samples at 1:100. J Immunother Cancer (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 3d
Invitrogen Foxp3 antibody (eBioscience, 17-5773-82) was used in flow cytometry on mouse samples (fig 3d). Theranostics (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100
Invitrogen Foxp3 antibody (Thermo Fischer, 35-5773-80) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 1f
Invitrogen Foxp3 antibody (eBioscience, 17-5773-82) was used in flow cytometry on mouse samples (fig 1f). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...; fig 1j
Invitrogen Foxp3 antibody (eBioscience, 48-5773-80) was used in flow cytometry on mouse samples at 1:100 (fig 1j). Proc Natl Acad Sci U S A (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 5g
Invitrogen Foxp3 antibody (eBiosciences, 17-5773-82) was used in flow cytometry on mouse samples (fig 5g). J Immunother Cancer (2021) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 3d
Invitrogen Foxp3 antibody (eBioscience, 14-5773-82) was used in immunohistochemistry on mouse samples at 1:50 (fig 3d). Int J Mol Sci (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:40; loading ...; fig 3f
Invitrogen Foxp3 antibody (eBiosciences, FJK-16S) was used in flow cytometry on mouse samples at 1:40 (fig 3f). Nat Commun (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 4l
Invitrogen Foxp3 antibody (Invitrogen, 45-5773-82) was used in flow cytometry on mouse samples (fig 4l). Mol Cancer (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...; fig s3b
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples at 1:100 (fig s3b). Cancer Res (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...; fig 2e
Invitrogen Foxp3 antibody (eBioscience, 17-5773-82) was used in flow cytometry on mouse samples at 1:100 (fig 2e). elife (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:200; fig 2c
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples at 1:200 (fig 2c). Front Immunol (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen Foxp3 antibody (eBioscience, 17-5773-82) was used in flow cytometry on mouse samples (fig 1c). Cell Mol Gastroenterol Hepatol (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 2c
Invitrogen Foxp3 antibody (eBiosciences, 48-5773-82) was used in flow cytometry on mouse samples (fig 2c). Cell (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...
Invitrogen Foxp3 antibody (eBiosciences, FJK-16S) was used in flow cytometry on mouse samples . Front Immunol (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:50; loading ...; fig 7a
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples at 1:50 (fig 7a). Front Immunol (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 6e
Invitrogen Foxp3 antibody (eBioscience, 17-5773-82) was used in flow cytometry on mouse samples (fig 6e). Antioxidants (Basel) (2021) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry; mouse; loading ...
Invitrogen Foxp3 antibody (Thermo, 14-5773-37) was used in immunohistochemistry on mouse samples . Cell Rep (2021) ncbi
mouse monoclonal (3G3)
  • flow cytometry; mouse; loading ...; fig s1a, s4f
Invitrogen Foxp3 antibody (eBioscience, 3G3) was used in flow cytometry on mouse samples (fig s1a, s4f). J Immunother Cancer (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100
Invitrogen Foxp3 antibody (Thermo Fisher Scientific, 45-5773-82) was used in flow cytometry on mouse samples at 1:100. elife (2021) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - frozen section; mouse; 1:300; loading ...; fig s1e
Invitrogen Foxp3 antibody (eBioscience, 14577382) was used in immunohistochemistry - frozen section on mouse samples at 1:300 (fig s1e). J Neuroinflammation (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s7c
Invitrogen Foxp3 antibody (eBioscience, 12-5773-80) was used in flow cytometry on mouse samples (fig s7c). Sci Adv (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...
Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples . Aging Cell (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3c
Invitrogen Foxp3 antibody (eBioscience, 17-5773-80) was used in flow cytometry on mouse samples (fig 3c). Nat Commun (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:200; fig 5e
Invitrogen Foxp3 antibody (eBiosciences, 48-5773-82) was used in flow cytometry on mouse samples at 1:200 (fig 5e). Cancer Res (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s1b
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s1b). J Immunother Cancer (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:50; fig s17b
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples at 1:50 (fig s17b). Science (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...
Invitrogen Foxp3 antibody (eBiosciences, 11-5773-82) was used in flow cytometry on mouse samples at 1:100. Nature (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...
Invitrogen Foxp3 antibody (Invitrogen, 53-5773-82) was used in flow cytometry on mouse samples . J Clin Invest (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3d
Invitrogen Foxp3 antibody (eBiosciences, 17-5773-82) was used in flow cytometry on mouse samples (fig 3d). Biomedicines (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; horses; 1:10; loading ...; fig 1
Invitrogen Foxp3 antibody (Life Technologies, FJK-16s) was used in flow cytometry on horses samples at 1:10 (fig 1). Antioxidants (Basel) (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; horses; 1:10; loading ...; fig 1
Invitrogen Foxp3 antibody (Life Technologies, FJK-16s) was used in flow cytometry on horses samples at 1:10 (fig 1). Animals (Basel) (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; horses; 1:10; loading ...; fig 1
Invitrogen Foxp3 antibody (Life Technologies, FJK-16s) was used in flow cytometry on horses samples at 1:10 (fig 1). BMC Cancer (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; horses; 1:10; loading ...; fig 1
Invitrogen Foxp3 antibody (Life Technologies, FJK-16s) was used in flow cytometry on horses samples at 1:10 (fig 1). Antioxidants (Basel) (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...; fig s6-2
Invitrogen Foxp3 antibody (Invitrogen, FJK-16S) was used in flow cytometry on mouse samples at 1:100 (fig s6-2). elife (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...
Invitrogen Foxp3 antibody (Thermo Fisher, FJK-16S) was used in flow cytometry on mouse samples . Front Immunol (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 2b
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 2b). Mucosal Immunol (2021) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...
Invitrogen Foxp3 antibody (ThermoFisher, FJK-16s) was used in flow cytometry on mouse samples at 1:100. elife (2020) ncbi
rat monoclonal (FJK-16s)
Invitrogen Foxp3 antibody (eBiosciences, 12-5773-82) was used . Aging Cell (2020) ncbi
rat monoclonal (FJK-16s)
  • immunocytochemistry; mouse; loading ...; fig s1l
Invitrogen Foxp3 antibody (eBioscience, 17-5773-82) was used in immunocytochemistry on mouse samples (fig s1l). Cell (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen Foxp3 antibody (eBioscience/Thermo Fisher Scientific, FJK-16s) was used in flow cytometry on mouse samples (fig 4b). Sci Adv (2020) ncbi
rat monoclonal (NRRF-30)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen Foxp3 antibody (eBioscience, NRRF-30) was used in flow cytometry on mouse samples (fig 3b). BMC Immunol (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...; fig 9b
Invitrogen Foxp3 antibody (eBioscience, 12-5773-82) was used in flow cytometry on mouse samples at 1:100 (fig 9b). elife (2020) ncbi
rat monoclonal (FJK-16s)
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used . Nature (2020) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig 2d
  • flow cytometry; mouse; 1:100; loading ...; fig 2j
Invitrogen Foxp3 antibody (eBioscience, FJK-16S) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig 2d) and in flow cytometry on mouse samples at 1:100 (fig 2j). elife (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 5c, 5d
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 5c, 5d). BMC Biol (2020) ncbi
rat monoclonal (NRRF-30)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen Foxp3 antibody (eBioscience, NRRF-30) was used in flow cytometry on mouse samples (fig 1b). BMC Infect Dis (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:300; loading ...; fig s7c
Invitrogen Foxp3 antibody (Invitrogen, 12-5773-80) was used in flow cytometry on mouse samples at 1:300 (fig s7c). Cell Res (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...; fig 3
Invitrogen Foxp3 antibody (eBioscience, 17-5773-82) was used in flow cytometry on mouse samples at 1:100 (fig 3). Nat Commun (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...; fig 2s1
Invitrogen Foxp3 antibody (ThermoFisher, 58-5773-82) was used in flow cytometry on mouse samples at 1:100 (fig 2s1). elife (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:200; loading ...; fig 1s2a
Invitrogen Foxp3 antibody (eBioscience, 17-5773-82) was used in flow cytometry on mouse samples at 1:200 (fig 1s2a). elife (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 5c
Invitrogen Foxp3 antibody (eBioscience, 12-5773-82) was used in flow cytometry on mouse samples (fig 5c). Aging (Albany NY) (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 7
Invitrogen Foxp3 antibody (ThermoFisher Scientific, FJK-16s) was used in flow cytometry on mouse samples (fig 7). Am J Physiol Endocrinol Metab (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 6s1
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 6s1). elife (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; fig s15e
Invitrogen Foxp3 antibody (Thermo Fisher, 53-5773-80) was used in flow cytometry on mouse samples at 1:100 (fig s15e). Nat Commun (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s4a
Invitrogen Foxp3 antibody (Thermo Fisher, 53-5773-80) was used in flow cytometry on mouse samples (fig s4a). Cell (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1, 2, 3d
Invitrogen Foxp3 antibody (eBioscience, 14-5773-82) was used in flow cytometry on mouse samples (fig 1, 2, 3d). JCI Insight (2019) ncbi
rat monoclonal (NRRF-30)
  • mass cytometry; mouse; 6 ug/ml; loading ...; fig 5d
Invitrogen Foxp3 antibody (eBioscience, NRRF-30) was used in mass cytometry on mouse samples at 6 ug/ml (fig 5d). Science (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 7j
Invitrogen Foxp3 antibody (ThermoFisher, 17-5773-80) was used in flow cytometry on mouse samples (fig 7j). Cell Rep (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...; fig 4b
Invitrogen Foxp3 antibody (Thermo Fisher, FJK-16s) was used in flow cytometry on mouse samples at 1:100 (fig 4b). Cell Rep (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...; fig 5b
Invitrogen Foxp3 antibody (eBioscience, 12577382) was used in flow cytometry on mouse samples at 1:100 (fig 5b). Nat Commun (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 4c
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 4c). Nature (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig 1g
Invitrogen Foxp3 antibody (Thermo Fisher, PA1-46126) was used in immunohistochemistry - paraffin section on human samples (fig 1g). Cancer Med (2020) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Foxp3 antibody (eBioscience, 25577382) was used in flow cytometry on mouse samples (fig 2a). Cell Rep (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig e8b
Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples (fig e8b). Nature (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s3j
Invitrogen Foxp3 antibody (eBioscience, 12-5773-80) was used in flow cytometry on mouse samples (fig s3j). Nature (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3a
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 3a). Aging (Albany NY) (2019) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4h
Invitrogen Foxp3 antibody (Thermo Fisher, 14-5773-82) was used in immunohistochemistry - paraffin section on mouse samples (fig 4h). Cell (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s1d
Invitrogen Foxp3 antibody (eBioscience, 45-5773-82) was used in flow cytometry on mouse samples (fig s1d). Cell (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...; fig s5
Invitrogen Foxp3 antibody (eBioscience, 17-5773-82) was used in flow cytometry on mouse samples at 1:100 (fig s5). Science (2019) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2a
Invitrogen Foxp3 antibody (Thermo Fisher Scientific, FJK-16s) was used in immunohistochemistry - paraffin section on mouse samples (fig 2a). J Immunother Cancer (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:200; loading ...; fig 3c
Invitrogen Foxp3 antibody (Thermo Fischer, 25-5773-82) was used in flow cytometry on mouse samples at 1:200 (fig 3c). Nat Commun (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:250; loading ...; fig 3e, 3f, s6c, s6d
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples at 1:250 (fig 3e, 3f, s6c, s6d). Science (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:300; loading ...; fig 2f
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples at 1:300 (fig 2f). Nat Commun (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . Nature (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 6c
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 6c). Proc Natl Acad Sci U S A (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s7a
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s7a). Sci Adv (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 6d
Invitrogen Foxp3 antibody (eBioscience, 11-5773-82) was used in flow cytometry on mouse samples (fig 6d). Cell (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 2d, e5m
Invitrogen Foxp3 antibody (eBioscience, 12-5773-82) was used in flow cytometry on mouse samples (fig 2d, e5m). Nature (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s3b
Invitrogen Foxp3 antibody (Thermo Fisher, 48-5773-82) was used in flow cytometry on mouse samples (fig s3b). Cell (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 1b). J Clin Invest (2019) ncbi
rat monoclonal (NRRF-30)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig e5c
  • flow cytometry; mouse; loading ...; fig e5b
Invitrogen Foxp3 antibody (eBioscience, 14-4771-80) was used in immunohistochemistry - paraffin section on mouse samples (fig e5c) and in flow cytometry on mouse samples (fig e5b). Nature (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3h
Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples (fig 3h). J Exp Med (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 2c
Invitrogen Foxp3 antibody (Thermo Fisher Scientific, 56-5773-82) was used in flow cytometry on mouse samples (fig 2c). J Clin Invest (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...; fig 2e
Invitrogen Foxp3 antibody (Thermo Fisher Scientific, 12-5773-82) was used in flow cytometry on mouse samples at 1:100 (fig 2e). elife (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...; fig s3d
Invitrogen Foxp3 antibody (eBioscience, 45-5773-82) was used in flow cytometry on mouse samples at 1:100 (fig s3d). Cell (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Foxp3 antibody (eBioscience, 12-5773-80) was used in flow cytometry on mouse samples (fig 2a). Immunity (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig e1b, e1c, e1d
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig e1b, e1c, e1d). Nature (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 4c, 4d
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 4c, 4d). Front Immunol (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s2d
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s2d). Cell Rep (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3a
Invitrogen Foxp3 antibody (eBioscience, 48-5773-82) was used in flow cytometry on mouse samples (fig 3a). Nat Commun (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen Foxp3 antibody (eBioScience, 17577382) was used in flow cytometry on mouse samples (fig 4a). J Cyst Fibros (2019) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s3g
Invitrogen Foxp3 antibody (eBioscience, 14-5773-82) was used in immunohistochemistry - frozen section on mouse samples (fig s3g). Nat Commun (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3b, s5b
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 3b, s5b). JCI Insight (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3f
Invitrogen Foxp3 antibody (eBioscience, 17-5773-80) was used in flow cytometry on mouse samples (fig 3f). Cell Mol Gastroenterol Hepatol (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1a, 2c
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 1a, 2c). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig s1b
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig s1b). J Pathol (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s8a
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s8a). J Clin Invest (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s5a, s5b
Invitrogen Foxp3 antibody (Thermo Fisher, FJK-16) was used in flow cytometry on mouse samples (fig s5a, s5b). J Clin Invest (2019) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...; fig s4c
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples at 1:100 (fig s4c). Nat Commun (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s7d
Invitrogen Foxp3 antibody (eBioscience, 12-5773-80) was used in flow cytometry on mouse samples (fig s7d). Nat Commun (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s1a). Blood (2018) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 2e
Invitrogen Foxp3 antibody (eBioscience, 14-5773) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2e). Immunity (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:200; loading ...; fig s10a
Invitrogen Foxp3 antibody (eBioscience, FJK-163) was used in flow cytometry on mouse samples at 1:200 (fig s10a). J Clin Invest (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:200; loading ...; fig s10a
Invitrogen Foxp3 antibody (eBioscience, FJK-163) was used in flow cytometry on mouse samples at 1:200 (fig s10a). J Exp Med (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1f
  • western blot; mouse; loading ...; fig s4e
Invitrogen Foxp3 antibody (Thermo Fisher Scientific, 12-5773-82) was used in flow cytometry on mouse samples (fig 1f) and in western blot on mouse samples (fig s4e). Immunity (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 4c
Invitrogen Foxp3 antibody (Thermo Fisher Scientific, FJK-16) was used in flow cytometry on mouse samples (fig 4c). Eur J Immunol (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:300; loading ...; fig s12c
Invitrogen Foxp3 antibody (Thermo Fisher Scientific, 53-5773-82) was used in flow cytometry on mouse samples at 1:300 (fig s12c). Nat Commun (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 6e
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 6e). J Clin Invest (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen Foxp3 antibody (eBioscience, FJK-16) was used in flow cytometry on mouse samples (fig 4a). Int J Obes (Lond) (2018) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; fig 5c
Invitrogen Foxp3 antibody (eBioscience, 14-5773) was used in immunohistochemistry - paraffin section on mouse samples (fig 5c). J Clin Invest (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 4d
  • immunohistochemistry; mouse; loading ...; fig 7a
Invitrogen Foxp3 antibody (eBioscience, 17-5773-82) was used in flow cytometry on mouse samples (fig 4d) and in immunohistochemistry on mouse samples (fig 7a). J Clin Invest (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 1c). Front Immunol (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1g
Invitrogen Foxp3 antibody (eBioscience, FJK-16 s) was used in flow cytometry on mouse samples (fig 1g). Cell Rep (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s5a
Invitrogen Foxp3 antibody (eBioscience, FJK16s) was used in flow cytometry on mouse samples (fig s5a). Front Immunol (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 4f
Invitrogen Foxp3 antibody (eBioscience, 12-5773-82) was used in flow cytometry on mouse samples (fig 4f). Science (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1f
Invitrogen Foxp3 antibody (ebioscience, FJK-16S) was used in flow cytometry on mouse samples (fig 1f). Nat Commun (2018) ncbi
mouse monoclonal (150D/E4)
  • flow cytometry; mouse; loading ...; fig 5c
Invitrogen Foxp3 antibody (eBioscience, 150D/E4) was used in flow cytometry on mouse samples (fig 5c). Cell Metab (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3h
Invitrogen Foxp3 antibody (eBioscience, 12-5773-82) was used in flow cytometry on mouse samples (fig 3h). Science (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 8
Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples (fig 8). J Immunol (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 9c
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 9c). J Exp Med (2018) ncbi
mouse monoclonal (eBio7979 (221D/D3))
  • immunohistochemistry - paraffin section; human; loading ...; fig 5b
Invitrogen Foxp3 antibody (eBioscience, 14-7979) was used in immunohistochemistry - paraffin section on human samples (fig 5b). Int J Cancer (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 5a
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 5a). J Immunol (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s1a). J Exp Med (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 5f
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 5f). J Exp Med (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; human; 1:100; fig 1a
Invitrogen Foxp3 antibody (eBioscience, FJK-16S) was used in flow cytometry on human samples at 1:100 (fig 1a). Nat Commun (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s4e
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s4e). J Clin Invest (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3e
Invitrogen Foxp3 antibody (eBioscience, 115773) was used in flow cytometry on mouse samples (fig 3e). Br J Pharmacol (2018) ncbi
domestic rabbit recombinant (5H10L18)
  • western blot; human; 1:1000; loading ...; fig 4b
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 5a
  • western blot; mouse; 1:1000; loading ...; fig 5c
Invitrogen Foxp3 antibody (Thermo Scientific, 700914) was used in western blot on human samples at 1:1000 (fig 4b), in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 5a) and in western blot on mouse samples at 1:1000 (fig 5c). Br J Pharmacol (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 2a). J Immunol (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Foxp3 antibody (eBioscience, FJK-16S) was used in flow cytometry on mouse samples (fig 2a). EMBO J (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:200; loading ...; fig 5b
Invitrogen Foxp3 antibody (eBioscience, FJK-16S) was used in flow cytometry on mouse samples at 1:200 (fig 5b). Infect Immun (2018) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5
Invitrogen Foxp3 antibody (eBiosciences, 14-5773-82) was used in immunohistochemistry - paraffin section on mouse samples (fig 5). PLoS ONE (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 3b). J Immunol (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2018) ncbi
rat monoclonal (NRRF-30)
  • flow cytometry; mouse; loading ...; fig 1a
In order to study the role of hypercholesterolemia in T cell receptor signaling and regulatory T cell population, Invitrogen Foxp3 antibody (eBioscience, NRRF-30) was used in flow cytometry on mouse samples (fig 1a). Sci Rep (2017) ncbi
mouse monoclonal (eBio7979 (221D/D3))
  • western blot; mouse; loading ...; fig 1d
In order to study the role of hypercholesterolemia in T cell receptor signaling and regulatory T cell population, Invitrogen Foxp3 antibody (eBioscience, eBio7979) was used in western blot on mouse samples (fig 1d). Sci Rep (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1a
In order to study the role of hypercholesterolemia in T cell receptor signaling and regulatory T cell population, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 1a). Sci Rep (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s2a
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s2a). Cancer Res (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s2a
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s2a). J Clin Invest (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 4b
  • immunohistochemistry; mouse; loading ...; fig 4f
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 4b) and in immunohistochemistry on mouse samples (fig 4f). Nature (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen Foxp3 antibody (ebioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s1a). Nat Commun (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; rat; loading ...; fig s7
In order to visualize calcium signaling in encephalitogenic T cells through two-photon microscopy, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on rat samples (fig s7). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 4a
In order to evaluate mouse models of hepacivirus infection, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 4a). Science (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3a
In order to study the involvement of the Ox40/Ox40 ligand pathway in systemic lupus erythematosus, Invitrogen Foxp3 antibody (eBioscience, 17-5773) was used in flow cytometry on mouse samples (fig 3a). J Immunol (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 6d
In order to study the regulatory mechanism for the sex-dependent stroke mortality, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 6d). Cell Immunol (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s1a). Eur J Immunol (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; human; loading ...; fig 2d
  • flow cytometry; mouse; loading ...; fig 2d
In order to study the effect of human induced pluripotent stem cells-derived mesenchymal stem cells on T cell phenotype after xenotransplantation, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on human samples (fig 2d) and in flow cytometry on mouse samples (fig 2d). Stem Cells (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s2a
In order to investigate the role of endothelial TLR4 and the microbiome in cerebral cavernous malformations, Invitrogen Foxp3 antibody (eBioscience, 50-5773-82) was used in flow cytometry on mouse samples (fig s2a). Nature (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1g
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 1g). J Allergy Clin Immunol (2018) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 7b
Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples (fig 7b). J Exp Med (2017) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1c
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunohistochemistry - frozen section on mouse samples (fig 1c) and in flow cytometry on mouse samples (fig 2d). Immunology (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 2a). Immunology (2017) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5i
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunohistochemistry - paraffin section on mouse samples (fig 5i). Cell Metab (2017) ncbi
mouse monoclonal (150D/E4)
  • chromatin immunoprecipitation; mouse; fig 2b
Invitrogen Foxp3 antibody (eBioscience, 14-4774-82) was used in chromatin immunoprecipitation on mouse samples (fig 2b). Cell Metab (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s7d
In order to investigate the involvement of thymic antigen-presenting cells in the epigenetic imprinting of alloantigen-specific regulatory T cells, Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples (fig s7d). Oncotarget (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3c
Invitrogen Foxp3 antibody (eBiosciences, FJK-16S) was used in flow cytometry on mouse samples (fig 3c). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (150D/E4)
  • western blot; human; fig 2g
In order to examine the effect of glucose-6-phosphate transporter mutation on immune cell homeostasis and CD4+ T cell functions, Invitrogen Foxp3 antibody (eBioscience, 150D/E4) was used in western blot on human samples (fig 2g). J Immunol (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s1h
In order to assess the contribution of viral infection to the development of celiac disease, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s1h). Science (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s5d
In order to study intestinal immune responses during acute graft-versus-host disease, Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples (fig s5d). J Clin Invest (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...; fig 6i
In order to test if oncolytic poxvirus treatment improves anti-PD-L1 immunotherapy, Invitrogen Foxp3 antibody (eBioscience, 17-5773-82) was used in flow cytometry on mouse samples at 1:100 (fig 6i). Nat Commun (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 1e
In order to study the role of moesin during the generation of TGF-beta-induced T regulatory cells, Invitrogen Foxp3 antibody (eBioscience, FJK-16) was used in flow cytometry on mouse samples (fig 1e). J Clin Invest (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1b
In order to study anti-cancer immunity after Treg depletion in mice., Invitrogen Foxp3 antibody (ebioscience, 11?\5773?\82) was used in flow cytometry on mouse samples (fig 1b). Immun Inflamm Dis (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 6e
In order to study the therapeutic TnP peptide in inflammation and demyelination in a mouse model of multiple sclerosis., Invitrogen Foxp3 antibody (eBioscience, 45-5773-82) was used in flow cytometry on mouse samples (fig 6e). PLoS ONE (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1,3
In order to elucidate the interaction between tumor-associated and -infiltrating lymphocytes in ovarian cancer, Invitrogen Foxp3 antibody (eBioscience, 12-5773-82) was used in flow cytometry on mouse samples (fig 1,3). Oncoimmunology (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...; fig 3g
In order to evaluate the use of a recombinant Newcastle disease virus expressing ICOS ligand to treat cancer, Invitrogen Foxp3 antibody (eBioscience, 56-5773) was used in flow cytometry on mouse samples at 1:100 (fig 3g). Nat Commun (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 4h
In order to determine the contribution of B cell to obesity-induced insulin resistance, Invitrogen Foxp3 antibody (eBiosciences, 11-5773-82) was used in flow cytometry on mouse samples (fig 4h). J Clin Invest (2017) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; 1:800; loading ...; fig st7
  • immunohistochemistry - paraffin section; rat; 1:800; loading ...; fig st7
In order to outline the protocols for antibodies used for immunohistochemical studies, Invitrogen Foxp3 antibody (eBioscience, 14-5773) was used in immunohistochemistry - paraffin section on mouse samples at 1:800 (fig st7) and in immunohistochemistry - paraffin section on rat samples at 1:800 (fig st7). J Toxicol Pathol (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 2b
In order to test the effect of paeoniflorin in experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis, Invitrogen Foxp3 antibody (eBioscience, 17-5773) was used in flow cytometry on mouse samples (fig 2b). Sci Rep (2017) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 6a
  • flow cytometry; mouse
In order to show a role for Hippo signaling in the epicardium in recruiting T regulatory cells post infarct, Invitrogen Foxp3 antibody (Ebioscience, 14-5773-82) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 6a) and in flow cytometry on mouse samples . J Clin Invest (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Foxp3 antibody (eBioscience, FJK-16S) was used in flow cytometry on mouse samples (fig 1a). Blood (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 4c
In order to assess the use of anti-CCR4 antibody in a mouse model of renal cell carcinoma, Invitrogen Foxp3 antibody (eBioscience, 56-5773) was used in flow cytometry on mouse samples (fig 4c). J Clin Invest (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1g
In order to assess the effects of dietary fiber and short chain fatty acids on the intestinal immune system and microbiota, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 1g). J Immunol (2017) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4f
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunohistochemistry - paraffin section on mouse samples (fig 4f). J Dermatol Sci (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1k
In order to explore the role of PKCalpha-DOCK8-Cdc42 signaling in T cell migration, Invitrogen Foxp3 antibody (eBioscience, FJK-16S) was used in flow cytometry on mouse samples (fig 1k). J Exp Med (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; rat; loading ...; fig 1f
Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on rat samples (fig 1f). Eur J Immunol (2017) ncbi
rat monoclonal (FJK-16s)
  • western blot; mouse; loading ...; fig 5d
In order to assess the role of p38 signaling in limiting regulatory T cell induction, Invitrogen Foxp3 antibody (eBioscience, 14-5773) was used in western blot on mouse samples (fig 5d). J Biol Chem (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; loading ...; fig 5l
In order to explore the role of Axl in promoting a suppressive myeloid microenvironment in response to ionizing radiation therapy in combination with checkpoint immunotherapy, Invitrogen Foxp3 antibody (eBiosciences, 61-5773) was used in flow cytometry on mouse samples at 1:100 (fig 5l). Nat Commun (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s2a
In order to elucidate how P2X7 regulates the contraction of intestinal CD4 positive effector T cells, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s2a). Mucosal Immunol (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 6a
Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples (fig 6a). Sci Rep (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3f
Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples (fig 3f). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 2c
In order to find that Tritrichomonas muris contributes to T cell-driven colitis, Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples (fig 2c). J Exp Med (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 4d
In order to explore how apoptotic intestinal epithelial cells are processed and sampled, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 4d). Nature (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 6a
In order to study CD153+ PD-1+ CD44hi CD4+ T cells in the visceral adipose tissue of high fat diet-fed obese mice, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 6a). J Clin Invest (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...
In order to study the role of TMEM16F in limiting T cell responses in mice infected with virus, Invitrogen Foxp3 antibody (eBioscience, 12-5773-82) was used in flow cytometry on mouse samples . J Exp Med (2016) ncbi
mouse monoclonal (150D/E4)
  • flow cytometry; mouse; loading ...
In order to study the role of MCH I in natural killer cell tolerance and hyporesponsiveness, Invitrogen Foxp3 antibody (eBioscience, 150D/E4) was used in flow cytometry on mouse samples . J Immunol (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s5a
In order to characterize systemic antimicrobial CD4 positive T cell reactivity, Invitrogen Foxp3 antibody (eBioscience, FJK 16s) was used in flow cytometry on mouse samples (fig s5a). Immunology (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s2e
In order to identify and characterize a Nei endonuclease VIII-like 3 mutation in three siblings from a consanguineous family with autoimmunity, Invitrogen Foxp3 antibody (eBioscience, FKJ.16s) was used in flow cytometry on mouse samples (fig s2e). J Clin Invest (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen Foxp3 antibody (eBiosciences, 17-5773-80) was used in flow cytometry on mouse samples (fig s1a). Nat Immunol (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 2c
In order to study T cell migration in inflammatory demyelinating lesions confined to optic nerves and spinal cord, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 2c). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3d
In order to explore signaling pathways regulated by RLTPR in T and B cells, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 3d). J Exp Med (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 6a
In order to investigate allergic responses to food allergens in WASP-deficient animals, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 6a). J Clin Invest (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1a
In order to discuss how Th1-driven inflammation affects Treg homeostasis in atherosclerosis, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 1a). Circ Res (2016) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 11C
  • flow cytometry; mouse; loading ...; fig 12
In order to study the effect of IL-10 signaling in infectious neurological diseases, Invitrogen Foxp3 antibody (eBioscience, 14-5773) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 11C) and in flow cytometry on mouse samples (fig 12). PLoS ONE (2016) ncbi
mouse monoclonal (eBio7979 (221D/D3))
  • western blot; human; loading ...; fig 1a
In order to show reverse post-translational regulation of HIF-1alpha by Foxp3, Invitrogen Foxp3 antibody (eBioscience, eBio7979) was used in western blot on human samples (fig 1a). Oncotarget (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples (fig 2a). J Exp Med (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3c
In order to determine the contribution of lymphatic drainage to tumor inflammation and immunity, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 3c). J Clin Invest (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3e
In order to report that MARCH 8 controls surface expression of major histocompatibility complex class II on thymic epithelial cells, Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples (fig 3e). J Exp Med (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; human; 1:100; fig 1
  • flow cytometry; mouse; 1:100; fig 1
Invitrogen Foxp3 antibody (eBiosciences, 58-5773-82) was used in flow cytometry on human samples at 1:100 (fig 1) and in flow cytometry on mouse samples at 1:100 (fig 1). Nat Commun (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 2
In order to test if a diet high in fats affects the development of respiratory tolerance, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 2). PLoS ONE (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 2a
In order to assess how ABCG1 loss in T cells affects atherosclerosis, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 2a). J Clin Invest (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s7
In order to report that poly-N-acetylglucosamine production by Staphylococcus epidermidis biofilms exacerbates disease, Invitrogen Foxp3 antibody (eBioscience, FJK-16S) was used in flow cytometry on mouse samples (fig s7). Infect Immun (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig s3
In order to investigate osmostress-dependent and -independent functions of Nfat5 in T cells, Invitrogen Foxp3 antibody (eBiosciences, 12-5773-80) was used in flow cytometry on mouse samples (fig s3). Immunol Cell Biol (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 3a
In order to explore the contribution of IL-33 in a model of rheumatoid arthritis, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 3a). J Immunol (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 5
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 5). Clin Cancer Res (2017) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 4
In order to report that vaccine-induced T regulatory cells aid to control de novo primed autoreactive effector CD8(+) T cells in a diabetes model, Invitrogen Foxp3 antibody (eBioscience, 12-5773) was used in flow cytometry on mouse samples (fig 4). Sci Rep (2016) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig s4c
In order to investigate the stromal contribution to the microenvironment of tumor-draining lymph nodes, Invitrogen Foxp3 antibody (eBioscience, 13-5773) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig s4c). Nat Immunol (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:200; fig 1
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, Invitrogen Foxp3 antibody (eBioscience, 17-5773-82) was used in flow cytometry on mouse samples at 1:200 (fig 1). Nat Immunol (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; fig st1
Invitrogen Foxp3 antibody (eBioscience, 25-5773) was used in flow cytometry on mouse samples at 1:100 (fig st1). Nat Commun (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig s6
In order to analyze inhibition of IL-17-mediated colon inflammation and tumorigenesis by ROR-gamma-t ubiquitination by Itch, Invitrogen Foxp3 antibody (eBioscience, 12-5773-80A) was used in flow cytometry on mouse samples (fig s6). Nat Immunol (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 2
Invitrogen Foxp3 antibody (eBioscience, 12-5773) was used in flow cytometry on mouse samples (fig 2). Mol Med Rep (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 4
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 4). J Clin Invest (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 2e
Invitrogen Foxp3 antibody (eBiosciences, FJK-16-s) was used in flow cytometry on mouse samples (fig 2e). Sci Rep (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s1
In order to show that ATG16L1 and NOD2 are required for Bacteroides fragilis-mediated protection from colitis, Invitrogen Foxp3 antibody (eBioscience, FJK- 16s) was used in flow cytometry on mouse samples (fig s1). Science (2016) ncbi
rat monoclonal (NRRF-30)
  • flow cytometry; mouse; fig 1
In order to analyze the induction of immune-mediated survival advantage in murine intracranial glioma by agonist anti-GITR monoclonal antibody and stereotactic radation, Invitrogen Foxp3 antibody (eBioscience, 12477182) was used in flow cytometry on mouse samples (fig 1). J Immunother Cancer (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig s8
Invitrogen Foxp3 antibody (eBioscience, FJK16s) was used in flow cytometry on mouse samples (fig s8). Sci Rep (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; dogs; 1:20; fig 2
Invitrogen Foxp3 antibody (eBioscience, 12?C5773) was used in flow cytometry on dogs samples at 1:20 (fig 2). PLoS ONE (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 1f
Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples (fig 1f). Eur J Immunol (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig s2
In order to describe a role for Nbn in skin homeostasis, Invitrogen Foxp3 antibody (eBiosciences, 17-5773-82) was used in flow cytometry on mouse samples (fig s2). Oncotarget (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; fig s5
Invitrogen Foxp3 antibody (eBioscience, 12-5773-82) was used in flow cytometry on mouse samples at 1:100 (fig s5). Nat Commun (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:50; loading ...; fig 4b
In order to study the virological features of entovirus 71 and host responses resulting from infection, Invitrogen Foxp3 antibody (eBioscience, 12-5773) was used in flow cytometry on mouse samples at 1:50 (fig 4b). Mol Med Rep (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig s1
In order to characterize promotion of an effective anti-tumor immune response by enhancing the production of type 1 interferons by 2'-5' oligoadenylate synthetase-like 1 (OASL1) deficiency in mice, Invitrogen Foxp3 antibody (eBioscience, FJK-16S) was used in flow cytometry on mouse samples (fig s1). Cancer Immunol Immunother (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig s4h
In order to determine the effects of an altered intestinal microbiota and microbial metabolites on graft-versus-host disease, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s4h). Nat Immunol (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig s5c
In order to report that the maternal microbiota shapes the offspring's immune system, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s5c). Science (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 1
Invitrogen Foxp3 antibody (e-Bioscience, 35-5773) was used in flow cytometry on mouse samples (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (150D/E4)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to analyze differentially expressed granzyme inhibitors in pediatric primitive neuroectodermal tumors of the central nervous system, Invitrogen Foxp3 antibody (Ebioscience, 150D/E4) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). PLoS ONE (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 2
In order to establish that autophagy is essential for maintenance of a balanced CD4 positive intestinal T cell response, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 2). elife (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 1
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 1). J Exp Med (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; rat; fig 5
Invitrogen Foxp3 antibody (eBioscience, 11-5773) was used in flow cytometry on rat samples (fig 5). Exp Ther Med (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 4g
In order to ask if T-bet regulates other T regulatory cell functions after entering the inflammatory site, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 4g). J Immunol (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 7a
In order to show that Bhlhe40 expression marks encephalitogenic T helper cells and that the PTX-IL-1-Bhlhe40 pathway is active in mice with experimental autoimmune encephalomyelitis, Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples (fig 7a). J Exp Med (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; fig 1
Invitrogen Foxp3 antibody (eBioscience, FJK-16 s) was used in flow cytometry on mouse samples at 1:100 (fig 1). Nat Commun (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 3
  • immunocytochemistry; mouse; 1:150
In order to examine the contribution of Foxo1 to activated T cells, Invitrogen Foxp3 antibody (eBiocience, FJK-16 s) was used in flow cytometry on mouse samples (fig 3) and in immunocytochemistry on mouse samples at 1:150. Nature (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 3
In order to examine the effect of 4-methylumbelliferone treatment on experimental autoimmune encephalomyelitis, Invitrogen Foxp3 antibody (eBioscience, FJK.16a) was used in flow cytometry on mouse samples (fig 3). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 4, 5
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 4, 5). PLoS Pathog (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 7
Invitrogen Foxp3 antibody (eBioscience, 48-5773-82) was used in flow cytometry on mouse samples (fig 7). Eur J Immunol (2016) ncbi
rat monoclonal (FJK-16s)
  • immunocytochemistry; mouse; fig 2
In order to investigate how Tregs are maintained in adipose tissue, Invitrogen Foxp3 antibody (eBioscience, FJK-16) was used in immunocytochemistry on mouse samples (fig 2). Sci Rep (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig s4
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s4). Theranostics (2015) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse
In order to study hepatocellular carcinoma and ectopic lymphoid structures function as microniches for tumor progenitor cells, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunohistochemistry - paraffin section on mouse samples . Nat Immunol (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 4
Invitrogen Foxp3 antibody (eBioscience, 25-5773-82) was used in flow cytometry on mouse samples (fig 4). Aging Cell (2016) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 6
Invitrogen Foxp3 antibody (eBioscience, 56-5773-80) was used in flow cytometry on mouse samples (fig 6). Oncotarget (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to explore the impact of chronic antigenic stimulation on CD4(+) T cell dynamics, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100; fig 3
Invitrogen Foxp3 antibody (eBioscience, 48-5773-82) was used in flow cytometry on mouse samples at 1:100 (fig 3). Nat Commun (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 3
  • immunohistochemistry; mouse; fig 6c
Invitrogen Foxp3 antibody (eBioscience, FJK-16a) was used in flow cytometry on mouse samples (fig 3) and in immunohistochemistry on mouse samples (fig 6c). J Inflamm (Lond) (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:200; fig 1
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples at 1:200 (fig 1). Nat Commun (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 3
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 3). J Immunol (2015) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; bovine; 1:100; loading ...; fig 1h
In order to report the effect of pre-infection with bovine viral diarrhea virus on thymic immune cells from calves challenged with bovine herpesvirus 1, Invitrogen Foxp3 antibody (eBiosciences, FJK-16) was used in immunohistochemistry - paraffin section on bovine samples at 1:100 (fig 1h). Transbound Emerg Dis (2017) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry; mouse; 1:20; fig 2
In order to study how mitigation of Alzheimer's disease pathology occurs by breaking immune tolerance by targeting Foxp3(+) regulatory T cells, Invitrogen Foxp3 antibody (eBioscience, 13-5773-80) was used in immunohistochemistry on mouse samples at 1:20 (fig 2). Nat Commun (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 4b). Cancer Res (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to investigate the induction and role of Tregs during the early pre-patent larval stage of infection with Schistosoma mansoni, Invitrogen Foxp3 antibody (eBioscience, FJK-16S) was used in flow cytometry on mouse samples . Infect Immun (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 1
Invitrogen Foxp3 antibody (eBioscience, JFK 16s) was used in flow cytometry on mouse samples (fig 1). Immunity (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 2
Invitrogen Foxp3 antibody (eBioscience, 12-5773) was used in flow cytometry on mouse samples (fig 2). Int J Obes (Lond) (2015) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; human; fig s8
In order to describe the use of CCR9 expression to create primary gastrointestinal tumors in immunodeficient mice by tail-vein injection, Invitrogen Foxp3 antibody (ebiosciences, fjk-16s) was used in immunohistochemistry - paraffin section on human samples (fig s8). Nat Biotechnol (2015) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry; mouse; 1:250; fig 4d
In order to determine the immune profile of a murine ovarian cancer model., Invitrogen Foxp3 antibody (eBioscience, 14-5773) was used in immunohistochemistry on mouse samples at 1:250 (fig 4d). J Immunother Cancer (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 5
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 5). PLoS ONE (2015) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry; human; 1:200
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunohistochemistry on human samples at 1:200. Cancer Immunol Res (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 5
Invitrogen Foxp3 antibody (eBioscience, 17-5773) was used in flow cytometry on mouse samples (fig 5). EMBO Mol Med (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; loading ...; fig 6b
  • immunohistochemistry; mouse; loading ...; fig 3b
In order to determine if specific B cell subsets or if B cell-derived interleukin-10 contributes to tolerance, Invitrogen Foxp3 antibody (eBioscience, FKJ-16s) was used in flow cytometry on mouse samples (fig 6b) and in immunohistochemistry on mouse samples (fig 3b). Transplantation (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 8
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 8). PLoS ONE (2015) ncbi
mouse monoclonal (150D/E4)
  • flow cytometry; mouse; fig 3
Invitrogen Foxp3 antibody (eBioscience, 150D/E4) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig s4
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s4). PLoS Pathog (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:400; fig s7
Invitrogen Foxp3 antibody (eBioscience, 48-5773-82) was used in flow cytometry on mouse samples at 1:400 (fig s7). Nat Commun (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16S) was used in flow cytometry on mouse samples . Nat Immunol (2015) ncbi
mouse monoclonal (eBio7979 (221D/D3))
  • western blot; mouse; 1:500; fig 5,6
Invitrogen Foxp3 antibody (eBioscience, eBio7979) was used in western blot on mouse samples at 1:500 (fig 5,6). Nat Commun (2015) ncbi
rat monoclonal (FJK-16s)
  • western blot; mouse; 1:100; fig 5,6
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in western blot on mouse samples at 1:100 (fig 5,6). Nat Commun (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 1
In order to elucidate the mechanisms by which RANKL promotes bone formation and erosion, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 1). J Bone Miner Res (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 2
Invitrogen Foxp3 antibody (eBioscience, 17-5773-82) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . Eur J Immunol (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . Cancer Immunol Res (2015) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; fig s5
In order to study the contribution of SEMA4D-PLXNB1 interactions to immune-cell trafficking in the tumor microenvironment, Invitrogen Foxp3 antibody (ebioscince, FJK-16s) was used in immunohistochemistry - paraffin section on mouse samples (fig s5). Cancer Immunol Res (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 6
In order to report that GP96 is required for T regulatory cell maintenance and function, Invitrogen Foxp3 antibody (eBioscience, FJK-16) was used in flow cytometry on mouse samples (fig 6). J Clin Invest (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig s2
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s2). PLoS Pathog (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK -16s) was used in flow cytometry on mouse samples . Sci Rep (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; human; fig 5
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on human samples (fig 5). Cell Res (2015) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 2
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2) and in flow cytometry on mouse samples . Immunology (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; tbl 1
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (tbl 1). J Neuroinflammation (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig s5
In order to show that the PTEN-mTORC2 axis maintains T regulatory cell stability and coordinates their control of effector responses, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s5). Nat Immunol (2015) ncbi
mouse monoclonal (150D/E4)
  • flow cytometry; rat; fig 1
Invitrogen Foxp3 antibody (eBiosciences, 150D/E4) was used in flow cytometry on rat samples (fig 1). Mol Vis (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 2
Invitrogen Foxp3 antibody (eBioscience, FJK-16S) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - frozen section; mouse
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunohistochemistry - frozen section on mouse samples and in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples . J Am Heart Assoc (2014) ncbi
rat monoclonal (FJK-16s)
  • immunocytochemistry; human
  • flow cytometry; pigs
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunocytochemistry on human samples and in flow cytometry on pigs samples . Dev Comp Immunol (2015) ncbi
mouse monoclonal (eBio7979 (221D/D3))
  • western blot; mouse
In order to identify DUBA as a suppressor of IL-17 production in T cells, Invitrogen Foxp3 antibody (eBiosciences, eBio7979) was used in western blot on mouse samples . Nature (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to identify DUBA as a suppressor of IL-17 production in T cells, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . Nature (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; pigs
In order to summarize the current knowledge on porcine alphabeta T cells, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on pigs samples . Mol Immunol (2015) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry; mouse; 1:25
In order to investigate the role of Tregs in nerve injury-induced pain hypersensitivity, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunohistochemistry on mouse samples at 1:25. Cytokine (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 4
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 4). J Heart Lung Transplant (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . J Clin Invest (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 2
In order to analyze induction of murine cardiac allograft survival and regulatory T cells from treadmill exercise, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 2). Transpl Int (2015) ncbi
rat monoclonal (FJK-16s)
  • immunocytochemistry; mouse
In order to examine the role of the immunological synapse in T cell activation, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunocytochemistry on mouse samples . Immunol Cell Biol (2015) ncbi
rat monoclonal (NRRF-30)
  • immunohistochemistry - frozen section; mouse; 1:100
  • flow cytometry; mouse; 1:40
Invitrogen Foxp3 antibody (eBioscience, NRRF-30) was used in immunohistochemistry - frozen section on mouse samples at 1:100 and in flow cytometry on mouse samples at 1:40. PLoS ONE (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 7
  • immunohistochemistry; mouse; fig 7
In order to assess IL-25 and IL-23 and reciprocal regulation of lymphoid tissue development in the large intestine, Invitrogen Foxp3 antibody (Ebioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 7) and in immunohistochemistry on mouse samples (fig 7). Mucosal Immunol (2015) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100
Invitrogen Foxp3 antibody (eBioscience, FJK-16S) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2014) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - frozen section; mouse; fig 3
  • flow cytometry; mouse; fig 5
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunohistochemistry - frozen section on mouse samples (fig 3) and in flow cytometry on mouse samples (fig 5). Am J Pathol (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to study the role of CD93 molecule in mature dendritic cells and T cells, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . Immunobiology (2015) ncbi
rat monoclonal (FJK-16s)
  • western blot; mouse
Invitrogen Foxp3 antibody (eBioscience, 85-17-5773-80) was used in western blot on mouse samples . J Mol Cell Cardiol (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to investigate the role of T reg cells in exhaustion of lymphocytic choriomeningitis virus-specific CD8 T cells, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 4
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK- 16s) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; human
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16 s) was used in flow cytometry on mouse samples . Nanomedicine (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to study Bacillus Calmette-Guerin DeltaureC::hly and the superior protection against tuberculosis caused by central memory CD4+ T cells, Invitrogen Foxp3 antibody (eBioscience, FJL-16s) was used in flow cytometry on mouse samples . J Infect Dis (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . Cancer Res (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . Cancer Immunol Res (2014) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; fig 4
Invitrogen Foxp3 antibody (eBioscience, FJK-16) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). PLoS ONE (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to determine if HSPs ameliorate ischemic renal injury in vivo using HSF-1 KO mice, Invitrogen Foxp3 antibody (Ebioscience, 11-5773-82) was used in flow cytometry on mouse samples . Kidney Int (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to investigate the role of thoracic thymus in T cell development and homeostasis, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, 17-5773-82) was used in flow cytometry on mouse samples . Ann Neurol (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to demonstrate that CTLA-4 promotes Tc17 differentiation and robust Tc17 responses, Invitrogen Foxp3 antibody (eBioscience, FJK-16S9) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry; dogs; 1:400
In order to compare two treatment regiments for idiopathic inflammatory bowel disease, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunohistochemistry on dogs samples at 1:400. PLoS ONE (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 4
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; 1:100
In order to study the involvement of endothelium in efficient Treg T cell recruitment in vivo, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2014) ncbi
mouse monoclonal (eBio7979 (221D/D3))
  • immunohistochemistry - paraffin section; domestic sheep; 1:250
In order to test if detrimental inflammatory response of the fetal gut results from local or systemic inflammatory responses, Invitrogen Foxp3 antibody (eBioscience, 14-7979-82) was used in immunohistochemistry - paraffin section on domestic sheep samples at 1:250. Am J Physiol Gastrointest Liver Physiol (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to characterize the Treg populations the Friend retrovirus mouse model, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . Virol Sin (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . Immunology (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . J Invest Dermatol (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to characterize tumor-associated macrophages isolated from gastrointestinal stromal tumors, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . J Exp Med (2013) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (ebioscience, FJK-16s) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 3
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2013) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig s2
In order to use a mouse model to examine the link between the microbiota and atopic dermatitis, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s2). J Invest Dermatol (2013) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig s3
In order to determine the contribution of Arg1 to lung inflammation and pathophysiology, Invitrogen Foxp3 antibody (eBioscience, FJK-16S) was used in flow cytometry on mouse samples (fig s3). PLoS ONE (2013) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to review the role of S1P lyase in T cell-mediated disease, Invitrogen Foxp3 antibody (ebioscience, FJK-16s) was used in flow cytometry on mouse samples . PLoS ONE (2013) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 6
In order to identify factors that promote the development of Foxp3(+) T regulatory cells during helminth infections, Invitrogen Foxp3 antibody (ebioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 6). Eur J Immunol (2013) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig s4
In order to compare two dendritic cell modification strategies to inhibit allogeneic T-cell proliferation, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig s4). Eur J Immunol (2013) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry; mouse; fig 6
In order to use neuropilin 1 expression to distinguish n from i T regulatory cells in mouse models of spontaneous autoimmune encephalomyelitis and lung inflammation, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunohistochemistry on mouse samples (fig 6). J Exp Med (2012) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 7
In order to study the influence of TCR signaling to negative selection and regulatory T cell development, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 7). J Exp Med (2012) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to examine the effects of Inchingorei-san treatment on the alloimmune responses in a murine model of cardiac allograft transplantation, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . Evid Based Complement Alternat Med (2012) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to determine how thermal processing influences ovalbumin's ability to induce allergic symptoms and immune responses in mouse model of food allergy, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . PLoS ONE (2012) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 6
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 6). PLoS ONE (2012) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 2
In order to assess the effect of sounds on alloimmune responses in a murine model of cardiac allograft transplantation, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 2). J Cardiothorac Surg (2012) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to study the contribution of IL-10 in mice infected with respiratory syncytial virus, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . PLoS ONE (2012) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to report the effect of T regulatory cell depletion during acute respiratory syncytial virus infection, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . Mucosal Immunol (2012) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . J Immunol (2011) ncbi
mouse monoclonal (eBio7979 (221D/D3))
  • immunohistochemistry - paraffin section; human; 1:50; tbl 2
In order to identify biomarkers to distinguish between true recurrence and new primary cases of ipsilateral breast tumor recurrence, Invitrogen Foxp3 antibody (eBioscience, eBio7979) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 2). Breast Cancer (Auckl) (2011) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to determine the origin of tumor macrophages, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . Nature (2011) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - frozen section; mouse; fig 1
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunohistochemistry - frozen section on mouse samples (fig 1). PLoS ONE (2011) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 1
In order to identify signaling pathways that regulate thymic selection of un-manipulated polyclonal natural CD25(+)foxp3(+) regulatory T cells, Invitrogen Foxp3 antibody (eBioscience, FJK16s) was used in flow cytometry on mouse samples (fig 1). PLoS ONE (2011) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - frozen section; mouse; fig 1
In order to study Th17 cells in glia-derived tumors of the central nervous system, Invitrogen Foxp3 antibody (Ebioscience, FJK-16S) was used in immunohistochemistry - frozen section on mouse samples (fig 1). PLoS ONE (2010) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 5, 6
In order to report that NAD(+) regulates the survival, phenotype, and function of T regulatory cells via the ART2-P2X7 pathway, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 5, 6). J Exp Med (2010) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to examine how maternal immune stimulation affects the adaptive immune system and pathobiology of the offspring, Invitrogen Foxp3 antibody (eBioscience, clone FJK16s) was used in flow cytometry on mouse samples . Brain Behav Immun (2011) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 2
In order to report sex-dependent, B7-H1-dependent differences in tumor immunity, Invitrogen Foxp3 antibody (eBioscience, FJK-16a) was used in flow cytometry on mouse samples (fig 2). J Immunol (2010) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 2
In order to characterize T cells and arthritis using +/+, skg/+, skg/skg, and skg/- mice, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 2). J Immunol (2010) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 1
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 1). Blood (2010) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to study the influence of Treg on pathogen-specific CD8+ T-cell responses in vivo, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . Blood (2009) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; human; fig 1
In order to examine the therapeutic potential of anti-CD137 mAb in lymphoma, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on human samples (fig 1). Blood (2009) ncbi
mouse monoclonal (eBio7979 (221D/D3))
  • western blot; mouse; 2 ug/ml; fig 7
Invitrogen Foxp3 antibody (eBioscience, eBio7979) was used in western blot on mouse samples at 2 ug/ml (fig 7). J Immunol (2009) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 6
  • flow cytometry; mouse; fig 5
Invitrogen Foxp3 antibody (eBioscience, FJK-16S) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 6) and in flow cytometry on mouse samples (fig 5). J Immunol (2009) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry; mouse; fig 4
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunohistochemistry on mouse samples (fig 4). J Immunol (2009) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 5c
In order to elucidate the role of IL-17 in influenza A infection, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 5c). J Immunol (2009) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to examine the role of naturally occurring regulatory dendritic cells in a mouse model of chronic graft-versus-host disease, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . Blood (2009) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 8
In order to study the role of the transcription regulator CCCTC-binding factor in Th2 differentiation, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 8). J Immunol (2009) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to assess the role of T regulatory cells in Th2-type airway inflammation in mice, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . J Immunol (2008) ncbi
mouse monoclonal (eBio7979 (221D/D3))
  • immunohistochemistry; human; 1:50; fig 2
In order to study autoantibodies and tumor-infiltrating T cells in epithelial ovarian cancer, Invitrogen Foxp3 antibody (eBioscience, 14-7979) was used in immunohistochemistry on human samples at 1:50 (fig 2). PLoS ONE (2008) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to test if mesenchymal stem cells have immunomodulatory properties in solid organ allotransplantation, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . J Immunol (2008) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to demonstrate that CD83 expression confers immunosuppressive function to CD4 positive T cells, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . J Immunol (2008) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 1d
In order to report that TGFbeta1 is required for the regulatory function of T regulatory cells, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 1d). Clin Immunol (2008) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 5
In order to define the contributions of apoptosis and anergy to the maintenance of self-tolerance to a systemic antigen, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 5). J Immunol (2008) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to elucidate whether UVB exposure inhibits the expansion of effector CD4+ and CD8+ T cells in skin-draining lymph nodes and reduces the number of CD4+ and IFN-gamma+ CD8+ T cells at sites of challenge, Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples . Am J Pathol (2008) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 4
In order to study how multifactorial adjuvants show reduced toxicity and enhanced efficacy compared to unitary adjuvants as cancer vaccines, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 4). Blood (2008) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to provide evidence that lymphotoxin pathway signals regulate development of the composition and organization of the thymus, specifically the medullary epithelial compartment, Invitrogen Foxp3 antibody (eBioscience, FJK-16S) was used in flow cytometry on mouse samples . J Immunol (2007) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 3
Invitrogen Foxp3 antibody (eBioscience, FJK-16S) was used in flow cytometry on mouse samples (fig 3). Int J Parasitol (2008) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 8
In order to describe retinoids as positive regulatory factors for generating gut-homing FoxP3+ T cells in both humans and mice, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 8). J Immunol (2007) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . Blood (2007) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to quantify expression of Foxp3 on CD8+ T cells in the spleen during anterior chamber-associated immune deviation, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . Mol Vis (2007) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to study the regulation of CTLA-4+ and CD25+ T cells in schistosome infection, Invitrogen Foxp3 antibody (eBiosciences, FJK-16s) was used in flow cytometry on mouse samples . Parasite Immunol (2007) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 1a
In order to discuss the development and functions of effector and memory Foxp3+ T cells, Invitrogen Foxp3 antibody (eBioscience, FKJ-16S) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2007) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 1
In order to determine the expression of CD39 in mouse and human T cells, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 1). Blood (2007) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 4B
In order to characterize and compare T helper 1 and 17 cells, Invitrogen Foxp3 antibody (eBioscience, FJK16) was used in flow cytometry on mouse samples (fig 4B). J Leukoc Biol (2007) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
  • western blot; mouse; fig 1B
In order to study GRAIL expression in murine CD4+ T cells with a described anergic phenotype, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples and in western blot on mouse samples (fig 1B). J Biol Chem (2007) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 6C
In order to examine tolerance mechanisms in a concanavalin A-induced immune-mediated liver injury in mouse model, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 6C). Hepatology (2007) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to test if CD8 blockade promotes the development of CD4+ regulatory T cells, Invitrogen Foxp3 antibody (eBioscience, FJK-IGS) was used in flow cytometry on mouse samples . Int Immunopharmacol (2007) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig S1
Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig S1). J Exp Med (2006) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; fig 6
In order to identify antigens that result in age-dependent spontaneous loss of tolerance, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Clin Immunol (2006) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to study a reduction of the number of splenic Foxp3+ regulatory T cells by pertussis toxin, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . J Immunol (2006) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 5
In order to investigate the role of GPR83 in the peripheral generation of Foxp3+ T regulatory cells, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 5). J Immunol (2006) ncbi
rat monoclonal (FJK-16s)
  • immunohistochemistry - paraffin section; mouse; fig 4
  • flow cytometry; mouse; fig 6
In order to conclude that dendritic cell aggregates are involved in the expansion or differentiation of CD103+ CD25- CD4+ Foxp3-expressing regulatory T cells, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in immunohistochemistry - paraffin section on mouse samples (fig 4) and in flow cytometry on mouse samples (fig 6). Am J Pathol (2006) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to evaluate the antitumor effects of purified Salmonella typhimurium flagellin, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . J Immunol (2006) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse
In order to investigate the mechanism involved in the suppression of CD8+ T cells by Friend retrovirus-induced T regulatory cells, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples . J Immunol (2006) ncbi
rat monoclonal (FJK-16s)
  • flow cytometry; mouse; fig 1
In order to report that Cbl-b plays an integral role in T cell TGF-beta signaling, Invitrogen Foxp3 antibody (eBioscience, FJK-16s) was used in flow cytometry on mouse samples (fig 1). J Immunol (2006) ncbi
BioLegend
mouse monoclonal (150D)
  • flow cytometry; rat; loading ...; fig 10a
BioLegend Foxp3 antibody (BioLegend, 150D) was used in flow cytometry on rat samples (fig 10a). PLoS ONE (2022) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig 6i
BioLegend Foxp3 antibody (Biolegend, 126403) was used in flow cytometry on mouse samples (fig 6i). Adv Sci (Weinh) (2022) ncbi
mouse monoclonal (150D)
  • flow cytometry; mouse; loading ...; fig s5e
BioLegend Foxp3 antibody (Biolegend, 150D) was used in flow cytometry on mouse samples (fig s5e). Leukemia (2022) ncbi
mouse monoclonal (150D)
  • flow cytometry; mouse; fig 2f
BioLegend Foxp3 antibody (Biolegend, 150D) was used in flow cytometry on mouse samples (fig 2f). Theranostics (2022) ncbi
mouse monoclonal (150D)
  • flow cytometry; human; loading ...; fig 1c
BioLegend Foxp3 antibody (Biolegend, 150D) was used in flow cytometry on human samples (fig 1c). Oncoimmunology (2022) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig 7b
BioLegend Foxp3 antibody (Biolegend, MF-14) was used in flow cytometry on mouse samples (fig 7b). Nat Commun (2022) ncbi
mouse monoclonal (150D)
  • flow cytometry; mouse; loading ...; fig 2i, 6d, 6e
BioLegend Foxp3 antibody (BioLegend, 320008) was used in flow cytometry on mouse samples (fig 2i, 6d, 6e). Mol Ther Nucleic Acids (2022) ncbi
rat monoclonal (MF-14)
  • immunohistochemistry - frozen section; mouse; 1:250; fig s7i
  • flow cytometry; mouse; 1:100; fig s6c, s7g, s21g, s21j
BioLegend Foxp3 antibody (Biolegend, 126407) was used in immunohistochemistry - frozen section on mouse samples at 1:250 (fig s7i) and in flow cytometry on mouse samples at 1:100 (fig s6c, s7g, s21g, s21j). Nat Nanotechnol (2022) ncbi
mouse monoclonal (150D)
  • flow cytometry; mouse; fig 5g
BioLegend Foxp3 antibody (BioLegend, 150D) was used in flow cytometry on mouse samples (fig 5g). Sci Adv (2021) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; 1:100; loading ...; fig s2b, s3b, s4d
BioLegend Foxp3 antibody (Biolegend, MF-14) was used in flow cytometry on mouse samples at 1:100 (fig s2b, s3b, s4d). Nat Commun (2021) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; fig 6a
BioLegend Foxp3 antibody (Biolegend, 126419) was used in flow cytometry on mouse samples (fig 6a). Cell Death Dis (2021) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; 1:50; loading ...; fig 3f
BioLegend Foxp3 antibody (BioLegend, MF-14) was used in flow cytometry on mouse samples at 1:50 (fig 3f). Cancer Res (2021) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig s1a, s2b
BioLegend Foxp3 antibody (Biolegend, MF-14) was used in flow cytometry on mouse samples (fig s1a, s2b). Int J Mol Sci (2021) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig 3c, 4a
BioLegend Foxp3 antibody (BioLegend, 126403) was used in flow cytometry on mouse samples (fig 3c, 4a). Cell Death Discov (2021) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...
BioLegend Foxp3 antibody (BioLegend, 126410) was used in flow cytometry on mouse samples . Int J Mol Sci (2021) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; 1:100; loading ...; fig 6e
BioLegend Foxp3 antibody (Biolegend, 126403) was used in flow cytometry on mouse samples at 1:100 (fig 6e). Front Immunol (2021) ncbi
mouse monoclonal (150D)
  • flow cytometry; mouse; 1:100; loading ...; fig 1a
BioLegend Foxp3 antibody (Biolegend, 150D) was used in flow cytometry on mouse samples at 1:100 (fig 1a). Nat Commun (2021) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig 4e
BioLegend Foxp3 antibody (Biolegend, MF-14) was used in flow cytometry on mouse samples (fig 4e). Front Immunol (2021) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig s4c
BioLegend Foxp3 antibody (Biolegend, MF-14) was used in flow cytometry on mouse samples (fig s4c). Proc Natl Acad Sci U S A (2021) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig s2a, s2b, s2c
BioLegend Foxp3 antibody (Biolegend, 126406) was used in flow cytometry on mouse samples (fig s2a, s2b, s2c). Proc Natl Acad Sci U S A (2021) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig 1f
BioLegend Foxp3 antibody (BioLegend, MF-14) was used in flow cytometry on mouse samples (fig 1f). Proc Natl Acad Sci U S A (2020) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig 1s1a
BioLegend Foxp3 antibody (Biolegend, 126406) was used in flow cytometry on mouse samples (fig 1s1a). elife (2020) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...
BioLegend Foxp3 antibody (Biolegend, MF-14) was used in flow cytometry on mouse samples . J Immunother Cancer (2020) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig s17
BioLegend Foxp3 antibody (BioLegend, 126401) was used in flow cytometry on mouse samples (fig s17). Nat Commun (2020) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig 6a
BioLegend Foxp3 antibody (BioLegend, MF-14) was used in flow cytometry on mouse samples (fig 6a). Sci Adv (2020) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig 4d
BioLegend Foxp3 antibody (Biolegend, MF-14) was used in flow cytometry on mouse samples (fig 4d). BMC Immunol (2019) ncbi
mouse monoclonal (150D)
  • flow cytometry; human; 1:100; loading ...; fig 7a
BioLegend Foxp3 antibody (Biolegend, 320012) was used in flow cytometry on human samples at 1:100 (fig 7a). elife (2019) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig 1a, 2d, s3e
BioLegend Foxp3 antibody (BioLegend, MF-14) was used in flow cytometry on mouse samples (fig 1a, 2d, s3e). Sci Adv (2019) ncbi
mouse monoclonal (150D)
  • flow cytometry; human; loading ...; fig 4f
BioLegend Foxp3 antibody (Biolegend, 320014) was used in flow cytometry on human samples (fig 4f). Cell Mol Gastroenterol Hepatol (2020) ncbi
mouse monoclonal (150D)
  • flow cytometry; mouse; 1:500; loading ...; fig e2f
BioLegend Foxp3 antibody (Biolegend, 320008) was used in flow cytometry on mouse samples at 1:500 (fig e2f). Nature (2019) ncbi
mouse monoclonal (150D)
  • flow cytometry; mouse; 1:40; loading ...; fig 6s1
BioLegend Foxp3 antibody (Biolegend, 320007) was used in flow cytometry on mouse samples at 1:40 (fig 6s1). elife (2019) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; fig 4f
BioLegend Foxp3 antibody (BioLegend, MF-14) was used in flow cytometry on mouse samples (fig 4f). Nature (2019) ncbi
mouse monoclonal (150D)
  • flow cytometry; mouse; loading ...; fig 3b
BioLegend Foxp3 antibody (Biolegend, 150D) was used in flow cytometry on mouse samples (fig 3b). Int J Cancer (2019) ncbi
mouse monoclonal (150D)
  • flow cytometry; rhesus macaque; loading ...; fig 2g
BioLegend Foxp3 antibody (Biolegend, 150D) was used in flow cytometry on rhesus macaque samples (fig 2g). J Virol (2019) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; 2.5 ug/ml; loading ...; fig s4
BioLegend Foxp3 antibody (Biolegend, 126403) was used in flow cytometry on mouse samples at 2.5 ug/ml (fig s4). Nat Commun (2018) ncbi
mouse monoclonal (150D)
  • flow cytometry; human; loading ...; fig 3c
BioLegend Foxp3 antibody (Biolegend, 320013) was used in flow cytometry on human samples (fig 3c). Biosci Rep (2018) ncbi
mouse monoclonal (150D)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend Foxp3 antibody (BioLegend, 150D) was used in flow cytometry on mouse samples (fig s2a). J Clin Invest (2018) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig 9f
BioLegend Foxp3 antibody (BioLegend, MF-14) was used in flow cytometry on mouse samples (fig 9f). J Exp Med (2018) ncbi
mouse monoclonal (150D)
  • flow cytometry; mouse; 1:50; loading ...; fig 5b
BioLegend Foxp3 antibody (Biolegend, 150D) was used in flow cytometry on mouse samples at 1:50 (fig 5b). Nat Commun (2017) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend Foxp3 antibody (BioLegend, MF-14) was used in flow cytometry on mouse samples (fig s2a). J Clin Invest (2017) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; fig s5i
In order to demonstrate that type 1 T helper cells play a crucial role in vessel normalization, BioLegend Foxp3 antibody (Biolegend, MF14) was used in flow cytometry on mouse samples (fig s5i). Nature (2017) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig 4d
BioLegend Foxp3 antibody (Biolegend, MF-14) was used in flow cytometry on mouse samples (fig 4d). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (150D)
  • flow cytometry; mouse; loading ...; fig 4c
In order to discover that SIRPalpha is highly expressed in human renal cell carcinoma and melanoma, BioLegend Foxp3 antibody (BioLegend, 150D) was used in flow cytometry on mouse samples (fig 4c). JCI Insight (2017) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig 3e
In order to determine the effect of a high salt diet on intestinal immunity and the risk of inflammatory bowel disease, BioLegend Foxp3 antibody (BioLegend, MF-14) was used in flow cytometry on mouse samples (fig 3e). Oncotarget (2017) ncbi
rat monoclonal (MF-14)
  • immunohistochemistry - frozen section; human; fig 2b
In order to investigate the basis for T regulatory cell accumulation in melanoma, BioLegend Foxp3 antibody (Biolegend, MF-14) was used in immunohistochemistry - frozen section on human samples (fig 2b). Cancer Res (2016) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Foxp3 antibody (biolegend, 126408) was used in flow cytometry on mouse samples (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; 1:300; loading ...; fig 4g
In order to investigate the stromal contribution to the microenvironment of tumor-draining lymph nodes, BioLegend Foxp3 antibody (Biolegend, MF-14) was used in flow cytometry on mouse samples at 1:300 (fig 4g). Nat Immunol (2016) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; fig 5
BioLegend Foxp3 antibody (BioLegend, MF-14) was used in flow cytometry on mouse samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (150D)
  • chromatin immunoprecipitation; mouse; fig 4
In order to study the requisite for the function of regulatory T cells known as phosphatase PP2A, BioLegend Foxp3 antibody (Biolegend, 150D) was used in chromatin immunoprecipitation on mouse samples (fig 4). Nat Immunol (2016) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig 7e
In order to observe that Suppressor of Cytokine Signaling 3-deficient bone marrow-derived macrophages display enhanced and prolonged expression of pro-inflammatory M1 cytokines when exposed to glioma tumor cell conditioned medium in vitro, BioLegend Foxp3 antibody (BioLegend, MF-14) was used in flow cytometry on mouse samples (fig 7e). Oncotarget (2016) ncbi
mouse monoclonal (150D)
  • flow cytometry; mouse; fig 5d
BioLegend Foxp3 antibody (BioLegend, 150D) was used in flow cytometry on mouse samples (fig 5d). Gastroenterology (2016) ncbi
mouse monoclonal (150D)
  • flow cytometry; mouse; fig 6
In order to study how a novel multi-drug metronomic chemotherapy can delay tumor growth in mice significantly, BioLegend Foxp3 antibody (BioLegend, 150D) was used in flow cytometry on mouse samples (fig 6). J Transl Med (2016) ncbi
rat monoclonal (MF-14)
  • western blot; mouse; fig 1
BioLegend Foxp3 antibody (Biolegend, MF-14) was used in western blot on mouse samples (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (150D)
  • western blot; mouse; 1:500; fig 4
BioLegend Foxp3 antibody (Biolegend, 150D) was used in western blot on mouse samples at 1:500 (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (150D)
  • flow cytometry; human
BioLegend Foxp3 antibody (Biolegend, 320014) was used in flow cytometry on human samples . Mol Oncol (2015) ncbi
mouse monoclonal (150D)
  • flow cytometry; mouse; fig 2
In order to study engineered anti-melanoma vaccines that modulate cytokine priming and silence PD-L1 simultaneously by use of ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy, BioLegend Foxp3 antibody (BioLegend, 320014) was used in flow cytometry on mouse samples (fig 2). Oncoimmunology (2014) ncbi
mouse monoclonal (150D)
  • flow cytometry; human; fig 5
BioLegend Foxp3 antibody (Biolegend, 150D) was used in flow cytometry on human samples (fig 5). J Cell Mol Med (2015) ncbi
mouse monoclonal (150D)
  • flow cytometry; mouse
BioLegend Foxp3 antibody (BioLegend, 150D) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
mouse monoclonal (150D)
  • flow cytometry; rat; fig 7
BioLegend Foxp3 antibody (BioLegend, 150D) was used in flow cytometry on rat samples (fig 7). Eur J Immunol (2015) ncbi
rat monoclonal (MF-14)
BioLegend Foxp3 antibody (Biolegend, MF-14) was used . J Virol (2014) ncbi
mouse monoclonal (150D)
In order to study the modulation of CD4 T-cell senescence and cytokine production and the roles played by Menin and Bach2, BioLegend Foxp3 antibody (BioLegend, 150D) was used . Nat Commun (2014) ncbi
mouse monoclonal (150D)
  • flow cytometry; mouse
BioLegend Foxp3 antibody (Biolegend, 320013) was used in flow cytometry on mouse samples . Exp Parasitol (2014) ncbi
mouse monoclonal (150D)
  • immunocytochemistry; human; 1:50
BioLegend Foxp3 antibody (BioLegend, 150D) was used in immunocytochemistry on human samples at 1:50. Nephrology (Carlton) (2014) ncbi
rat monoclonal (MF-14)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Foxp3 antibody (BioLegend, MF-14) was used in flow cytometry on mouse samples (fig 1a). J Leukoc Biol (2014) ncbi
Abcam
mouse monoclonal (mAbcam 22510)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 1g
Abcam Foxp3 antibody (Abcam, 22510) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 1g). Front Med (Lausanne) (2022) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry; mouse; loading ...; fig 3d
Abcam Foxp3 antibody (Abcam, ab20034) was used in immunohistochemistry on mouse samples (fig 3d). Oncoimmunology (2022) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s10a
Abcam Foxp3 antibody (Abcam, ab20034) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s10a). Oncoimmunology (2022) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 4e
Abcam Foxp3 antibody (Abcam, ab20034) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4e). EBioMedicine (2022) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry; human; 1:100; fig 4b
Abcam Foxp3 antibody (Abcam, ab20034) was used in immunohistochemistry on human samples at 1:100 (fig 4b). Cancers (Basel) (2022) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; 1:300; loading ...; tbl 3
Abcam Foxp3 antibody (Abcam, Ab20034) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 3). J Cell Mol Med (2022) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1d, 1e
Abcam Foxp3 antibody (Abcam, ab20034) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1d, 1e). Onco Targets Ther (2021) ncbi
domestic rabbit monoclonal (EPR22102-37)
  • western blot; human; 1:50; loading ...; fig 4h
Abcam Foxp3 antibody (Abcam, ab215206) was used in western blot on human samples at 1:50 (fig 4h). J Cell Mol Med (2021) ncbi
mouse monoclonal (3G3)
  • flow cytometry; mouse; fig s3d
Abcam Foxp3 antibody (Abcam, ab210232) was used in flow cytometry on mouse samples (fig s3d). Mol Cancer (2021) ncbi
domestic rabbit monoclonal (EPR22102-37)
  • immunohistochemistry; mouse; 1:500; fig 5b
Abcam Foxp3 antibody (Abcam, ab215206) was used in immunohistochemistry on mouse samples at 1:500 (fig 5b). Vaccines (Basel) (2021) ncbi
domestic rabbit monoclonal (EPR22102-37)
  • immunohistochemistry; mouse; 1:200; fig 2f
  • western blot; mouse; 1:1000; loading ...; fig 7b
Abcam Foxp3 antibody (Abcam, ab215206) was used in immunohistochemistry on mouse samples at 1:200 (fig 2f) and in western blot on mouse samples at 1:1000 (fig 7b). Cell Death Discov (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:500; fig 2e
Abcam Foxp3 antibody (Abcam, ab75763) was used in western blot on mouse samples at 1:500 (fig 2e). Allergy Asthma Clin Immunol (2021) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry; human; loading ...; fig s4
Abcam Foxp3 antibody (Abcam, ab20034) was used in immunohistochemistry on human samples (fig s4). Sci Rep (2021) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry; human; 1:200; loading ...; fig s2z
Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry on human samples at 1:200 (fig s2z). Neuropathol Appl Neurobiol (2021) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry; human; 1:100; loading ...; fig 1
Abcam Foxp3 antibody (Abcam, 236/E7) was used in immunohistochemistry on human samples at 1:100 (fig 1). Mol Clin Oncol (2021) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry; human; 1:50; fig 1f
Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry on human samples at 1:50 (fig 1f). BMC Cancer (2021) ncbi
mouse monoclonal (mAbcam 22510)
  • immunohistochemistry; human; 1:50; loading ...
Abcam Foxp3 antibody (Abcam, 22510) was used in immunohistochemistry on human samples at 1:50. Ann Hematol (2021) ncbi
mouse monoclonal (mAbcam 22510)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 7a
Abcam Foxp3 antibody (Abcam, mAbcam22510) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 7a). Arthritis Res Ther (2020) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1c
Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1c). Breast Cancer Res (2020) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 3c
Abcam Foxp3 antibody (Abcam, ab2034) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3c). Front Immunol (2019) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; 1:400; loading ...; fig 3a
Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 3a). Cancer Sci (2020) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 1f
Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 1f). J Invest Dermatol (2019) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; fig 1a
Abcam Foxp3 antibody (Abcam, 20034) was used in immunohistochemistry - paraffin section on human samples (fig 1a). Sci Rep (2017) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 2k
Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2k). Arch Dermatol Res (2017) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry; mouse; loading ...; fig s3b
Abcam Foxp3 antibody (Abcam, ab20034) was used in immunohistochemistry on mouse samples (fig s3b). FASEB J (2017) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2c
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry - paraffin section on human samples (fig 2c). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (mAbcam 22510)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 1
In order to investigate infiltrating T cells in liver cancer through single-cell sequencing, Abcam Foxp3 antibody (Abcam, ab22510) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Cell (2017) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry; human; 1:50; loading ...; fig 2c
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Abcam Foxp3 antibody (Abcam, ab20034) was used in immunohistochemistry on human samples at 1:50 (fig 2c). Cell Res (2017) ncbi
mouse monoclonal (236a/E7)
  • western blot; human; loading ...; fig 3D
Abcam Foxp3 antibody (Abcam, ab20034) was used in western blot on human samples (fig 3D). Int J Mol Sci (2017) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - frozen section; human; loading ...; fig 4b
In order to observe that the use of chimeric antigen receptor technology is a clinically applicable refinement of regulatory T cell therapy for organ transplantation, Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry - frozen section on human samples (fig 4b). Am J Transplant (2017) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry; human; fig 1c
In order to profile the infiltration levels of immune cell populations in 19 cancer types, Abcam Foxp3 antibody (Abcam, ab20034) was used in immunohistochemistry on human samples (fig 1c). Genome Biol (2016) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 2c
In order to investigate the role of PD-L1 and T-cell infiltration in metastatic high-grade osteosarcoma, Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2c). Cancer Immunol Immunother (2017) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; 20 ug/ml; loading ...; fig 3a
Abcam Foxp3 antibody (Abcam, ab20034) was used in immunohistochemistry - paraffin section on human samples at 20 ug/ml (fig 3a). J Immunol Res (2016) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1
Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Cancer Sci (2016) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 3
In order to characterize cases of recurrent panniculitis in children with lipoatrophy, Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry - paraffin section on human samples (tbl 3). J Eur Acad Dermatol Venereol (2017) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; fig 2b
In order to report that patients with PTEN mutations experience autoimmunity and lymphoid hyperplasia, Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry - paraffin section on human samples (fig 2b). J Allergy Clin Immunol (2017) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry; mouse; fig 6b
In order to utilize humanized major histocompatibility class I- and class II-deficient NOG mice to assess the antitumor effect of an anti-programmed death-1 antibody, Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry on mouse samples (fig 6b). Clin Cancer Res (2017) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 3
Abcam Foxp3 antibody (abcam, ab20034) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 3). Mol Med Rep (2016) ncbi
mouse monoclonal (mAbcam 22510)
  • immunohistochemistry - paraffin section; human; fig 1F
Abcam Foxp3 antibody (Abcam, ab22510) was used in immunohistochemistry - paraffin section on human samples (fig 1F). PLoS ONE (2016) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1
In order to study the role of neuropathy and imbalanced Foxp3/IL-17 in bone marrow microenvironment of acute myeloid leukemia patients, Abcam Foxp3 antibody (Abcam, ab20034) was used in immunohistochemistry - paraffin section on human samples (fig 1). Oncotarget (2016) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 3
Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3). Mod Pathol (2016) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1
In order to correlate tumor infiltrating lymphocyte types with clinical outcomes in patients with head and neck squamous cell carcinoma, Abcam Foxp3 antibody (Abcam, Ab20034) was used in immunohistochemistry - paraffin section on human samples (fig 1). Head Neck (2016) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry; human; 1:50; tbl 2
In order to evaluate the reliance on EBV or NF-kappaB signaling instead of B-cell receptor signaling in regards to complete phenotypic characterization of PTLD, Abcam Foxp3 antibody (Abcam, ab20034) was used in immunohistochemistry on human samples at 1:50 (tbl 2). Hematol Oncol (2017) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess how proportional balance of tumor associated macrophages and tumor infiltrating lymphocytes in microsatellite-unstable gastric carcinoma is a prognostic indicator of M2 macrophages, Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry - paraffin section on human samples at 1:100. PLoS ONE (2015) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2
Abcam Foxp3 antibody (Abcam, AB20034) was used in immunohistochemistry - paraffin section on human samples (fig 2). J Immunother Cancer (2015) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human
In order to examine the histopathological patterns and their associations with clinical characteristics in Chinese patients with nasal inverted papilloma, Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry - paraffin section on human samples . Laryngoscope (2016) ncbi
mouse monoclonal (mAbcam 22510)
  • immunohistochemistry - paraffin section; human; 20 ug/ml; loading ...; fig 3b
  • western blot; human; loading ...; fig 3f
Abcam Foxp3 antibody (abcam, ab22510) was used in immunohistochemistry - paraffin section on human samples at 20 ug/ml (fig 3b) and in western blot on human samples (fig 3f). PLoS ONE (2015) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry; human; fig 5
In order to determine the expression and function of HLA-G, HLA-G-regulatory microRNAs and the immune cell infiltration in renal cell carcinoma samples, Abcam Foxp3 antibody (Abcam, ab20034) was used in immunohistochemistry on human samples (fig 5). Oncoimmunology (2015) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human
Abcam Foxp3 antibody (Abcam, ab20034) was used in immunohistochemistry - paraffin section on human samples . Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; 1:800
Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry - paraffin section on human samples at 1:800. J Dermatol Sci (2015) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; fig St1A
Abcam Foxp3 antibody (Abcam, ab20034) was used in immunohistochemistry - paraffin section on human samples (fig St1A). Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry; human
In order to study the role of lymph node in the early rectal cancer, Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry on human samples . Dis Markers (2014) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; 1:60
Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry - paraffin section on human samples at 1:60. World J Gastroenterol (2015) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; 1:180; fig 4
In order to characterize location and tumor infiltration patterns as key prognostic factors when analyzing CD8+ T-cells and FoxP3+ T-regulatory cells in ovarian carcinoma, Abcam Foxp3 antibody (Abcam, ab20034) was used in immunohistochemistry - paraffin section on human samples at 1:180 (fig 4). PLoS ONE (2014) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; fig 1
Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Cancer Discov (2015) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry; human; loading ...; fig 1c
Abcam Foxp3 antibody (Abcam, ab20034) was used in immunohistochemistry on human samples (fig 1c). Liver Int (2015) ncbi
mouse monoclonal (mAbcam 22510)
  • western blot; human; loading ...; fig 1a
Abcam Foxp3 antibody (Abcam, ab22510) was used in western blot on human samples (fig 1a). Liver Int (2015) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human; 1:100
Abcam Foxp3 antibody (Abcam, 236 A/E7) was used in immunohistochemistry - paraffin section on human samples at 1:100. Br J Dermatol (2015) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry; human; 1:100
Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry on human samples at 1:100. PLoS Pathog (2014) ncbi
mouse monoclonal (236a/E7)
  • immunohistochemistry - paraffin section; human
Abcam Foxp3 antibody (Abcam, 236A/E7) was used in immunohistochemistry - paraffin section on human samples . Cancer (2011) ncbi
Santa Cruz Biotechnology
mouse monoclonal (2A11G9)
  • western blot; human; loading ...; fig 5f
Santa Cruz Biotechnology Foxp3 antibody (Santa Cruz, SC-53876) was used in western blot on human samples (fig 5f). J Immunother Cancer (2022) ncbi
mouse monoclonal (2A11G9)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig s6c
Santa Cruz Biotechnology Foxp3 antibody (Santa, sc-53876) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig s6c). Theranostics (2021) ncbi
mouse monoclonal (2A11G9)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4
  • western blot; mouse; 1:500; loading ...; fig 6a, 6b
Santa Cruz Biotechnology Foxp3 antibody (Santa Cruz, sc-53,876) was used in immunohistochemistry - paraffin section on mouse samples (fig 4) and in western blot on mouse samples at 1:500 (fig 6a, 6b). BMC Nephrol (2019) ncbi
mouse monoclonal (F-9)
  • immunohistochemistry - paraffin section; mouse; tbl 1
In order to characterize histomorphometric tumors by induction of colorectal cancer in mice, Santa Cruz Biotechnology Foxp3 antibody (Santa Cruz, sc166212) was used in immunohistochemistry - paraffin section on mouse samples (tbl 1). Methods Mol Biol (2015) ncbi
R&D Systems
domestic rabbit monoclonal (1054C)
  • immunohistochemistry; human; 1:100; loading ...; fig s2d
R&D Systems Foxp3 antibody (R&D System, MAB8214) was used in immunohistochemistry on human samples at 1:100 (fig s2d). Adv Sci (Weinh) (2021) ncbi
Novus Biologicals
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 3f
Novus Biologicals Foxp3 antibody (Novus, NB100-39002) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 3f). Aging (Albany NY) (2019) ncbi
domestic rabbit polyclonal
In order to use personalized immunotherapy to target individual tumor-specific mutations in patients, Novus Biologicals Foxp3 antibody (Novus Biologicals, NB100-39002) was used . Nature (2015) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D6O8R)
  • immunohistochemistry - paraffin section; mouse; 1:750; loading ...; fig s2
Cell Signaling Technology Foxp3 antibody (Cell Signaling, 12653) was used in immunohistochemistry - paraffin section on mouse samples at 1:750 (fig s2). Development (2022) ncbi
domestic rabbit monoclonal (D6O8R)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 4c
Cell Signaling Technology Foxp3 antibody (CST, 12653S) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4c). EBioMedicine (2022) ncbi
domestic rabbit monoclonal (D6O8R)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5c
Cell Signaling Technology Foxp3 antibody (Cell Signaling, D6O8R) was used in immunohistochemistry - paraffin section on human samples (fig 5c). Oncoimmunology (2022) ncbi
domestic rabbit monoclonal (D6O8R)
  • immunohistochemistry; mouse; loading ...; fig s4a
Cell Signaling Technology Foxp3 antibody (Cell Signaling, 12653) was used in immunohistochemistry on mouse samples (fig s4a). Cells (2021) ncbi
domestic rabbit monoclonal (D6O8R)
  • immunohistochemistry - paraffin section; mouse; fig 6d
Cell Signaling Technology Foxp3 antibody (CST, 12653S) was used in immunohistochemistry - paraffin section on mouse samples (fig 6d). iScience (2021) ncbi
domestic rabbit monoclonal (D6O8R)
  • immunohistochemistry - paraffin section; mouse; fig 6
Cell Signaling Technology Foxp3 antibody (CST, 12653) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (D6O8R)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s4d
Cell Signaling Technology Foxp3 antibody (CST, 12653) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s4d). Cancer Res (2021) ncbi
domestic rabbit monoclonal (D6O8R)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig s6f
Cell Signaling Technology Foxp3 antibody (CST, 12653) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6f). Nat Commun (2021) ncbi
domestic rabbit monoclonal (D6O8R)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 5f
Cell Signaling Technology Foxp3 antibody (Cell Signaling, 12653) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 5f). Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (D6O8R)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 3
Cell Signaling Technology Foxp3 antibody (Cell Signaling, D6OR) was used in immunohistochemistry on mouse samples at 1:100 (fig 3). Sci Rep (2020) ncbi
domestic rabbit monoclonal (D6O8R)
  • immunocytochemistry; mouse; loading ...; fig s3i
Cell Signaling Technology Foxp3 antibody (Cell Signaling Technology, 12653) was used in immunocytochemistry on mouse samples (fig s3i). Immunity (2018) ncbi
Tonbo Biosciences
mouse monoclonal (3G3)
  • flow cytometry; mouse; 1:100; loading ...; fig 5a
Tonbo Biosciences Foxp3 antibody (Tonbo, 3G3) was used in flow cytometry on mouse samples at 1:100 (fig 5a). J Immunol Res (2021) ncbi
mouse monoclonal (3G3)
  • flow cytometry; mouse; loading ...; fig 4b
Tonbo Biosciences Foxp3 antibody (Tonbo, 3G3) was used in flow cytometry on mouse samples (fig 4b). Nutrients (2018) ncbi
mouse monoclonal (3G3)
  • flow cytometry; mouse; loading ...; fig 2e
In order to determine the role of CD6 in T cells using knock out mice, Tonbo Biosciences Foxp3 antibody (TONBO Bioscience, 3G3) was used in flow cytometry on mouse samples (fig 2e). J Exp Med (2016) ncbi
BD Biosciences
rat monoclonal (MF23)
  • flow cytometry; mouse; loading ...; fig 3a
BD Biosciences Foxp3 antibody (BD, 560401) was used in flow cytometry on mouse samples (fig 3a). J Immunother Cancer (2022) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; loading ...; fig 2k
BD Biosciences Foxp3 antibody (BD, 560401) was used in flow cytometry on mouse samples (fig 2k). Cell Rep (2022) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; 1:50; fig 3e
BD Biosciences Foxp3 antibody (BD Biosciences, 560408) was used in flow cytometry on mouse samples at 1:50 (fig 3e). Proc Natl Acad Sci U S A (2022) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; 1:100; loading ...; fig 5o
BD Biosciences Foxp3 antibody (BD Biosciences, 560408) was used in flow cytometry on mouse samples at 1:100 (fig 5o). Nat Commun (2022) ncbi
rat monoclonal (R16-715)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s3a
  • flow cytometry; mouse; loading ...; fig 2a
BD Biosciences Foxp3 antibody (BD, R16-715) was used in immunohistochemistry - paraffin section on mouse samples (fig s3a) and in flow cytometry on mouse samples (fig 2a). JCI Insight (2022) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; fig 5b
BD Biosciences Foxp3 antibody (BD Biosciences, MF23) was used in flow cytometry on mouse samples (fig 5b). J Immunother Cancer (2021) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; fig 7
BD Biosciences Foxp3 antibody (BD Bioscience, MF23) was used in flow cytometry on mouse samples (fig 7). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; loading ...; fig 2i, s1b
BD Biosciences Foxp3 antibody (BD, 560408) was used in flow cytometry on mouse samples (fig 2i, s1b). J Clin Invest (2020) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; loading ...; fig 6c, s6b
BD Biosciences Foxp3 antibody (BD, 560414) was used in flow cytometry on mouse samples (fig 6c, s6b). Nat Commun (2020) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; fig 3h
BD Biosciences Foxp3 antibody (BD Biosciences, MF23) was used in flow cytometry on mouse samples (fig 3h). Sci Adv (2019) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; loading ...; fig s6e
BD Biosciences Foxp3 antibody (BD Bioscience, 562466) was used in flow cytometry on mouse samples (fig s6e). Science (2019) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; loading ...; fig 5e
BD Biosciences Foxp3 antibody (BD, 560401) was used in flow cytometry on mouse samples (fig 5e). Oncoimmunology (2018) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; fig s3f
BD Biosciences Foxp3 antibody (BD, 561293) was used in flow cytometry on mouse samples (fig s3f). Cell (2018) ncbi
rat monoclonal (MF23)
  • flow cytometry; human; loading ...; fig 3b
BD Biosciences Foxp3 antibody (BD, 562996) was used in flow cytometry on human samples (fig 3b). J Clin Invest (2018) ncbi
rat monoclonal (MF23)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences Foxp3 antibody (BD Bioscience, 560408) was used in flow cytometry on human samples (fig s1a). Immunity (2018) ncbi
rat monoclonal (R16-715)
  • flow cytometry; mouse; 1:100; loading ...; fig 5a
BD Biosciences Foxp3 antibody (BD Biosciences, 563486) was used in flow cytometry on mouse samples at 1:100 (fig 5a). Nat Commun (2018) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; loading ...; fig 8b
BD Biosciences Foxp3 antibody (BD Bioscience, MF23) was used in flow cytometry on mouse samples (fig 8b). Nat Commun (2018) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; fig 9c
BD Biosciences Foxp3 antibody (BD Biosciences, MF23) was used in flow cytometry on mouse samples (fig 9c). J Immunol (2017) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; loading ...; fig 2e
BD Biosciences Foxp3 antibody (BD Pharmingen, MF23) was used in flow cytometry on mouse samples (fig 2e). J Immunol (2017) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; fig 2
BD Biosciences Foxp3 antibody (BD Pharmingen, 560408) was used in flow cytometry on mouse samples (fig 2). PLoS Pathog (2016) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; loading ...; fig 2b
In order to explore the role of the JAK/STAT pathway in controlling Foxp3 in regulatory T cells, BD Biosciences Foxp3 antibody (BD, MF23) was used in flow cytometry on mouse samples (fig 2b). PLoS ONE (2016) ncbi
rat monoclonal (R16-715)
  • flow cytometry; mouse; 1:1000; fig 1
BD Biosciences Foxp3 antibody (BD Bioscience, R16-715) was used in flow cytometry on mouse samples at 1:1000 (fig 1). J Endod (2016) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; loading ...; fig 4
In order to report a role for effector T helper type 2 cells during T cell receptor-independent innate-like immune responses, BD Biosciences Foxp3 antibody (BD Biosciences, MF23) was used in flow cytometry on mouse samples (fig 4). Nat Immunol (2015) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; fig 6
BD Biosciences Foxp3 antibody (BD, MF23) was used in flow cytometry on mouse samples (fig 6). Leukemia (2016) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse; 1:100; fig s3
In order to study modulation of the composition of the gut microbiota by ganoderma lucidum that reduces obesity in mice, BD Biosciences Foxp3 antibody (BD Pharmingen, 560403) was used in flow cytometry on mouse samples at 1:100 (fig s3). Nat Commun (2015) ncbi
rat monoclonal (MF23)
  • flow cytometry; human
  • flow cytometry; mouse
BD Biosciences Foxp3 antibody (BD Pharmingen, MF23) was used in flow cytometry on human samples and in flow cytometry on mouse samples . Cancer Immunol Res (2015) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse
In order to examine the effects of Withaferin A treatment using two mouse models of amyotrophic lateral sclerosis, BD Biosciences Foxp3 antibody (BD, MF23) was used in flow cytometry on mouse samples . Neurotherapeutics (2015) ncbi
rat monoclonal (MF23)
  • flow cytometry; mouse
In order to identify a relationship between resistant cancers and myeloid-derived suppressor cells, BD Biosciences Foxp3 antibody (BD Biosciences, MF23) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
Articles Reviewed
  1. Ravindranathan S, Passang T, Li J, Wang S, Dhamsania R, Ware M, et al. Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma. Nat Commun. 2022;13:6418 pubmed publisher
  2. Bath N, Verhoven B, Wilson N, Zeng W, Zhong W, Coons L, et al. APRIL/BLyS deficient rats prevent donor specific antibody (DSA) production and cell proliferation in rodent kidney transplant model. PLoS ONE. 2022;17:e0275564 pubmed publisher
  3. Ni H, Zhang H, Li L, Huang H, Guo H, Zhang L, et al. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer. J Immunother Cancer. 2022;10: pubmed publisher
  4. Lin J, Lv J, Yu S, Chen Y, Wang H, Chen J. Transcript Engineered Extracellular Vesicles Alleviate Alloreactive Dynamics in Renal Transplantation. Adv Sci (Weinh). 2022;9:e2202633 pubmed publisher
  5. Amaral E, Foreman T, Namasivayam S, Hilligan K, Kauffman K, Barbosa Bomfim C, et al. GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection. J Exp Med. 2022;219: pubmed publisher
  6. Lee A, Pingali S, Pinilla Ibarz J, Atchison M, Koumenis C, Argon Y, et al. Loss of AID exacerbates the malignant progression of CLL. Leukemia. 2022;36:2430-2442 pubmed publisher
  7. Costain A, Phythian Adams A, Colombo S, Marley A, Owusu C, Cook P, et al. Dynamics of Host Immune Response Development During Schistosoma mansoni Infection. Front Immunol. 2022;13:906338 pubmed publisher
  8. Que W, Ma K, Hu X, Guo W, Li X. Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells. Sci Adv. 2022;8:eabo4413 pubmed publisher
  9. Xie F, Zhou X, Su P, Li H, Tu Y, Du J, et al. Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-β type II receptor signaling. Nat Commun. 2022;13:4461 pubmed publisher
  10. Kasahara K, Sasaki N, Amin H, Tanaka T, Horibe S, Yamashita T, et al. Depletion of Foxp3+ regulatory T cells augments CD4+ T cell immune responses in atherosclerosis-prone hypercholesterolemic mice. Heliyon. 2022;8:e09981 pubmed publisher
  11. Wu B, Song M, Dong Q, Xiang G, Li J, Ma X, et al. UBR5 promotes tumor immune evasion through enhancing IFN-γ-induced PDL1 transcription in triple negative breast cancer. Theranostics. 2022;12:5086-5102 pubmed publisher
  12. Pi xf1 eros A, Kulkarni A, Gao H, Orr K, Glenn L, Huang F, et al. Proinflammatory signaling in islet β cells propagates invasion of pathogenic immune cells in autoimmune diabetes. Cell Rep. 2022;39:111011 pubmed publisher
  13. Son M, Park I, Kim S, Ma H, Kim J, Kim T, et al. Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function. Front Immunol. 2022;13:870817 pubmed publisher
  14. Lu L, Li T, Feng X, Liu Z, Liu Y, Chao T, et al. Excessive immunosuppression by regulatory T cells antagonizes T cell response to schistosome infection in PD-1-deficient mice. PLoS Pathog. 2022;18:e1010596 pubmed publisher
  15. Wang Y, Feng R, Cheng G, Huang B, Tian J, Gan Y, et al. Low Dose Interleukin-2 Ameliorates Sjögren's Syndrome in a Murine Model. Front Med (Lausanne). 2022;9:887354 pubmed publisher
  16. Zhang R, Wang Y, Liu D, Luo Q, Du P, Zhang H, et al. Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice. Front Pharmacol. 2022;13:870848 pubmed publisher
  17. Pan C, Wu Q, Wang S, Mei Z, Zhang L, Gao X, et al. Combination with Toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma. Oncoimmunology. 2022;11:2073010 pubmed publisher
  18. Melese E, Franks E, Cederberg R, Harbourne B, Shi R, Wadsworth B, et al. CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development. Oncoimmunology. 2022;11:2010905 pubmed publisher
  19. Brown G, Ca xf1 ete P, Wang H, Medhavy A, Bones J, Roco J, et al. TLR7 gain-of-function genetic variation causes human lupus. Nature. 2022;605:349-356 pubmed publisher
  20. Ozmadenci D, Shankara Narayanan J, Andrew J, Ojalill M, Barrie A, Jiang S, et al. Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis. Proc Natl Acad Sci U S A. 2022;119:e2117065119 pubmed publisher
  21. Piao W, Li L, Saxena V, Iyyathurai J, Lakhan R, Zhang Y, et al. PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration. Nat Commun. 2022;13:2176 pubmed publisher
  22. Saxena V, Piao W, Li L, Paluskievicz C, Xiong Y, Simon T, et al. Treg tissue stability depends on lymphotoxin beta-receptor- and adenosine-receptor-driven lymphatic endothelial cell responses. Cell Rep. 2022;39:110727 pubmed publisher
  23. Meléndez E, Chondronasiou D, Mosteiro L, Mart xed nez de Villarreal J, Fern xe1 ndez Alfara M, Lynch C, et al. Natural killer cells act as an extrinsic barrier for in vivo reprogramming. Development. 2022;149: pubmed publisher
  24. Wedge M, Jennings V, Crupi M, Poutou J, Jamieson T, Pelin A, et al. Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy. Nat Commun. 2022;13:1898 pubmed publisher
  25. Reed J, Spinelli P, Falcone S, He M, Goeke C, Susiarjo M. Evaluating the Effects of BPA and TBBPA Exposure on Pregnancy Loss and Maternal-Fetal Immune Cells in Mice. Environ Health Perspect. 2022;130:37010 pubmed publisher
  26. Tu J, Han D, Fang Y, Jiang H, Tan X, Xu Z, et al. MicroRNA-10b promotes arthritis development by disrupting CD4+ T cell subtypes. Mol Ther Nucleic Acids. 2022;27:733-750 pubmed publisher
  27. Yang J, Zhang Q, Wang J, Lou Y, Hong Z, Wei S, et al. Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy. EBioMedicine. 2022;78:103958 pubmed publisher
  28. Sun D, Wang W, Guo F, Pitter M, Du W, Wei S, et al. DOT1L affects colorectal carcinogenesis via altering T cell subsets and oncogenic pathway. Oncoimmunology. 2022;11:2052640 pubmed publisher
  29. Ploeger C, Schreck J, Huth T, Fraas A, Albrecht T, Charbel A, et al. STAT1 and STAT3 Exhibit a Crosstalk and Are Associated with Increased Inflammation in Hepatocellular Carcinoma. Cancers (Basel). 2022;14: pubmed publisher
  30. D Addio F, Maestroni A, Assi E, Ben Nasr M, Amabile G, Usuelli V, et al. The IGFBP3/TMEM219 pathway regulates beta cell homeostasis. Nat Commun. 2022;13:684 pubmed publisher
  31. Quách T, Huang W, Sahu R, Diadhiou C, Raparia C, Johnson R, et al. Context-dependent induction of autoimmunity by TNF signaling deficiency. JCI Insight. 2022;7: pubmed publisher
  32. Keller E, Dvorina N, Jørgensen T. Spontaneous CD4+ T Cell Activation and Differentiation in Lupus-Prone B6.Nba2 Mice Is IFNAR-Independent. Int J Mol Sci. 2022;23: pubmed publisher
  33. Pulkka O, Viisanen L, Tynninen O, Laaksonen M, Reichardt P, Reichardt A, et al. Fibrinogen-like protein 2 in gastrointestinal stromal tumour. J Cell Mol Med. 2022;26:1083-1094 pubmed publisher
  34. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed publisher
  35. Ma X, Gao Y, Chen Y, Liu J, Yang C, Bao C, et al. M2-Type Macrophages Induce Tregs Generation by Activating the TGF-β/Smad Signalling Pathway to Promote Colorectal Cancer Development. Onco Targets Ther. 2021;14:5391-5402 pubmed publisher
  36. Stoff M, Ebbecke T, Ciurkiewicz M, Pavasutthipaisit S, Mayer Lambertz S, St xf6 rk T, et al. C-type lectin receptor DCIR contributes to hippocampal injury in acute neurotropic virus infection. Sci Rep. 2021;11:23819 pubmed publisher
  37. Zhu Y, Elsheikha H, Wang J, Fang S, He J, Zhu X, et al. Synergy between Toxoplasma gondii type I ΔGRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors. J Immunother Cancer. 2021;9: pubmed publisher
  38. Fearon A, Slabber C, Kuklin A, Bachofner M, Tortola L, Pohlmeier L, et al. Fibroblast growth factor receptor 3 in hepatocytes protects from toxin-induced liver injury and fibrosis. iScience. 2021;24:103143 pubmed publisher
  39. Ni Y, Hu B, Wu G, Shao Z, Zheng Y, Zhang R, et al. Interruption of neutrophil extracellular traps formation dictates host defense and tubular HOXA5 stability to augment efficacy of anti-Fn14 therapy against septic AKI. Theranostics. 2021;11:9431-9451 pubmed publisher
  40. Horiuchi S, Wu H, Liu W, Schmitt N, Provot J, Liu Y, et al. Tox2 is required for the maintenance of GC TFH cells and the generation of memory TFH cells. Sci Adv. 2021;7:eabj1249 pubmed publisher
  41. Kim M, Borcherding N, Ahmed K, Voigt A, Vishwakarma A, Kolb R, et al. CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells. Nat Commun. 2021;12:5764 pubmed publisher
  42. Liu H, Pedros C, Kong K, Canonigo Balancio A, Xue W, Altman A. Leveraging the Treg-intrinsic CTLA4-PKCη signaling pathway for cancer immunotherapy. J Immunother Cancer. 2021;9: pubmed publisher
  43. Zou J, Pei X, Xing D, Wu X, Chen S. LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 via targeting FOXP3. J Cell Mol Med. 2021;25:9826-9836 pubmed publisher
  44. Jiang Y, Yuan Y, Chen M, Li S, Bai J, Zhang Y, et al. PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression. Theranostics. 2021;11:9162-9176 pubmed publisher
  45. Malenica I, Adam J, Corgnac S, Mezquita L, Auclin E, Damei I, et al. Integrin-αV-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade. Nat Commun. 2021;12:5209 pubmed publisher
  46. Liu Z, Wang T, She Y, Wu K, Gu S, Li L, et al. N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer. 2021;20:105 pubmed publisher
  47. Moreira T, Mangani D, Cox L, Leibowitz J, Lobo E, Oliveira M, et al. PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis. Nat Commun. 2021;12:4907 pubmed publisher
  48. Xu P, Xiong W, Lin Y, Fan L, Pan H, Li Y. Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression. Cell Death Dis. 2021;12:779 pubmed publisher
  49. Guo L, Xie H, Zhang Z, Wang Z, Peng S, Niu Y, et al. Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer. Vaccines (Basel). 2021;9: pubmed publisher
  50. Kim G, Kim W, Lim S, Lee H, Koo J, Nam K, et al. In Vivo Induction of Regulatory T Cells Via CTLA-4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse. Adv Sci (Weinh). 2021;8:2004973 pubmed publisher
  51. Van De Velde L, Allen E, Crawford J, Wilson T, Guy C, Russier M, et al. Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1-Dependent Myeloid Cells. Cancer Res. 2021;81:5047-5059 pubmed publisher
  52. Toyama S, Moniaga C, Nakae S, Kurosawa M, Ogawa H, Tominaga M, et al. Regulatory T Cells Exhibit Interleukin-33-Dependent Migratory Behavior during Skin Barrier Disruption. Int J Mol Sci. 2021;22: pubmed publisher
  53. Goyette M, Elkholi I, Apcher C, Kuasne H, Rothlin C, Muller W, et al. Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  54. Lauret Marie Joseph E, Kirilovsky A, Lecoester B, El Sissy C, Boullerot L, Rangan L, et al. Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy. J Immunother Cancer. 2021;9: pubmed publisher
  55. Lu J, Wang W, Li P, Wang X, Gao C, Zhang B, et al. MiR-146a regulates regulatory T cells to suppress heart transplant rejection in mice. Cell Death Discov. 2021;7:165 pubmed publisher
  56. Pavasutthipaisit S, Stoff M, Ebbecke T, Ciurkiewicz M, Mayer Lambertz S, Stork T, et al. CARD9 Deficiency Increases Hippocampal Injury Following Acute Neurotropic Picornavirus Infection but Does Not Affect Pathogen Elimination. Int J Mol Sci. 2021;22: pubmed publisher
  57. Maier J, Rogg M, Helmstädter M, Sammarco A, Walz G, Werner M, et al. A Novel Model for Nephrotic Syndrome Reveals Associated Dysbiosis of the Gut Microbiome and Extramedullary Hematopoiesis. Cells. 2021;10: pubmed publisher
  58. Hering L, Katkeviciute E, Schwarzfischer M, Niechcial A, Riggs J, Wawrzyniak M, et al. Macrophages Compensate for Loss of Protein Tyrosine Phosphatase N2 in Dendritic Cells to Protect from Elevated Colitis. Int J Mol Sci. 2021;22: pubmed publisher
  59. Zhou J, Lu Y, Wu W, Feng Y. Taurine promotes the production of CD4+CD25+FOXP3+ Treg cells through regulating IL-35/STAT1 pathway in a mouse allergic rhinitis model. Allergy Asthma Clin Immunol. 2021;17:59 pubmed publisher
  60. Lacy M, Burger C, Shami A, Ahmadsei M, Winkels H, Nitz K, et al. Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease. Nat Commun. 2021;12:3754 pubmed publisher
  61. Steele L, Mannion A, Shaw G, MacLennan K, Cook G, Rudd C, et al. Non-redundant activity of GSK-3α and GSK-3β in T cell-mediated tumor rejection. iScience. 2021;24:102555 pubmed publisher
  62. Zhang J, Qi J, Wei H, Lei Y, Yu H, Liu N, et al. TGFβ1 in Cancer-Associated Fibroblasts Is Associated With Progression and Radiosensitivity in Small-Cell Lung Cancer. Front Cell Dev Biol. 2021;9:667645 pubmed publisher
  63. Yan C, Saleh N, Yang J, Nebhan C, Vilgelm A, Reddy E, et al. Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade. Mol Cancer. 2021;20:85 pubmed publisher
  64. Parodi B, Sanna A, Cedola A, Uccelli A, Kerlero de Rosbo N. Hydroxycarboxylic Acid Receptor 2, a Pleiotropically Linked Receptor for the Multiple Sclerosis Drug, Monomethyl Fumarate. Possible Implications for the Inflammatory Response. Front Immunol. 2021;12:655212 pubmed publisher
  65. Lomphithak T, Akara Amornthum P, Murakami K, Hashimoto M, Usubuchi H, Iwabuchi E, et al. Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma. Sci Rep. 2021;11:11743 pubmed publisher
  66. Kemp S, Carpenter E, Steele N, Donahue K, Nwosu Z, Pacheco A, et al. Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB-Mediated Production of CXCL1. Cancer Res. 2021;81:4305-4318 pubmed publisher
  67. Zimmer T, Broekaart D, Luinenburg M, Mijnsbergen C, Anink J, Sim N, et al. Balloon cells promote immune system activation in focal cortical dysplasia type 2b. Neuropathol Appl Neurobiol. 2021;47:826-839 pubmed publisher
  68. Glassman C, Su L, Majri Morrison S, Winkelmann H, Mo F, Li P, et al. Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist. elife. 2021;10: pubmed publisher
  69. Amoozgar Z, Kloepper J, Ren J, Tay R, Kazer S, Kiner E, et al. Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas. Nat Commun. 2021;12:2582 pubmed publisher
  70. Reis M, Willis G, Fernandez Gonzalez A, Yeung V, Taglauer E, Magaletta M, et al. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Restore Thymic Architecture and T Cell Function Disrupted by Neonatal Hyperoxia. Front Immunol. 2021;12:640595 pubmed publisher
  71. Zhang S, Li L, Xie D, Reddy S, Sleasman J, Ma L, et al. Regulation of Intrinsic and Bystander T Follicular Helper Cell Differentiation and Autoimmunity by Tsc1. Front Immunol. 2021;12:620437 pubmed publisher
  72. Go D, Lee S, Lee S, Woo S, Kim K, Kim K, et al. Programmed Death Ligand 1-Expressing Classical Dendritic Cells MitigateHelicobacter-Induced Gastritis. Cell Mol Gastroenterol Hepatol. 2021;12:715-739 pubmed publisher
  73. Lin X, Twelkmeyer T, Zhu D, Zhang L, Zhao Y, Zhang C, et al. Homeostatic regulation of T follicular helper and antibody response to particle antigens by IL-1Ra of medullary sinus macrophage origin. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  74. Gangoso E, Southgate B, Bradley L, Rus S, Gálvez Cancino F, McGivern N, et al. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion. Cell. 2021;184:2454-2470.e26 pubmed publisher
  75. Jhala G, Selck C, Chee J, Kwong C, Pappas E, Thomas H, et al. Tolerance to Proinsulin-1 Reduces Autoimmune Diabetes in NOD Mice. Front Immunol. 2021;12:645817 pubmed publisher
  76. Zheng W, Song H, Luo Z, Wu H, Chen L, Wang Y, et al. Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressor cells through the nAChR/ERK pathway. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  77. Borges P, Waclawiak I, Georgii J, Fraga Junior V, Barros J, Lemos F, et al. Adenosine Diphosphate Improves Wound Healing in Diabetic Mice Through P2Y12 Receptor Activation. Front Immunol. 2021;12:651740 pubmed publisher
  78. Roux C, Mucciolo G, Kopecka J, Novelli F, Riganti C, Cappello P. IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine. Antioxidants (Basel). 2021;10: pubmed publisher
  79. Harada Y, Kazama S, Morikawa T, Sonoda H, Ishi H, Emoto S, et al. Clinical significance of CD8+ and FoxP3+ tumor-infiltrating lymphocytes and MFG-E8 expression in lower rectal cancer with preoperative chemoradiotherapy. Mol Clin Oncol. 2021;14:87 pubmed publisher
  80. Goncalves S, Yin K, Ito Y, Chan A, Olan I, Gough S, et al. COX2 regulates senescence secretome composition and senescence surveillance through PGE2. Cell Rep. 2021;34:108860 pubmed publisher
  81. Kuroda H, Jamiyan T, Yamaguchi R, Kakumoto A, Abe A, Harada O, et al. Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast. BMC Cancer. 2021;21:286 pubmed publisher
  82. Brune M, Stussi G, Lundberg P, Vela V, Heim D, Manz M, et al. Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort. Ann Hematol. 2021;100:1169-1179 pubmed publisher
  83. Yin H, Zhang X, Yang P, Zhang X, Peng Y, Li D, et al. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat Commun. 2021;12:1394 pubmed publisher
  84. Choi Y, Kim Y, Oh S, Suh K, Kim Y, Lee G, et al. Senescent Tumor Cells Build a Cytokine Shield in Colorectal Cancer. Adv Sci (Weinh). 2021;8:2002497 pubmed publisher
  85. Can xe8 S, Van Snick J, Uyttenhove C, Pilotte L, van den Eynde B. TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism. J Immunother Cancer. 2021;9: pubmed publisher
  86. Zhang Y, Xiong D, Li Y, Xu G, Zhang B, Liu Y, et al. Schistosoma japonicum Infection in Treg-Specific USP21 Knockout Mice. J Immunol Res. 2021;2021:6613162 pubmed publisher
  87. Sun Z, Yao Y, You M, Liu J, Guo W, Qi Z, et al. The kinase PDK1 is critical for promoting T follicular helper cell differentiation. elife. 2021;10: pubmed publisher
  88. Mpekris F, Panagi M, Voutouri C, Martin J, Samuel R, Takahashi S, et al. Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano-immunotherapy in Breast Cancer Lung Metastasis. Adv Sci (Weinh). 2021;8:2001917 pubmed publisher
  89. Malone K, Diaz Diaz A, Shearer J, Moore A, Waeber C. The effect of fingolimod on regulatory T cells in a mouse model of brain ischaemia. J Neuroinflammation. 2021;18:37 pubmed publisher
  90. Phan T, Schink L, Mann J, Merk V, Zwicky P, Mundt S, et al. Keratinocytes control skin immune homeostasis through de novo-synthesized glucocorticoids. Sci Adv. 2021;7: pubmed publisher
  91. Nian Y, Iske J, Maenosono R, Minami K, Heinbokel T, Quante M, et al. Targeting age-specific changes in CD4+ T cell metabolism ameliorates alloimmune responses and prolongs graft survival. Aging Cell. 2021;20:e13299 pubmed publisher
  92. Steele N, Biffi G, Kemp S, Zhang Y, Drouillard D, Syu L, et al. Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer. Clin Cancer Res. 2021;: pubmed publisher
  93. Yang Y, Li X, Ma Z, Wang C, Yang Q, Byrne Steele M, et al. CTLA-4 expression by B-1a B cells is essential for immune tolerance. Nat Commun. 2021;12:525 pubmed publisher
  94. Kharkwal S, Johndrow C, Veerapen N, Kharkwal H, Saavedra Avila N, Carreño L, et al. Serial Stimulation of Invariant Natural Killer T Cells with Covalently Stabilized Bispecific T-cell Engagers Generates Antitumor Immunity While Avoiding Anergy. Cancer Res. 2021;81:1788-1801 pubmed publisher
  95. Brownlie D, Doughty Shenton D, Yh Soong D, Nixon C, O Carragher N, M Carlin L, et al. Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β. J Immunother Cancer. 2021;9: pubmed publisher
  96. Break T, Oikonomou V, Dutzan N, Desai J, Swidergall M, Freiwald T, et al. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science. 2021;371: pubmed publisher
  97. Sanmarco L, Wheeler M, Gutiérrez Vázquez C, Polonio C, Linnerbauer M, Pinho Ribeiro F, et al. Gut-licensed IFNγ+ NK cells drive LAMP1+TRAIL+ anti-inflammatory astrocytes. Nature. 2021;: pubmed publisher
  98. Suah A, Tran D, Khiew S, Andrade M, Pollard J, Jain D, et al. Pregnancy-induced humoral sensitization overrides T cell tolerance to fetus-matched allografts in mice. J Clin Invest. 2021;131: pubmed publisher
  99. Ebelt N, Zuniga E, Marzagalli M, Zamloot V, Blazar B, Salgia R, et al. Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Restructures the Immune Contexture to Improve Checkpoint Blockade Efficacy. Biomedicines. 2020;8: pubmed publisher
  100. Piszczatowska K, Przybylska D, Sikora E, Mosieniak G. Inhibition of NADPH Oxidases Activity by Diphenyleneiodonium Chloride as a Mechanism of Senescence Induction in Human Cancer Cells. Antioxidants (Basel). 2020;9: pubmed publisher
  101. Yasuoka M, Monteiro B, Fantinato Neto P, Paiano R, Fantoni D, Otsuki D, et al. Transient Pulmonary Artery Hypertension in Holstein Neonate Calves. Animals (Basel). 2020;10: pubmed publisher
  102. Zhang Z, Zheng Q, Liu Y, Sun L, Han P, Wang R, et al. Human CD133-positive hematopoietic progenitor cells enhance the malignancy of breast cancer cells. BMC Cancer. 2020;20:1158 pubmed publisher
  103. Witkowska Piłaszewicz O, Pingwara R, Winnicka A. The Effect of Physical Training on Peripheral Blood Mononuclear Cell Ex Vivo Proliferation, Differentiation, Activity, and Reactive Oxygen Species Production in Racehorses. Antioxidants (Basel). 2020;9: pubmed publisher
  104. Jensen I, Jensen S, Sjaastad F, Gibson Corley K, Dileepan T, Griffith T, et al. Sepsis impedes EAE disease development and diminishes autoantigen-specific naive CD4 T cells. elife. 2020;9: pubmed publisher
  105. Myers D, Abram C, Wildes D, Belwafa A, Welsh A, Schulze C, et al. Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity. Front Immunol. 2020;11:576310 pubmed publisher
  106. Zhao L, Hu S, Davila M, Yang J, Lin Y, Albanese J, et al. Coordinated co-migration of CCR10+ antibody-producing B cells with helper T cells for colonic homeostatic regulation. Mucosal Immunol. 2021;14:420-430 pubmed publisher
  107. Fernandes R, Li C, Wang G, Yang X, Savvides C, Glassman C, et al. Discovery of surrogate agonists for visceral fat Treg cells that modulate metabolic indices in vivo. elife. 2020;9: pubmed publisher
  108. Li N, Kang Y, Wang L, Huff S, Tang R, Hui H, et al. ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment. Proc Natl Acad Sci U S A. 2020;117:20159-20170 pubmed publisher
  109. Runyan C, Welch L, Lecuona E, Shigemura M, Amarelle L, Abdala Valencia H, et al. Impaired phagocytic function in CX3CR1+ tissue-resident skeletal muscle macrophages prevents muscle recovery after influenza A virus-induced pneumonia in old mice. Aging Cell. 2020;: pubmed publisher
  110. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  111. Peligero Cruz C, Givony T, Sebé Pedrós A, Dobes J, Kadouri N, Nevo S, et al. IL18 signaling promotes homing of mature Tregs into the thymus. elife. 2020;9: pubmed publisher
  112. Svensson M, Zoccheddu M, Yang S, Nygaard G, Secchi C, Doody K, et al. Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal. Sci Adv. 2020;6:eaba4353 pubmed publisher
  113. Seitz V, Kleo K, Dröge A, Schaper S, Elezkurtaj S, Bedjaoui N, et al. Evidence for a role of RUNX1 as recombinase cofactor for TCRβ rearrangements and pathological deletions in ETV6-RUNX1 ALL. Sci Rep. 2020;10:10024 pubmed publisher
  114. Ning Y, Ding J, Sun X, Xie Y, Su M, Ma C, et al. HDAC9 deficiency promotes tumor progression by decreasing the CD8+ dendritic cell infiltration of the tumor microenvironment. J Immunother Cancer. 2020;8: pubmed publisher
  115. Zhou S, Wu W, Wang Z, Wang Z, Su Q, Li X, et al. RelB regulates the homeostatic proliferation but not the function of Tregs. BMC Immunol. 2020;21:37 pubmed publisher
  116. Domingo Gonzalez R, Zanini F, Che X, Liu M, Jones R, Swift M, et al. Diverse homeostatic and immunomodulatory roles of immune cells in the developing mouse lung at single cell resolution. elife. 2020;9: pubmed publisher
  117. Yamamoto K, Venida A, Yano J, Biancur D, Kakiuchi M, Gupta S, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581:100-105 pubmed publisher
  118. Hanaoka H, Nishimoto T, Okazaki Y, Takeuchi T, Kuwana M. A unique thymus-derived regulatory T cell subset associated with systemic lupus erythematosus. Arthritis Res Ther. 2020;22:88 pubmed publisher
  119. Kim M, Chung Y, Kim H, Woo J, Ahn S, Park S. Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast. Breast Cancer Res. 2020;22:32 pubmed publisher
  120. Stebegg M, Bignon A, Hill D, Silva Cayetano A, Krueger C, Vanderleyden I, et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. elife. 2020;9: pubmed publisher
  121. von Roemeling C, Wang Y, Qie Y, Yuan H, Zhao H, Liu X, et al. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun. 2020;11:1508 pubmed publisher
  122. Zhang S, Liang W, Luo L, Sun S, Wang F. The role of T cell trafficking in CTLA-4 blockade-induced gut immunopathology. BMC Biol. 2020;18:29 pubmed publisher
  123. Fu Y, Ding Y, Wang Q, Zhu F, Tan Y, Lu X, et al. Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2. Sci Adv. 2020;6:eaay9269 pubmed publisher
  124. Bergmann B, Fei Y, Jirholt P, Hu Z, Bergquist M, Ali A, et al. Pre-treatment with IL2 gene therapy alleviates Staphylococcus aureus arthritis in mice. BMC Infect Dis. 2020;20:185 pubmed publisher
  125. Hu X, Deng Q, Ma L, Li Q, Chen Y, Liao Y, et al. Meningeal lymphatic vessels regulate brain tumor drainage and immunity. Cell Res. 2020;30:229-243 pubmed publisher
  126. Aslan K, Turco V, Blobner J, Sonner J, Liuzzi A, Núñez N, et al. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas. Nat Commun. 2020;11:931 pubmed publisher
  127. Ferrer Font L, Mehta P, Harmos P, Schmidt A, Chappell S, Price K, et al. High-dimensional analysis of intestinal immune cells during helminth infection. elife. 2020;9: pubmed publisher
  128. Theivanthiran B, Evans K, Devito N, Plebanek M, Sturdivant M, Wachsmuth L, et al. A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy. J Clin Invest. 2020;130:2570-2586 pubmed publisher
  129. Lee J, Zhang J, Chung Y, Kim J, Kook C, Gonzalez Navajas J, et al. Inhibition of IRF4 in dendritic cells by PRR-independent and -dependent signals inhibit Th2 and promote Th17 responses. elife. 2020;9: pubmed publisher
  130. Bell L, Lenhart A, Rosenwald A, Monoranu C, Berberich Siebelt F. Lymphoid Aggregates in the CNS of Progressive Multiple Sclerosis Patients Lack Regulatory T Cells. Front Immunol. 2019;10:3090 pubmed publisher
  131. Liu Z, Wen J, Wu C, Hu C, Wang J, Bao Q, et al. MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma. Aging (Albany NY). 2020;12:1213-1236 pubmed publisher
  132. Singh K, Leu J, Barnoud T, Vonteddu P, Gnanapradeepan K, Lin C, et al. African-centric TP53 variant increases iron accumulation and bacterial pathogenesis but improves response to malaria toxin. Nat Commun. 2020;11:473 pubmed publisher
  133. Lawenius L, Scheffler J, Gustafsson K, Henning P, Nilsson K, Colldén H, et al. Pasteurized Akkermansia muciniphila protects from fat mass gain but not from bone loss. Am J Physiol Endocrinol Metab. 2020;318:E480-E491 pubmed publisher
  134. Canel M, Taggart D, Sims A, Lonergan D, Waizenegger I, Serrels A. T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity. elife. 2020;9: pubmed publisher
  135. Kimura S, Nakamura Y, Kobayashi N, Shiroguchi K, Kawakami E, Mutoh M, et al. Osteoprotegerin-dependent M cell self-regulation balances gut infection and immunity. Nat Commun. 2020;11:234 pubmed publisher
  136. Lee J, Hall J, Kroehling L, Wu L, Najar T, Nguyen H, et al. Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease. Cell. 2020;180:79-91.e16 pubmed publisher
  137. Raphael I, Gomez Rivera F, Raphael R, Robinson R, Nalawade S, Forsthuber T. TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells. JCI Insight. 2019;4: pubmed publisher
  138. Williford J, Ishihara J, Ishihara A, Mansurov A, Hosseinchi P, Marchell T, et al. Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Sci Adv. 2019;5:eaay1357 pubmed publisher
  139. Guo C, Allen B, Hiam K, Dodd D, Van Treuren W, Higginbottom S, et al. Depletion of microbiome-derived molecules in the host using Clostridium genetics. Science. 2019;366: pubmed publisher
  140. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  141. Mantani P, Dunér P, Ljungcrantz I, Nilsson J, Bjorkbacka H, Fredrikson G. ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions. BMC Immunol. 2019;20:47 pubmed publisher
  142. Shima T, Shimoda M, Shigenobu T, Ohtsuka T, Nishimura T, Emoto K, et al. Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma. Cancer Sci. 2020;111:727-738 pubmed publisher
  143. Li A, Herbst R, Canner D, Schenkel J, Smith O, Kim J, et al. IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development. Cell Rep. 2019;29:2998-3008.e8 pubmed publisher
  144. Shi L, Wang J, Ding N, Zhang Y, Zhu Y, Dong S, et al. Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy. Nat Commun. 2019;10:5421 pubmed publisher
  145. Hang S, Paik D, Yao L, Kim E, Jamma T, Lu J, et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature. 2019;576:143-148 pubmed publisher
  146. Martínez Fábregas J, Wilmes S, Wang L, Hafer M, Pohler E, Lokau J, et al. Kinetics of cytokine receptor trafficking determine signaling and functional selectivity. elife. 2019;8: pubmed publisher
  147. Li Z, Wang H, Zeng Q, Yan J, Hu Y, Li H, et al. p65/miR-23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma. Cancer Med. 2020;9:711-723 pubmed publisher
  148. Wang L, Shen E, Luo L, Rabe H, Wang Q, Yin J, et al. Control of Germinal Center Localization and Lineage Stability of Follicular Regulatory T Cells by the Blimp1 Transcription Factor. Cell Rep. 2019;29:1848-1861.e6 pubmed publisher
  149. Alspach E, Lussier D, Miceli A, Kizhvatov I, DuPage M, Luoma A, et al. MHC-II neoantigens shape tumour immunity and response to immunotherapy. Nature. 2019;574:696-701 pubmed publisher
  150. Lin F, Meng X, Guo Y, Cao W, Liu W, Xia Q, et al. Epigenetic initiation of the TH17 differentiation program is promoted by Cxxc finger protein 1. Sci Adv. 2019;5:eaax1608 pubmed publisher
  151. Benechet A, De Simone G, Di Lucia P, Cilenti F, Barbiera G, Le Bert N, et al. Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming. Nature. 2019;574:200-205 pubmed publisher
  152. Wang P, Qi X, Xu G, Liu J, Guo J, Li X, et al. CCL28 promotes locomotor recovery after spinal cord injury via recruiting regulatory T cells. Aging (Albany NY). 2019;11:7402-7415 pubmed publisher
  153. Wolf Y, Bartok O, Patkar S, Eli G, Cohen S, Litchfield K, et al. UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma. Cell. 2019;179:219-235.e21 pubmed publisher
  154. Fu D, Senouthai S, Wang J, You Y. Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance. BMC Nephrol. 2019;20:350 pubmed publisher
  155. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed publisher
  156. Collins N, Han S, Enamorado M, Link V, Huang B, Moseman E, et al. The Bone Marrow Protects and Optimizes Immunological Memory during Dietary Restriction. Cell. 2019;178:1088-1101.e15 pubmed publisher
  157. Rosshart S, Herz J, Vassallo B, Hunter A, Wall M, Badger J, et al. Laboratory mice born to wild mice have natural microbiota and model human immune responses. Science. 2019;365: pubmed publisher
  158. Sorrentino C, Yin Z, Ciummo S, Lanuti P, Lu L, Marchisio M, et al. Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival. J Immunother Cancer. 2019;7:201 pubmed publisher
  159. Leclerc M, Voilin E, Gros G, Corgnac S, de Montpreville V, Validire P, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun. 2019;10:3345 pubmed publisher
  160. Ansaldo E, Slayden L, Ching K, Koch M, Wolf N, Plichta D, et al. Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis. Science. 2019;364:1179-1184 pubmed publisher
  161. Rosenbaum M, Gewies A, Pechloff K, Heuser C, Engleitner T, Gehring T, et al. Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells. Nat Commun. 2019;10:2352 pubmed publisher
  162. Di Pilato M, Kim E, Cadilha B, Prüßmann J, Nasrallah M, Seruggia D, et al. Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy. Nature. 2019;570:112-116 pubmed publisher
  163. Sharma N, Vacher J, Allison J. TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. Proc Natl Acad Sci U S A. 2019;116:10453-10462 pubmed publisher
  164. Del Duca E, Pavel A, Dubin C, Song T, Wallace E, Peng X, et al. Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy Individuals. J Invest Dermatol. 2019;139:2228-2232.e10 pubmed publisher
  165. Kotov J, Kotov D, Linehan J, Bardwell V, Gearhart M, Jenkins M. BCL6 corepressor contributes to Th17 cell formation by inhibiting Th17 fate suppressors. J Exp Med. 2019;216:1450-1464 pubmed publisher
  166. Kawalkowska J, Ogbechi J, Venables P, Williams R. cIAP1/2 inhibition synergizes with TNF inhibition in autoimmunity by down-regulating IL-17A and inducing Tregs. Sci Adv. 2019;5:eaaw5422 pubmed publisher
  167. Miao Y, Yang H, Levorse J, Yuan S, Polak L, Sribour M, et al. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells. Cell. 2019;177:1172-1186.e14 pubmed publisher
  168. Esterházy D, Canesso M, Mesin L, Muller P, de Castro T, Lockhart A, et al. Compartmentalized gut lymph node drainage dictates adaptive immune responses. Nature. 2019;569:126-130 pubmed publisher
  169. Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed publisher
  170. Visekruna A, Hartmann S, Sillke Y, Glauben R, Fischer F, Raifer H, et al. Intestinal development and homeostasis require activation and apoptosis of diet-reactive T cells. J Clin Invest. 2019;129:1972-1983 pubmed publisher
  171. Yao W, Rose J, Wang W, Seth S, Jiang H, Taguchi A, et al. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Nature. 2019;: pubmed publisher
  172. Chakarov S, Lim H, Tan L, Lim S, See P, Lum J, et al. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science. 2019;363: pubmed publisher
  173. Xing S, Gai K, Li X, Shao P, Zeng Z, Zhao X, et al. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. J Exp Med. 2019;: pubmed publisher
  174. Anandagoda N, Willis J, Hertweck A, Roberts L, Jackson I, Gökmen M, et al. microRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance. J Clin Invest. 2019;129:1257-1271 pubmed publisher
  175. Han D, Liu J, Chen C, Dong L, Liu Y, Chang R, et al. Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. Nature. 2019;566:270-274 pubmed publisher
  176. Lavoie S, Conway K, Lassen K, Jijon H, Pan H, Chun E, et al. The Crohn's disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response. elife. 2019;8: pubmed publisher
  177. Contijoch E, Britton G, Yang C, Mogno I, Li Z, Ng R, et al. Gut microbiota density influences host physiology and is shaped by host and microbial factors. elife. 2019;8: pubmed publisher
  178. Wheeler M, Jaronen M, Covacu R, Zandee S, Scalisi G, Rothhammer V, et al. Environmental Control of Astrocyte Pathogenic Activities in CNS Inflammation. Cell. 2019;176:581-596.e18 pubmed publisher
  179. Britton G, Contijoch E, Mogno I, Vennaro O, Llewellyn S, Ng R, et al. Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice. Immunity. 2019;50:212-224.e4 pubmed publisher
  180. Silva D, Yu S, Ulge U, Spangler J, Jude K, Labao Almeida C, et al. De novo design of potent and selective mimics of IL-2 and IL-15. Nature. 2019;565:186-191 pubmed publisher
  181. Maseda D, Banerjee A, Johnson E, Washington M, Kim H, Lau K, et al. mPGES-1-Mediated Production of PGE2 and EP4 Receptor Sensing Regulate T Cell Colonic Inflammation. Front Immunol. 2018;9:2954 pubmed publisher
  182. Cornelissen L, Blanas A, van der Horst J, Kruijssen L, Zaal A, O Toole T, et al. Disruption of sialic acid metabolism drives tumor growth by augmenting CD8+ T cell apoptosis. Int J Cancer. 2019;144:2290-2302 pubmed publisher
  183. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  184. Tordesillas L, Lozano Ojalvo D, Dunkin D, Mondoulet L, Agudo J, Merad M, et al. PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs. Nat Commun. 2018;9:5238 pubmed publisher
  185. Garić D, Tao S, Ahmed E, Youssef M, Kanagaratham C, Shah J, et al. Depletion of BAFF cytokine exacerbates infection in Pseudomonas aeruginosa infected mice. J Cyst Fibros. 2019;18:349-356 pubmed publisher
  186. Quandt J, Schlude C, Bartoschek M, Will R, Cid Arregui A, Schölch S, et al. Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses. Oncoimmunology. 2018;7:e1500671 pubmed publisher
  187. Fiore A, Ugel S, De Sanctis F, Sandri S, Fracasso G, Trovato R, et al. Induction of immunosuppressive functions and NF-κB by FLIP in monocytes. Nat Commun. 2018;9:5193 pubmed publisher
  188. Sato Y, Bolzenius J, Eteleeb A, Su X, Maher C, Sehn J, et al. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade. JCI Insight. 2018;3: pubmed publisher
  189. Kiyohara H, Sujino T, Teratani T, Miyamoto K, Arai M, Nomura E, et al. Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells. Cell Mol Gastroenterol Hepatol. 2019;7:135-156 pubmed publisher
  190. Atretkhany K, Mufazalov I, Dunst J, Kuchmiy A, Gogoleva V, Andruszewski D, et al. Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity. Proc Natl Acad Sci U S A. 2018;115:13051-13056 pubmed publisher
  191. Aarts S, Seijkens T, Kusters P, Van Tiel C, Reiche M, den Toom M, et al. Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis. J Pathol. 2019;247:471-480 pubmed publisher
  192. Dong S, Harrington B, Hu E, Greene J, Lehman A, Tran M, et al. PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression. J Clin Invest. 2019;129:122-136 pubmed publisher
  193. Sharma D, Malik A, Guy C, Vogel P, Kanneganti T. TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy. J Clin Invest. 2019;129:150-162 pubmed publisher
  194. Grohmann M, Wiede F, Dodd G, Gurzov E, Ooi G, Butt T, et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018;175:1289-1306.e20 pubmed publisher
  195. He Z, Zhang J, Huang Z, Du Q, Li N, Zhang Q, et al. Sumoylation of RORγt regulates TH17 differentiation and thymocyte development. Nat Commun. 2018;9:4870 pubmed publisher
  196. Singh A, Khare P, Obaid A, Conlon K, Basrur V, Depinho R, et al. SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2. Nat Commun. 2018;9:4515 pubmed publisher
  197. Humblet Baron S, Barber J, Roca C, Lenaerts A, Koni P, Liston A. Murine myeloproliferative disorder as a consequence of impaired collaboration between dendritic cells and CD4 T cells. Blood. 2018;: pubmed publisher
  198. Mollaoglu G, Jones A, Wait S, Mukhopadhyay A, Jeong S, Arya R, et al. The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment. Immunity. 2018;49:764-779.e9 pubmed publisher
  199. Hoang T, Harper J, Pino M, Wang H, Micci L, King C, et al. Bone Marrow-Derived CD4+ T Cells Are Depleted in Simian Immunodeficiency Virus-Infected Macaques and Contribute to the Size of the Replication-Competent Reservoir. J Virol. 2019;93: pubmed publisher
  200. Masuda J, Umemura C, Yokozawa M, Yamauchi K, Seko T, Yamashita M, et al. Dietary Supplementation of Selenoneine-Containing Tuna Dark Muscle Extract Effectively Reduces Pathology of Experimental Colorectal Cancers in Mice. Nutrients. 2018;10: pubmed publisher
  201. Schrand B, Clark E, Levay A, Capote A, Martínez O, Brenneman R, et al. Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity. Nat Commun. 2018;9:3348 pubmed publisher
  202. Zhao D, Kim Y, Jeong S, Greenson J, Chaudhry M, Hoepting M, et al. Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease. J Clin Invest. 2018;128:4970-4979 pubmed publisher
  203. Deason K, Troutman T, Jain A, Challa D, Mandraju R, Brewer T, et al. BCAP links IL-1R to the PI3K-mTOR pathway and regulates pathogenic Th17 cell differentiation. J Exp Med. 2018;215:2413-2428 pubmed publisher
  204. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed publisher
  205. Stathopoulou C, Gangaplara A, Mallett G, Flomerfelt F, Liniany L, Knight D, et al. PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells. Immunity. 2018;49:247-263.e7 pubmed publisher
  206. Baens M, Stirparo R, Lampi Y, Verbeke D, Vandepoel R, Cools J, et al. Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice. Eur J Immunol. 2018;48:1728-1738 pubmed publisher
  207. Cho S, Lee H, Yu I, Choi Y, Huang H, Hashemifar S, et al. Differential cell-intrinsic regulations of germinal center B and T cells by miR-146a and miR-146b. Nat Commun. 2018;9:2757 pubmed publisher
  208. Li J, Byrne K, Yan F, Yamazoe T, Chen Z, Baslan T, et al. Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy. Immunity. 2018;49:178-193.e7 pubmed publisher
  209. Daenthanasanmak A, Wu Y, Iamsawat S, Nguyen H, Bastian D, Zhang M, et al. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J Clin Invest. 2018;128:2787-2801 pubmed publisher
  210. Zhao S, Ding J, Wang S, Li C, Guo P, Zhang M, et al. Decreased expression of circulating Aire and increased Tfh/Tfr cells in myasthenia gravis patients. Biosci Rep. 2018;38: pubmed publisher
  211. Kyung D, Sung H, Kim Y, Kim K, Cho S, Choi J, et al. Global transcriptome analysis identifies weight regain-induced activation of adaptive immune responses in white adipose tissue of mice. Int J Obes (Lond). 2018;42:755-764 pubmed publisher
  212. Ubil E, Caskey L, Holtzhausen A, Hunter D, Story C, Earp H. Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response. J Clin Invest. 2018;128:2356-2369 pubmed publisher
  213. Emmerson A, Trevelin S, Mongue Din H, Becker P, Ortiz C, Smyth L, et al. Nox2 in regulatory T cells promotes angiotensin II-induced cardiovascular remodeling. J Clin Invest. 2018;128:3088-3101 pubmed publisher
  214. Georgiev H, Ravens I, Papadogianni G, Halle S, Malissen B, Loots G, et al. Shared and Unique Features Distinguishing Follicular T Helper and Regulatory Cells of Peripheral Lymph Node and Peyer's Patches. Front Immunol. 2018;9:714 pubmed publisher
  215. Tanaka S, Pfleger C, Lai J, Roan F, Sun S, Ziegler S. KAP1 Regulates Regulatory T Cell Function and Proliferation in Both Foxp3-Dependent and -Independent Manners. Cell Rep. 2018;23:796-807 pubmed publisher
  216. Silva M, Davoli Ferreira M, Medina T, Sesti Costa R, Silva G, Lopes C, et al. Canonical PI3Kγ signaling in myeloid cells restricts Trypanosoma cruzi infection and dampens chagasic myocarditis. Nat Commun. 2018;9:1513 pubmed publisher
  217. Varelias A, Bunting M, Ormerod K, Koyama M, Olver S, Straube J, et al. Recipient mucosal-associated invariant T cells control GVHD within the colon. J Clin Invest. 2018;128:1919-1936 pubmed publisher
  218. Prado C, Gaiazzi M, Gonzalez H, Ugalde V, Figueroa A, Osorio Barrios F, et al. Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis. Front Immunol. 2018;9:571 pubmed publisher
  219. Kornberg M, Bhargava P, Kim P, Putluri V, Snowman A, Putluri N, et al. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science. 2018;360:449-453 pubmed publisher
  220. Mencarelli A, Khameneh H, Fric J, Vacca M, El Daker S, Janela B, et al. Calcineurin-mediated IL-2 production by CD11chighMHCII+ myeloid cells is crucial for intestinal immune homeostasis. Nat Commun. 2018;9:1102 pubmed publisher
  221. Gaddis D, Padgett L, Wu R, McSkimming C, Romines V, Taylor A, et al. Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis. Nat Commun. 2018;9:1095 pubmed publisher
  222. Macdougall C, Wood E, Loschko J, Scagliotti V, Cassidy F, Robinson M, et al. Visceral Adipose Tissue Immune Homeostasis Is Regulated by the Crosstalk between Adipocytes and Dendritic Cell Subsets. Cell Metab. 2018;27:588-601.e4 pubmed publisher
  223. Sockolosky J, Trotta E, Parisi G, Picton L, Su L, Le A, et al. Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes. Science. 2018;359:1037-1042 pubmed publisher
  224. Kornete M, Marone R, Jeker L. Highly Efficient and Versatile Plasmid-Based Gene Editing in Primary T Cells. J Immunol. 2018;200:2489-2501 pubmed publisher
  225. Kim I, Kim K, Lee E, Oh D, Park C, Park S, et al. Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality. J Exp Med. 2018;215:963-983 pubmed publisher
  226. Qu S, Xue H, Dong X, Lin D, Wu R, Nabavi N, et al. Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model. Int J Cancer. 2018;143:419-429 pubmed publisher
  227. Kotov D, Kotov J, Goldberg M, Jenkins M. Many Th Cell Subsets Have Fas Ligand-Dependent Cytotoxic Potential. J Immunol. 2018;200:2004-2012 pubmed publisher
  228. Perry C, Muñoz Rojas A, Meeth K, Kellman L, Amezquita R, Thakral D, et al. Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity. J Exp Med. 2018;215:877-893 pubmed publisher
  229. Seki A, Rutz S. Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells. J Exp Med. 2018;215:985-997 pubmed publisher
  230. Hsieh W, Hsu T, Chang Y, Lai M. IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells. Nat Commun. 2018;9:463 pubmed publisher
  231. Wheeler D, Sariol A, Meyerholz D, Perlman S. Microglia are required for protection against lethal coronavirus encephalitis in mice. J Clin Invest. 2018;128:931-943 pubmed publisher
  232. Lu Y, Kim N, Jiang Y, Zhang H, Zheng D, Zhu F, et al. Cambogin suppresses dextran sulphate sodium-induced colitis by enhancing Treg cell stability and function. Br J Pharmacol. 2018;175:1085-1099 pubmed publisher
  233. Capucha T, Koren N, Nassar M, Heyman O, Nir T, Levy M, et al. Sequential BMP7/TGF-β1 signaling and microbiota instruct mucosal Langerhans cell differentiation. J Exp Med. 2018;215:481-500 pubmed publisher
  234. Ferdinand J, Richard A, Meylan F, Al Shamkhani A, Siegel R. Cleavage of TL1A Differentially Regulates Its Effects on Innate and Adaptive Immune Cells. J Immunol. 2018;200:1360-1369 pubmed publisher
  235. Fontaine M, Vogel I, Van Eycke Y, Galuppo A, Ajouaou Y, Decaestecker C, et al. Regulatory T cells constrain the TCR repertoire of antigen-stimulated conventional CD4 T cells. EMBO J. 2018;37:398-412 pubmed publisher
  236. Guimarães G, Gomes M, Campos P, Marinho F, de Assis N, Silveira T, et al. Immunoproteasome Subunits Are Required for CD8+ T Cell Function and Host Resistance to Brucella abortus Infection in Mice. Infect Immun. 2018;86: pubmed publisher
  237. Bäcker V, Cheung F, Siveke J, Fandrey J, Winning S. Knockdown of myeloid cell hypoxia-inducible factor-1? ameliorates the acute pathology in DSS-induced colitis. PLoS ONE. 2017;12:e0190074 pubmed publisher
  238. Burrack A, Malhotra D, Dileepan T, Osum K, Swanson L, Fife B, et al. Cutting Edge: Allograft Rejection Is Associated with Weak T Cell Responses to Many Different Graft Leukocyte-Derived Peptides. J Immunol. 2018;200:477-482 pubmed publisher
  239. Maseda D, Johnson E, Nyhoff L, Baron B, Kojima F, Wilhelm A, et al. mPGES1-Dependent Prostaglandin E2 (PGE2) Controls Antigen-Specific Th17 and Th1 Responses by Regulating T Autocrine and Paracrine PGE2 Production. J Immunol. 2018;200:725-736 pubmed publisher
  240. Mailer R, Gisterå A, Polyzos K, Ketelhuth D, Hansson G. Hypercholesterolemia Enhances T Cell Receptor Signaling and Increases the Regulatory T Cell Population. Sci Rep. 2017;7:15655 pubmed publisher
  241. Blom S, Paavolainen L, Bychkov D, Turkki R, Mäki Teeri P, Hemmes A, et al. Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis. Sci Rep. 2017;7:15580 pubmed publisher
  242. Kwak J, Laskowski J, Li H, McSharry M, Sippel T, Bullock B, et al. Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression. Cancer Res. 2018;78:143-156 pubmed publisher
  243. Wasiuk A, Testa J, Weidlick J, Sisson C, Vitale L, Widger J, et al. CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy. J Immunol. 2017;199:4110-4123 pubmed publisher
  244. Matsuyama K, Mizutani Y, Takahashi T, Shu E, Kanoh H, Miyazaki T, et al. Enhanced dendritic cells and regulatory T cells in the dermis of porokeratosis. Arch Dermatol Res. 2017;309:749-756 pubmed publisher
  245. Li B, Wang X, Choi I, Wang Y, Liu S, Pham A, et al. miR-146a modulates autoreactive Th17 cell differentiation and regulates organ-specific autoimmunity. J Clin Invest. 2017;127:3702-3716 pubmed publisher
  246. Goel S, Decristo M, Watt A, BrinJones H, Sceneay J, Li B, et al. CDK4/6 inhibition triggers anti-tumour immunity. Nature. 2017;548:471-475 pubmed publisher
  247. Yi W, Gupta S, Ricker E, Manni M, Jessberger R, Chinenov Y, et al. The mTORC1-4E-BP-eIF4E axis controls de novo Bcl6 protein synthesis in T cells and systemic autoimmunity. Nat Commun. 2017;8:254 pubmed publisher
  248. Funken D, Ishikawa Ankerhold H, Uhl B, Lerchenberger M, Rentsch M, Mayr D, et al. In situ targeting of dendritic cells sets tolerogenic environment and ameliorates CD4+ T-cell response in the postischemic liver. FASEB J. 2017;31:4796-4808 pubmed publisher
  249. Kyratsous N, Bauer I, Zhang G, Pesic M, Bartholomäus I, Mues M, et al. Visualizing context-dependent calcium signaling in encephalitogenic T cells in vivo by two-photon microscopy. Proc Natl Acad Sci U S A. 2017;114:E6381-E6389 pubmed publisher
  250. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed publisher
  251. Sitrin J, Suto E, Wuster A, Eastham Anderson J, Kim J, Austin C, et al. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice. J Immunol. 2017;199:1238-1249 pubmed publisher
  252. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  253. Zheng C, Zheng L, Yoo J, Guo H, Zhang Y, Guo X, et al. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell. 2017;169:1342-1356.e16 pubmed publisher
  254. Seifert H, Benedek G, Liang J, Nguyen H, Kent G, Vandenbark A, et al. Sex differences in regulatory cells in experimental stroke. Cell Immunol. 2017;318:49-54 pubmed publisher
  255. Xie M, Koh B, Hollister K, Wu H, Sun J, Kaplan M, et al. Bcl6 promotes follicular helper T-cell differentiation and PD-1 expression in a Blimp1-independent manner in mice. Eur J Immunol. 2017;47:1136-1141 pubmed publisher
  256. Hasan Z, Koizumi S, Sasaki D, Yamada H, Arakaki N, Fujihara Y, et al. JunB is essential for IL-23-dependent pathogenicity of Th17 cells. Nat Commun. 2017;8:15628 pubmed publisher
  257. Li C, Leng Y, Zhao B, Gao C, Du F, Jin N, et al. Human iPSC-MSC-Derived Xenografts Modulate Immune Responses by Inhibiting the Cleavage of Caspases. Stem Cells. 2017;35:1719-1732 pubmed publisher
  258. Tang A, Choi J, Kotzin J, Yang Y, Hong C, Hobson N, et al. Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature. 2017;545:305-310 pubmed publisher
  259. Burton O, Tamayo J, Stranks A, Koleoglou K, Oettgen H. Allergen-specific IgG antibody signaling through FcγRIIb promotes food tolerance. J Allergy Clin Immunol. 2018;141:189-201.e3 pubmed publisher
  260. Bagchi S, He Y, Zhang H, Cao L, Van Rhijn I, Moody D, et al. CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice. J Clin Invest. 2017;127:2339-2352 pubmed publisher
  261. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  262. Meinicke H, Bremser A, Brack M, Schrenk K, Pircher H, Izcue A. KLRG1 impairs regulatory T-cell competitive fitness in the gut. Immunology. 2017;152:65-73 pubmed publisher
  263. Meinicke H, Bremser A, Brack M, Akeus P, Pearson C, Bullers S, et al. Tumour-associated changes in intestinal epithelial cells cause local accumulation of KLRG1+ GATA3+ regulatory T cells in mice. Immunology. 2017;152:74-88 pubmed publisher
  264. Angelin A, Gil de Gómez L, Dahiya S, Jiao J, Guo L, Levine M, et al. Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments. Cell Metab. 2017;25:1282-1293.e7 pubmed publisher
  265. Garg G, Nikolouli E, Hardtke Wolenski M, Toker A, Ohkura N, Beckstette M, et al. Unique properties of thymic antigen-presenting cells promote epigenetic imprinting of alloantigen-specific regulatory T cells. Oncotarget. 2017;8:35542-35557 pubmed publisher
  266. Fu G, Xu Q, Qiu Y, Jin X, Xu T, Dong S, et al. Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1. J Exp Med. 2017;214:1453-1469 pubmed publisher
  267. Zemmour D, Pratama A, Loughhead S, Mathis D, Benoist C. Flicr, a long noncoding RNA, modulates Foxp3 expression and autoimmunity. Proc Natl Acad Sci U S A. 2017;114:E3472-E3480 pubmed publisher
  268. Melis D, Carbone F, Minopoli G, La Rocca C, Perna F, De Rosa V, et al. Cutting Edge: Increased Autoimmunity Risk in Glycogen Storage Disease Type 1b Is Associated with a Reduced Engagement of Glycolysis in T Cells and an Impaired Regulatory T Cell Function. J Immunol. 2017;198:3803-3808 pubmed publisher
  269. Bouziat R, Hinterleitner R, Brown J, Stencel Baerenwald J, Ikizler M, Mayassi T, et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science. 2017;356:44-50 pubmed publisher
  270. Bruce D, Stefanski H, Vincent B, Dant T, Reisdorf S, Bommiasamy H, et al. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest. 2017;127:1813-1825 pubmed publisher
  271. Tian L, Goldstein A, Wang H, Ching Lo H, Sun Kim I, Welte T, et al. Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming. Nature. 2017;544:250-254 pubmed publisher
  272. Liu Z, Ravindranathan R, Kalinski P, Guo Z, Bartlett D. Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy. Nat Commun. 2017;8:14754 pubmed publisher
  273. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed publisher
  274. Ansa Addo E, Zhang Y, Yang Y, Hussey G, Howley B, Salem M, et al. Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-β signaling. J Clin Invest. 2017;127:1321-1337 pubmed publisher
  275. Ramos G, van den Berg A, Nunes Silva V, Weirather J, Peters L, Burkard M, et al. Myocardial aging as a T-cell-mediated phenomenon. Proc Natl Acad Sci U S A. 2017;114:E2420-E2429 pubmed publisher
  276. Fisher S, Aston W, Chee J, Khong A, Cleaver A, Solin J, et al. Transient Treg depletion enhances therapeutic anti-cancer vaccination. Immun Inflamm Dis. 2017;5:16-28 pubmed publisher
  277. Komegae E, Souza T, Grund L, Lima C, Lopes Ferreira M. Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis. PLoS ONE. 2017;12:e0171796 pubmed publisher
  278. Huang R, Francois A, McGray A, Miliotto A, Odunsi K. Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer. Oncoimmunology. 2017;6:e1249561 pubmed publisher
  279. Zamarin D, Holmgaard R, Ricca J, Plitt T, Palese P, Sharma P, et al. Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity. Nat Commun. 2017;8:14340 pubmed publisher
  280. Ying W, Wollam J, Ofrecio J, Bandyopadhyay G, El Ouarrat D, Lee Y, et al. Adipose tissue B2 cells promote insulin resistance through leukotriene LTB4/LTB4R1 signaling. J Clin Invest. 2017;127:1019-1030 pubmed publisher
  281. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  282. Zhang H, Qi Y, Yuan Y, Cai L, Xu H, Zhang L, et al. Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation. Sci Rep. 2017;7:41887 pubmed publisher
  283. Ramjee V, Li D, Manderfield L, Liu F, Engleka K, Aghajanian H, et al. Epicardial YAP/TAZ orchestrate an immunosuppressive response following myocardial infarction. J Clin Invest. 2017;127:899-911 pubmed publisher
  284. Asano T, Meguri Y, Yoshioka T, Kishi Y, Iwamoto M, Nakamura M, et al. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. Blood. 2017;129:2186-2197 pubmed publisher
  285. Kempińska Podhorodecka A, Milkiewicz M, Wasik U, Ligocka J, Zawadzki M, Krawczyk M, et al. Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway. Int J Mol Sci. 2017;18: pubmed publisher
  286. Berlato C, Khan M, Schioppa T, Thompson R, Maniati E, Montfort A, et al. A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer. J Clin Invest. 2017;127:801-813 pubmed publisher
  287. Goverse G, Molenaar R, Macia L, Tan J, Erkelens M, Konijn T, et al. Diet-Derived Short Chain Fatty Acids Stimulate Intestinal Epithelial Cells To Induce Mucosal Tolerogenic Dendritic Cells. J Immunol. 2017;198:2172-2181 pubmed publisher
  288. Yanagita T, Murata Y, Tanaka D, Motegi S, Arai E, Daniwijaya E, et al. Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy. JCI Insight. 2017;2:e89140 pubmed publisher
  289. Rowe A, Yun H, Treat B, Kinchington P, Hendricks R. Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated Pathogen. J Immunol. 2017;198:1706-1717 pubmed publisher
  290. Mizutani H, Tamagawa Mineoka R, Minami Y, Yagita K, Katoh N. Constant light exposure impairs immune tolerance development in mice. J Dermatol Sci. 2017;86:63-70 pubmed publisher
  291. Xu X, Han L, Zhao G, Xue S, Gao Y, Xiao J, et al. LRCH1 interferes with DOCK8-Cdc42-induced T cell migration and ameliorates experimental autoimmune encephalomyelitis. J Exp Med. 2017;214:209-226 pubmed publisher
  292. Boardman D, Philippeos C, Fruhwirth G, Ibrahim M, Hannen R, Cooper D, et al. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. Am J Transplant. 2017;17:931-943 pubmed publisher
  293. Tuncel J, Haag S, Holmdahl R. MHC class II alleles associated with Th1 rather than Th17 type immunity drive the onset of early arthritis in a rat model of rheumatoid arthritis. Eur J Immunol. 2017;47:563-574 pubmed publisher
  294. Hayakawa M, Hayakawa H, Petrova T, Ritprajak P, Sutavani R, Jiménez Andrade G, et al. Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell Induction. J Biol Chem. 2017;292:1762-1772 pubmed publisher
  295. Aguilera T, Rafat M, Castellini L, Shehade H, Kariolis M, Hui A, et al. Reprogramming the immunological microenvironment through radiation and targeting Axl. Nat Commun. 2016;7:13898 pubmed publisher
  296. Hashimoto Hill S, Friesen L, Kim M, Kim C. Contraction of intestinal effector T cells by retinoic acid-induced purinergic receptor P2X7. Mucosal Immunol. 2017;10:912-923 pubmed publisher
  297. Wei Y, Lu C, Chen J, Cui G, Wang L, Yu T, et al. High salt diet stimulates gut Th17 response and exacerbates TNBS-induced colitis in mice. Oncotarget. 2017;8:70-82 pubmed publisher
  298. Yokota Nakatsuma A, Ohoka Y, Takeuchi H, Song S, Iwata M. Beta 1-integrin ligation and TLR ligation enhance GM-CSF-induced ALDH1A2 expression in dendritic cells, but differentially regulate their anti-inflammatory properties. Sci Rep. 2016;6:37914 pubmed publisher
  299. Hammer A, Yang G, Friedrich J, Kovacs A, Lee D, Grave K, et al. Role of the receptor Mas in macrophage-mediated inflammation in vivo. Proc Natl Acad Sci U S A. 2016;113:14109-14114 pubmed
  300. Senbabaoglu Y, Gejman R, Winer A, Liu M, Van Allen E, de Velasco G, et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 2016;17:231 pubmed
  301. Sundara Y, Kostine M, Cleven A, Bovee J, Schilham M, Cleton Jansen A. Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy. Cancer Immunol Immunother. 2017;66:119-128 pubmed publisher
  302. Escalante N, Lemire P, Cruz Tleugabulova M, Prescott D, Mortha A, Streutker C, et al. The common mouse protozoa Tritrichomonas muris alters mucosal T cell homeostasis and colitis susceptibility. J Exp Med. 2016;213:2841-2850 pubmed
  303. Cummings R, Barbet G, Bongers G, Hartmann B, Gettler K, Muniz L, et al. Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs. Nature. 2016;539:565-569 pubmed publisher
  304. Shirakawa K, Yan X, Shinmura K, Endo J, Kataoka M, Katsumata Y, et al. Obesity accelerates T cell senescence in murine visceral adipose tissue. J Clin Invest. 2016;126:4626-4639 pubmed publisher
  305. Hu Y, Kim J, He K, Wan Q, Kim J, Flach M, et al. Scramblase TMEM16F terminates T cell receptor signaling to restrict T cell exhaustion. J Exp Med. 2016;213:2759-2772 pubmed
  306. Shifrin N, Kissiov D, Ardolino M, Joncker N, Raulet D. Differential Role of Hematopoietic and Nonhematopoietic Cell Types in the Regulation of NK Cell Tolerance and Responsiveness. J Immunol. 2016;197:4127-4136 pubmed publisher
  307. Kwong Chung C, Ronchi F, Geuking M. Detrimental effect of systemic antimicrobial CD4+ T-cell reactivity on gut epithelial integrity. Immunology. 2017;150:221-235 pubmed publisher
  308. Kaewkangsadan V, Verma C, Eremin J, Cowley G, Ilyas M, Eremin O. Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer. J Immunol Res. 2016;2016:4757405 pubmed
  309. Massaad M, Zhou J, Tsuchimoto D, Chou J, Jabara H, Janssen E, et al. Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity. J Clin Invest. 2016;126:4219-4236 pubmed publisher
  310. Ogiya R, Niikura N, Kumaki N, Bianchini G, Kitano S, Iwamoto T, et al. Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients. Cancer Sci. 2016;107:1730-1735 pubmed publisher
  311. Gerriets V, Kishton R, Johnson M, Cohen S, Siska P, Nichols A, et al. Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression. Nat Immunol. 2016;17:1459-1466 pubmed publisher
  312. Klotz L, Kuzmanov I, Hucke S, Gross C, Posevitz V, Dreykluft A, et al. B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6182-E6191 pubmed
  313. Roncagalli R, Cucchetti M, Jarmuzynski N, Gregoire C, Bergot E, Audebert S, et al. The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells. J Exp Med. 2016;213:2437-2457 pubmed
  314. Lexmond W, Goettel J, Lyons J, Jacobse J, Deken M, Lawrence M, et al. FOXP3+ Tregs require WASP to restrain Th2-mediated food allergy. J Clin Invest. 2016;126:4030-4044 pubmed publisher
  315. Butcher M, Filipowicz A, Waseem T, McGary C, Crow K, Magilnick N, et al. Atherosclerosis-Driven Treg Plasticity Results in Formation of a Dysfunctional Subset of Plastic IFN?+ Th1/Tregs. Circ Res. 2016;119:1190-1203 pubmed publisher
  316. Klarquist J, Tobin K, Farhangi Oskuei P, Henning S, Fernandez M, Dellacecca E, et al. Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma. Cancer Res. 2016;76:6230-6240 pubmed
  317. Uhde A, Herder V, Akram Khan M, Ciurkiewicz M, Schaudien D, Teich R, et al. Viral Infection of the Central Nervous System Exacerbates Interleukin-10 Receptor Deficiency-Mediated Colitis in SJL Mice. PLoS ONE. 2016;11:e0161883 pubmed publisher
  318. Jou Y, Tsai Y, Lin C, Tung C, Shen C, Tsai H, et al. Foxp3 enhances HIF-1α target gene expression in human bladder cancer through decreasing its ubiquitin-proteasomal degradation. Oncotarget. 2016;7:65403-65417 pubmed publisher
  319. Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J Exp Med. 2016;213:1881-900 pubmed publisher
  320. Lund A, Wagner M, Fankhauser M, Steinskog E, Broggi M, Spranger S, et al. Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Invest. 2016;126:3389-402 pubmed publisher
  321. Moodley D, Yoshida H, Mostafavi S, Asinovski N, Ortiz Lopez A, Symanowicz P, et al. Network pharmacology of JAK inhibitors. Proc Natl Acad Sci U S A. 2016;113:9852-7 pubmed publisher
  322. Torrelo A, Noguera Morel L, Hernandez Martin A, Clemente D, Barja J, Buzon L, et al. Recurrent lipoatrophic panniculitis of children. J Eur Acad Dermatol Venereol. 2017;31:536-543 pubmed publisher
  323. Liu H, Jain R, Guan J, Vuong V, Ishido S, La Gruta N, et al. Ubiquitin ligase MARCH 8 cooperates with CD83 to control surface MHC II expression in thymic epithelium and CD4 T cell selection. J Exp Med. 2016;213:1695-703 pubmed publisher
  324. Shi L, Fu T, Guan B, Chen J, Blando J, Allison J, et al. Interdependent IL-7 and IFN-? signalling in T-cell controls tumour eradication by combined ?-CTLA-4+?-PD-1 therapy. Nat Commun. 2016;7:12335 pubmed publisher
  325. Pizzolla A, Oh D, Luong S, Prickett S, Henstridge D, Febbraio M, et al. High Fat Diet Inhibits Dendritic Cell and T Cell Response to Allergens but Does Not Impair Inhalational Respiratory Tolerance. PLoS ONE. 2016;11:e0160407 pubmed publisher
  326. Cheng H, Gaddis D, Wu R, McSkimming C, Haynes L, Taylor A, et al. Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest. 2016;126:3236-46 pubmed publisher
  327. Ferreirinha P, Pérez Cabezas B, Correia A, Miyazawa B, França A, Carvalhais V, et al. Poly-N-Acetylglucosamine Production by Staphylococcus epidermidis Cells Increases Their In Vivo Proinflammatory Effect. Infect Immun. 2016;84:2933-43 pubmed publisher
  328. Alberdi M, Iglesias M, Tejedor S, Merino R, Lopez Rodriguez C, Aramburu J. Context-dependent regulation of Th17-associated genes and IFN? expression by the transcription factor NFAT5. Immunol Cell Biol. 2017;95:56-67 pubmed publisher
  329. Chen H, Händel N, Ngeow J, Muller J, Huhn M, Yang H, et al. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol. 2017;139:607-620.e15 pubmed publisher
  330. Biton J, Khaleghparast Athari S, Thiolat A, Santinon F, Lemeiter D, Hervé R, et al. In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis. J Immunol. 2016;197:1708-19 pubmed publisher
  331. Seifert A, Zeng S, Zhang J, Kim T, Cohen N, Beckman M, et al. PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors. Clin Cancer Res. 2017;23:454-465 pubmed publisher
  332. Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, et al. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. Clin Cancer Res. 2017;23:149-158 pubmed publisher
  333. Stifter K, Schuster C, Schlosser M, Boehm B, Schirmbeck R. Exploring the induction of preproinsulin-specific Foxp3(+) CD4(+) Treg cells that inhibit CD8(+) T cell-mediated autoimmune diabetes by DNA vaccination. Sci Rep. 2016;6:29419 pubmed publisher
  334. Riedel A, Shorthouse D, Haas L, Hall B, Shields J. Tumor-induced stromal reprogramming drives lymph node transformation. Nat Immunol. 2016;17:1118-27 pubmed publisher
  335. Orta Mascaró M, Consuegra Fernández M, Carreras E, Roncagalli R, Carreras Sureda A, Alvarez P, et al. CD6 modulates thymocyte selection and peripheral T cell homeostasis. J Exp Med. 2016;213:1387-97 pubmed publisher
  336. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed publisher
  337. Brinkman C, Iwami D, Hritzo M, Xiong Y, Ahmad S, Simon T, et al. Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration. Nat Commun. 2016;7:12021 pubmed publisher
  338. Kathania M, Khare P, Zeng M, Cantarel B, Zhang H, Ueno H, et al. Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-?t ubiquitination. Nat Immunol. 2016;17:997-1004 pubmed publisher
  339. Gu L, Deng W, Sun X, Zhou H, Xu Q. Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17/Treg cell balance. Mol Med Rep. 2016;14:1153-61 pubmed publisher
  340. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  341. Wang T, Pan D, Zhou Z, You Y, Jiang C, Zhao X, et al. Dectin-3 Deficiency Promotes Colitis Development due to Impaired Antifungal Innate Immune Responses in the Gut. PLoS Pathog. 2016;12:e1005662 pubmed publisher
  342. Lim J, Im K, Lee E, Kim N, Nam Y, Jeon Y, et al. Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis. Sci Rep. 2016;6:26851 pubmed publisher
  343. Chu H, Khosravi A, Kusumawardhani I, Kwon A, Vasconcelos A, Cunha L, et al. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science. 2016;352:1116-20 pubmed publisher
  344. Patel M, Kim J, Theodros D, Tam A, Velarde E, Kochel C, et al. Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma. J Immunother Cancer. 2016;4:28 pubmed publisher
  345. Brandstätter O, Schanz O, Vorac J, König J, Mori T, Maruyama T, et al. Balancing intestinal and systemic inflammation through cell type-specific expression of the aryl hydrocarbon receptor repressor. Sci Rep. 2016;6:26091 pubmed publisher
  346. Guzera M, Szulc Dąbrowska L, Cywinska A, Archer J, Winnicka A. In Vitro Influence of Mycophenolic Acid on Selected Parameters of Stimulated Peripheral Canine Lymphocytes. PLoS ONE. 2016;11:e0154429 pubmed publisher
  347. Li Y, Nishikawa T, Kaneda Y. Platelet-cytokine Complex Suppresses Tumour Growth by Exploiting Intratumoural Thrombin-dependent Platelet Aggregation. Sci Rep. 2016;6:25077 pubmed publisher
  348. Ameratunga M, Asadi K, Lin X, Walkiewicz M, Murone C, Knight S, et al. PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC. PLoS ONE. 2016;11:e0153954 pubmed publisher
  349. Goldstein J, Burlion A, Zaragoza B, Sendeyo K, Polansky J, Huehn J, et al. Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression. PLoS ONE. 2016;11:e0153682 pubmed publisher
  350. Holmkvist P, Pool L, Hägerbrand K, Agace W, Rivollier A. IL-18R?-deficient CD4(+) T cells induce intestinal inflammation in the CD45RB(hi) transfer model of colitis despite impaired innate responsiveness. Eur J Immunol. 2016;46:1371-82 pubmed publisher
  351. Seidel P, Remus M, Delacher M, Grigaravicius P, Reuss D, Frappart L, et al. Epidermal Nbn deletion causes premature hair loss and a phenotype resembling psoriasiform dermatitis. Oncotarget. 2016;7:23006-18 pubmed publisher
  352. Du C, Duan Y, Wei W, Cai Y, Chai H, Lv J, et al. Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination. Nat Commun. 2016;7:11120 pubmed publisher
  353. Yue Y, Li P, Song N, Li B, Li Z, Guo Y, et al. Genomic and immunologic factors associated with viral pathogenesis in a lethal EV71 infected neonatal mouse model. Mol Med Rep. 2016;13:4183-90 pubmed publisher
  354. Sim C, Cho Y, Kim B, Baek I, Kim Y, Lee M. 2'-5' Oligoadenylate synthetase-like 1 (OASL1) deficiency in mice promotes an effective anti-tumor immune response by enhancing the production of type I interferons. Cancer Immunol Immunother. 2016;65:663-75 pubmed publisher
  355. Chen C, Liu Y, Hua M, Li X, Ji C, Ma D. Neuropathy correlated with imbalanced Foxp3/IL-17 in bone marrow microenvironment of patients with acute myeloid leukemia. Oncotarget. 2016;7:24455-65 pubmed publisher
  356. Mathewson N, Jenq R, Mathew A, Koenigsknecht M, Hanash A, Toubai T, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. 2016;17:505-513 pubmed publisher
  357. Gomez de Agüero M, Ganal Vonarburg S, Fuhrer T, Rupp S, Uchimura Y, Li H, et al. The maternal microbiota drives early postnatal innate immune development. Science. 2016;351:1296-302 pubmed publisher
  358. Apostolidis S, Rodríguez Rodríguez N, Suárez Fueyo A, Dioufa N, Ozcan E, Crispín J, et al. Phosphatase PP2A is requisite for the function of regulatory T cells. Nat Immunol. 2016;17:556-64 pubmed publisher
  359. McFarland B, Marks M, Rowse A, Fehling S, Gerigk M, Qin H, et al. Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma. Oncotarget. 2016;7:20621-35 pubmed publisher
  360. Friedman K, Brodsky A, Lu S, Wood S, Gill A, Lombardo K, et al. Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment. Mod Pathol. 2016;29:528-41 pubmed publisher
  361. Tosiek M, Fiette L, El Daker S, Eberl G, Freitas A. IL-15-dependent balance between Foxp3 and RORγt expression impacts inflammatory bowel disease. Nat Commun. 2016;7:10888 pubmed publisher
  362. Vermeulen J, Van Hecke W, Spliet W, Villacorta Hidalgo J, Fisch P, Broekhuizen R, et al. Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme Inhibitors. PLoS ONE. 2016;11:e0151465 pubmed publisher
  363. Seifert L, Werba G, Tiwari S, Giao Ly N, Nguy S, Alothman S, et al. Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. Gastroenterology. 2016;150:1659-1672.e5 pubmed publisher
  364. Tagliamonte M, Petrizzo A, Napolitano M, Luciano A, Rea D, Barbieri A, et al. A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice. J Transl Med. 2016;14:58 pubmed publisher
  365. Kabat A, Harrison O, Riffelmacher T, Moghaddam A, Pearson C, Laing A, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. elife. 2016;5:e12444 pubmed publisher
  366. Hu H, Wang H, Xiao Y, Jin J, Chang J, Zou Q, et al. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J Exp Med. 2016;213:399-414 pubmed publisher
  367. Hu G, Yang S, Hu W, Wen Z, He D, Zeng L, et al. Effect of cold stress on immunity in rats. Exp Ther Med. 2016;11:33-42 pubmed
  368. Xiong Y, Ahmad S, Iwami D, Brinkman C, Bromberg J. T-bet Regulates Natural Regulatory T Cell Afferent Lymphatic Migration and Suppressive Function. J Immunol. 2016;196:2526-40 pubmed publisher
  369. Nguyen N, Bellile E, Thomas D, McHugh J, Rozek L, Virani S, et al. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma. Head Neck. 2016;38:1074-84 pubmed publisher
  370. Haque M, Song J, Fino K, Sandhu P, Song X, Lei F, et al. Stem cell-derived tissue-associated regulatory T cells ameliorate the development of autoimmunity. Sci Rep. 2016;6:20588 pubmed publisher
  371. Lin C, Bradstreet T, Schwarzkopf E, Jarjour N, Chou C, Archambault A, et al. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J Exp Med. 2016;213:251-71 pubmed publisher
  372. Aloulou M, Carr E, Gador M, Bignon A, Liblau R, Fazilleau N, et al. Follicular regulatory T cells can be specific for the immunizing antigen and derive from naive T cells. Nat Commun. 2016;7:10579 pubmed publisher
  373. Menter T, Dickenmann M, Juskevicius D, Steiger J, Dirnhofer S, Tzankov A. Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling. Hematol Oncol. 2017;35:187-197 pubmed publisher
  374. Luo C, Liao W, Dadi S, Toure A, Li M. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature. 2016;529:532-6 pubmed publisher
  375. Kuipers H, Rieck M, Gurevich I, Nagy N, Butte M, Negrin R, et al. Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization. Proc Natl Acad Sci U S A. 2016;113:1339-44 pubmed publisher
  376. Yasuma K, Yasunaga J, Takemoto K, Sugata K, Mitobe Y, Takenouchi N, et al. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT). PLoS Pathog. 2016;12:e1005372 pubmed publisher
  377. Kim K, Wen X, Yang H, Kim W, Kang G. Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma. PLoS ONE. 2015;10:e0144192 pubmed publisher
  378. Carrascal J, Carrillo J, Arpa B, Egia Mendikute L, Rosell Mases E, Pujol Autonell I, et al. B-cell anergy induces a Th17 shift in a novel B lymphocyte transgenic NOD mouse model, the 116C-NOD mouse. Eur J Immunol. 2016;46:593-608 pubmed publisher
  379. Francisconi C, Vieira A, Biguetti C, Glowacki A, Trombone A, Letra A, et al. Characterization of the Protective Role of Regulatory T Cells in Experimental Periapical Lesion Development and Their Chemoattraction Manipulation as a Therapeutic Tool. J Endod. 2016;42:120-6 pubmed publisher
  380. Onodera T, Fukuhara A, Jang M, Shin J, Aoi K, Kikuta J, et al. Adipose tissue macrophages induce PPARγ-high FOXP3(+) regulatory T cells. Sci Rep. 2015;5:16801 pubmed publisher
  381. Kim J, Phan T, Nguyen V, Dinh Vu H, Zheng J, Yun M, et al. Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. Theranostics. 2015;5:1328-42 pubmed publisher
  382. Finkin S, Yuan D, Stein I, Taniguchi K, Weber A, Unger K, et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat Immunol. 2015;16:1235-44 pubmed publisher
  383. Feng Z, Puri S, Moudgil T, Wood W, Hoyt C, Wang C, et al. Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma. J Immunother Cancer. 2015;3:47 pubmed publisher
  384. Arriola Apelo S, Neuman J, Baar E, Syed F, Cummings N, Brar H, et al. Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system. Aging Cell. 2016;15:28-38 pubmed publisher
  385. Zhao L, Li C, Jin P, Ng C, Lin Z, Li Y, et al. Histopathological features of sinonasal inverted papillomas in chinese patients. Laryngoscope. 2016;126:E141-7 pubmed publisher
  386. Patel M, Jacobson B, Ji Y, Drees J, Tang S, Xiong K, et al. Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer. Oncotarget. 2015;6:33165-77 pubmed publisher
  387. Ladell K, Hazenberg M, Fitch M, Emson C, McEvoy Hein Asgarian B, Mold J, et al. Continuous Antigenic Stimulation of DO11.10 TCR Transgenic Mice in the Presence or Absence of IL-1?: Possible Implications for Mechanisms of T Cell Depletion in HIV Disease. J Immunol. 2015;195:4096-105 pubmed publisher
  388. Zanvit P, Konkel J, Jiao X, Kasagi S, Zhang D, Wu R, et al. Antibiotics in neonatal life increase murine susceptibility to experimental psoriasis. Nat Commun. 2015;6:8424 pubmed publisher
  389. Min S, Yan M, Kim S, Ravikumar S, Kwon S, Vanarsa K, et al. Green Tea Epigallocatechin-3-Gallate Suppresses Autoimmune Arthritis Through Indoleamine-2,3-Dioxygenase Expressing Dendritic Cells and the Nuclear Factor, Erythroid 2-Like 2 Antioxidant Pathway. J Inflamm (Lond). 2015;12:53 pubmed publisher
  390. Gao Y, Zhang M, Li J, Yang M, Liu Y, Guo X, et al. Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation. PLoS ONE. 2015;10:e0137881 pubmed publisher
  391. Xiao X, Shi X, Fan Y, Zhang X, Wu M, Lan P, et al. GITR subverts Foxp3(+) Tregs to boost Th9 immunity through regulation of histone acetylation. Nat Commun. 2015;6:8266 pubmed publisher
  392. Poncini C, Ilarregui J, Batalla E, Engels S, Cerliani J, Cucher M, et al. Trypanosoma cruzi Infection Imparts a Regulatory Program in Dendritic Cells and T Cells via Galectin-1-Dependent Mechanisms. J Immunol. 2015;195:3311-24 pubmed publisher
  393. Guo L, Huang Y, Chen X, Hu Li J, Urban J, Paul W. Innate immunological function of TH2 cells in vivo. Nat Immunol. 2015;16:1051-9 pubmed publisher
  394. Romero Palomo F, Risalde M, Gómez Villamandos J. Immunopathologic Changes in the Thymus of Calves Pre-infected with BVDV and Challenged with BHV-1. Transbound Emerg Dis. 2017;64:574-584 pubmed publisher
  395. Baruch K, Rosenzweig N, Kertser A, Deczkowska A, Sharif A, Spinrad A, et al. Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology. Nat Commun. 2015;6:7967 pubmed publisher
  396. Ngiow S, Young A, Jacquelot N, Yamazaki T, Enot D, Zitvogel L, et al. A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Cancer Res. 2015;75:3800-11 pubmed publisher
  397. Redpath S, Van Der Werf N, MacDonald A, Maizels R, Taylor M. Schistosoma mansoni Larvae Do Not Expand or Activate Foxp3+ Regulatory T Cells during Their Migratory Phase. Infect Immun. 2015;83:3881-9 pubmed publisher
  398. Jasinski Bergner S, Stoehr C, Bukur J, Massa C, Braun J, Hüttelmaier S, et al. Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma. Oncoimmunology. 2015;4:e1008805 pubmed
  399. Saulep Easton D, Vincent F, Quah P, Wei A, Ting S, Croce C, et al. The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells. Leukemia. 2016;30:163-72 pubmed publisher
  400. Chang C, Lin C, Lu C, Martel J, Ko Y, Ojcius D, et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun. 2015;6:7489 pubmed publisher
  401. Evonuk K, Baker B, Doyle R, Moseley C, Sestero C, Johnston B, et al. Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination. J Immunol. 2015;195:450-463 pubmed publisher
  402. Conde P, Rodriguez M, van der Touw W, Jimenez A, Burns M, Miller J, et al. DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance. Immunity. 2015;42:1143-58 pubmed publisher
  403. Holtzhausen A, Zhao F, Evans K, Tsutsui M, Orabona C, Tyler D, et al. Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy. Cancer Immunol Res. 2015;3:1082-95 pubmed publisher
  404. Khan I, Perrard X, Brunner G, Lui H, Sparks L, Smith S, et al. Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance. Int J Obes (Lond). 2015;39:1607-18 pubmed publisher
  405. Castiglioni A, Corna G, Rigamonti E, Basso V, Vezzoli M, Monno A, et al. FOXP3+ T Cells Recruited to Sites of Sterile Skeletal Muscle Injury Regulate the Fate of Satellite Cells and Guide Effective Tissue Regeneration. PLoS ONE. 2015;10:e0128094 pubmed publisher
  406. Chen H, Sun J, Huang Z, Hou H, Arcilla M, Rakhilin N, et al. Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting. Nat Biotechnol. 2015;33:656-60 pubmed publisher
  407. Liao J, Ovenell K, Curtis E, Cecil D, Koehnlein M, Rastetter L, et al. Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancer. J Immunother Cancer. 2015;3:16 pubmed publisher
  408. Wang Z, Wei M, Zhang H, Chen H, Germana S, Huang C, et al. Diphtheria-toxin based anti-human CCR4 immunotoxin for targeting human CCR4(+) cells in vivo. Mol Oncol. 2015;9:1458-70 pubmed publisher
  409. Liechtenstein T, Perez Janices N, Blanco Luquin I, Goyvaerts C, Schwarze J, Dufait I, et al. Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy. Oncoimmunology. 2014;3:e945378 pubmed
  410. Holm J, Sorobetea D, Kiilerich P, Ramayo Caldas Y, Estellé J, Ma T, et al. Chronic Trichuris muris Infection Decreases Diversity of the Intestinal Microbiota and Concomitantly Increases the Abundance of Lactobacilli. PLoS ONE. 2015;10:e0125495 pubmed publisher
  411. Kreiter S, Vormehr M, van de Roemer N, Diken M, Löwer M, Diekmann J, et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature. 2015;520:692-6 pubmed publisher
  412. Dennis K, Saadalla A, Blatner N, Wang S, Venkateswaran V, Gounari F, et al. T-cell Expression of IL10 Is Essential for Tumor Immune Surveillance in the Small Intestine. Cancer Immunol Res. 2015;3:806-14 pubmed publisher
  413. Li C, Li W, Xiao J, Jiao S, Teng F, Xue S, et al. ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy. EMBO Mol Med. 2015;7:754-69 pubmed publisher
  414. Lal G, Nakayama Y, Sethi A, Singh A, Burrell B, Kulkarni N, et al. Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance. Transplantation. 2015;99:1817-28 pubmed publisher
  415. Punt S, van Vliet M, Spaans V, de Kroon C, Fleuren G, Gorter A, et al. FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma. Cancer Immunol Immunother. 2015;64:745-53 pubmed publisher
  416. Romani R, Pirisinu I, Calvitti M, Pallotta M, Gargaro M, Bistoni G, et al. Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1. J Cell Mol Med. 2015;19:1593-605 pubmed publisher
  417. Van Den Ham K, Shio M, Rainone A, Fournier S, Krawczyk C, Olivier M. Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis. PLoS ONE. 2015;10:e0118451 pubmed publisher
  418. Kim Y, Lim H, Jung H, Wetsel R, Chung Y. Regulation of autoimmune germinal center reactions in lupus-prone BXD2 mice by follicular helper T cells. PLoS ONE. 2015;10:e0120294 pubmed publisher
  419. Wiesner D, Specht C, Lee C, Smith K, Mukaremera L, Lee S, et al. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog. 2015;11:e1004701 pubmed publisher
  420. Pratama A, Srivastava M, Williams N, Papa I, Lee S, Dinh X, et al. MicroRNA-146a regulates ICOS-ICOSL signalling to limit accumulation of T follicular helper cells and germinal centres. Nat Commun. 2015;6:6436 pubmed publisher
  421. Wensveen F, Jelenčić V, Valentić S, Šestan M, Wensveen T, Theurich S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16:376-85 pubmed publisher
  422. Hsiao H, Hsu T, Liu W, Hsieh W, Chou T, Wu Y, et al. Deltex1 antagonizes HIF-1α and sustains the stability of regulatory T cells in vivo. Nat Commun. 2015;6:6353 pubmed publisher
  423. Torres Cabala C, Curry J, Li Ning Tapia E, Ramos C, Tetzlaff M, Prieto V, et al. HTLV-1-associated infective dermatitis demonstrates low frequency of FOXP3-positive T-regulatory lymphocytes. J Dermatol Sci. 2015;77:150-5 pubmed publisher
  424. Buchwald Z, Yang C, Nellore S, Shashkova E, Davis J, Cline A, et al. A Bone Anabolic Effect of RANKL in a Murine Model of Osteoporosis Mediated Through FoxP3+ CD8 T Cells. J Bone Miner Res. 2015;30:1508-22 pubmed publisher
  425. Valle A, Barbagiovanni G, Jofra T, Stabilini A, Pérol L, Baeyens A, et al. Heterogeneous CD3 expression levels in differing T cell subsets correlate with the in vivo anti-CD3-mediated T cell modulation. J Immunol. 2015;194:2117-27 pubmed publisher
  426. Crncec I, Pathria P, Svinka J, Eferl R. Induction of colorectal cancer in mice and histomorphometric evaluation of tumors. Methods Mol Biol. 2015;1267:145-64 pubmed publisher
  427. Franckaert D, Schlenner S, Heirman N, Gill J, Skogberg G, Ekwall O, et al. Premature thymic involution is independent of structural plasticity of the thymic stroma. Eur J Immunol. 2015;45:1535-47 pubmed publisher
  428. Triplett T, Tucker C, Triplett K, Alderman Z, Sun L, Ling L, et al. STAT3 Signaling Is Required for Optimal Regression of Large Established Tumors in Mice Treated with Anti-OX40 and TGFβ Receptor Blockade. Cancer Immunol Res. 2015;3:526-35 pubmed publisher
  429. Engels C, Charehbili A, van de Velde C, Bastiaannet E, Sajet A, Putter H, et al. The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis. Breast Cancer Res Treat. 2015;149:587-96 pubmed publisher
  430. Evans E, Jonason A, Bussler H, Torno S, Veeraraghavan J, Reilly C, et al. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies. Cancer Immunol Res. 2015;3:689-701 pubmed publisher
  431. Däster S, Eppenberger Castori S, Hirt C, Zlobec I, Delko T, Nebiker C, et al. High frequency of CD8 positive lymphocyte infiltration correlates with lack of lymph node involvement in early rectal cancer. Dis Markers. 2014;2014:792183 pubmed publisher
  432. Zhang Y, Wu B, Metelli A, Thaxton J, Hong F, Rachidi S, et al. GP96 is a GARP chaperone and controls regulatory T cell functions. J Clin Invest. 2015;125:859-69 pubmed publisher
  433. Vorobjova T, Uibo O, Heilman K, Uibo R. Increased density of tolerogenic dendritic cells in the small bowel mucosa of celiac patients. World J Gastroenterol. 2015;21:439-52 pubmed publisher
  434. Clouthier D, Zhou A, Wortzman M, Luft O, Levy G, Watts T. GITR intrinsically sustains early type 1 and late follicular helper CD4 T cell accumulation to control a chronic viral infection. PLoS Pathog. 2015;11:e1004517 pubmed publisher
  435. Singh K, Hjort M, Thorvaldson L, Sandler S. Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naïve mice. Sci Rep. 2015;5:7767 pubmed publisher
  436. Hannani D, Vétizou M, Enot D, Rusakiewicz S, Chaput N, Klatzmann D, et al. Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Res. 2015;25:208-24 pubmed publisher
  437. Teixeira L, Moreira J, Melo J, Bezerra F, Marques R, Ferreirinha P, et al. Immune response in the adipose tissue of lean mice infected with the protozoan parasite Neospora caninum. Immunology. 2015;145:242-57 pubmed publisher
  438. Djukic M, Sostmann N, Bertsch T, Mecke M, Nessler S, Manig A, et al. Vitamin D deficiency decreases survival of bacterial meningoencephalitis in mice. J Neuroinflammation. 2015;12:208 pubmed publisher
  439. Shrestha S, Yang K, Guy C, Vogel P, Neale G, Chi H. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol. 2015;16:178-87 pubmed publisher
  440. Hildebrand A, Jarsch C, Kern Y, Böhringer D, Reinhard T, Schwartzkopff J. Subconjunctivally applied naïve Tregs support corneal graft survival in baby rats. Mol Vis. 2014;20:1749-57 pubmed
  441. Krishnamoorthy N, Burkett P, Dalli J, Abdulnour R, Colas R, Ramon S, et al. Cutting edge: maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation. J Immunol. 2015;194:863-7 pubmed publisher
  442. Yuan X, Dee M, Altman N, Malek T. IL-2Rβ-dependent signaling and CD103 functionally cooperate to maintain tolerance in the gut mucosa. J Immunol. 2015;194:1334-46 pubmed publisher
  443. Ikeda T, Hirata S, Takamatsu K, Haruta M, Tsukamoto H, Ito T, et al. Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells. PLoS ONE. 2014;9:e115198 pubmed publisher
  444. Harmon E, Fronhofer V, Keller R, Feustel P, Zhu X, Xu H, et al. Anti-inflammatory immune skewing is atheroprotective: Apoe−/−FcγRIIb−/− mice develop fibrous carotid plaques. J Am Heart Assoc. 2014;3:e001232 pubmed publisher
  445. Käser T, Mair K, Hammer S, Gerner W, Saalmüller A. Natural and inducible Tregs in swine: Helios expression and functional properties. Dev Comp Immunol. 2015;49:323-31 pubmed publisher
  446. Rutz S, Kayagaki N, Phung Q, Eidenschenk C, Noubade R, Wang X, et al. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature. 2015;518:417-21 pubmed publisher
  447. Gerner W, Talker S, Koinig H, Sedlak C, Mair K, Saalmüller A. Phenotypic and functional differentiation of porcine αβ T cells: current knowledge and available tools. Mol Immunol. 2015;66:3-13 pubmed publisher
  448. Lees J, Duffy S, Perera C, Moalem Taylor G. Depletion of Foxp3+ regulatory T cells increases severity of mechanical allodynia and significantly alters systemic cytokine levels following peripheral nerve injury. Cytokine. 2015;71:207-14 pubmed publisher
  449. Hou J, Zhang Q, Fujino M, Cai S, Ito H, Takahashi K, et al. 5-Aminolevulinic acid with ferrous iron induces permanent cardiac allograft acceptance in mice via induction of regulatory cells. J Heart Lung Transplant. 2015;34:254-63 pubmed publisher
  450. Peters A, Burkett P, Sobel R, Buckley C, Watson S, Bettelli E, et al. Podoplanin negatively regulates CD4+ effector T cell responses. J Clin Invest. 2015;125:129-40 pubmed publisher
  451. Uchiyama M, Jin X, Yin E, Shimokawa T, Niimi M. Treadmill exercise induces murine cardiac allograft survival and generates regulatory T cell. Transpl Int. 2015;28:352-62 pubmed publisher
  452. Patel P, Julien J, Kriz J. Early-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis. Neurotherapeutics. 2015;12:217-33 pubmed publisher
  453. Hermans C, Anz D, Engel J, Kirchner T, Endres S, Mayr D. Analysis of FoxP3+ T-regulatory cells and CD8+ T-cells in ovarian carcinoma: location and tumor infiltration patterns are key prognostic markers. PLoS ONE. 2014;9:e111757 pubmed publisher
  454. Llosa N, Cruise M, Tam A, Wicks E, Hechenbleikner E, Taube J, et al. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 2015;5:43-51 pubmed publisher
  455. Thauland T, Koguchi Y, Dustin M, Parker D. CD28-CD80 interactions control regulatory T cell motility and immunological synapse formation. J Immunol. 2014;193:5894-903 pubmed publisher
  456. Xie L, Choudhury G, Winters A, Yang S, Jin K. Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10. Eur J Immunol. 2015;45:180-91 pubmed publisher
  457. Lin W, Fan Z, Suo Y, Deng Y, Zhang M, Wang J, et al. The bullseye synapse formed between CD4+ T-cell and staphylococcal enterotoxin B-pulsed dendritic cell is a suppressive synapse in T-cell response. Immunol Cell Biol. 2015;93:99-110 pubmed publisher
  458. Maneva Radicheva L, Amatya C, Parker C, Ellefson J, Radichev I, Raghavan A, et al. Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1. PLoS ONE. 2014;9:e107213 pubmed publisher
  459. Donaldson D, Bradford B, Artis D, Mabbott N. Reciprocal regulation of lymphoid tissue development in the large intestine by IL-25 and IL-23. Mucosal Immunol. 2015;8:582-95 pubmed publisher
  460. Zasłona Z, Przybranowski S, Wilke C, Van Rooijen N, Teitz Tennenbaum S, Osterholzer J, et al. Resident alveolar macrophages suppress, whereas recruited monocytes promote, allergic lung inflammation in murine models of asthma. J Immunol. 2014;193:4245-53 pubmed publisher
  461. Burton B, Britton G, Fang H, Verhagen J, Smithers B, Sabatos Peyton C, et al. Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Nat Commun. 2014;5:4741 pubmed publisher
  462. Kobayashi T, Hamaguchi Y, Hasegawa M, Fujimoto M, Takehara K, Matsushita T. B cells promote tumor immunity against B16F10 melanoma. Am J Pathol. 2014;184:3120-9 pubmed publisher
  463. Kreiser S, Eckhardt J, Kuhnt C, Stein M, Krzyzak L, Seitz C, et al. Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. Immunobiology. 2015;220:270-9 pubmed publisher
  464. Wu C, He S, Peng Y, Kushwaha K, Lin J, Dong J, et al. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice. J Mol Cell Cardiol. 2014;76:33-45 pubmed publisher
  465. Penaloza MacMaster P, Kamphorst A, Wieland A, Araki K, Iyer S, West E, et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J Exp Med. 2014;211:1905-18 pubmed publisher
  466. Ishihara M, Seo N, Mitsui J, Muraoka D, Tanaka M, Mineno J, et al. Systemic CD8+ T cell-mediated tumoricidal effects by intratumoral treatment of oncolytic herpes simplex virus with the agonistic monoclonal antibody for murine glucocorticoid-induced tumor necrosis factor receptor. PLoS ONE. 2014;9:e104669 pubmed publisher
  467. Denton A, Roberts E, Linterman M, Fearon D. Fibroblastic reticular cells of the lymph node are required for retention of resting but not activated CD8+ T cells. Proc Natl Acad Sci U S A. 2014;111:12139-44 pubmed publisher
  468. Zhu Y, Knolhoff B, Meyer M, Nywening T, West B, Luo J, et al. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. 2014;74:5057-69 pubmed publisher
  469. Kim K, Skora A, Li Z, Liu Q, Tam A, Blosser R, et al. Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells. Proc Natl Acad Sci U S A. 2014;111:11774-9 pubmed publisher
  470. Zhang X, Gao L, Liang X, Guo M, Wang R, Pan Y, et al. HBV preS2 transactivates FOXP3 expression in malignant hepatocytes. Liver Int. 2015;35:1087-94 pubmed publisher
  471. Knuschke T, Bayer W, Rotan O, Sokolova V, Wadwa M, Kirschning C, et al. Prophylactic and therapeutic vaccination with a nanoparticle-based peptide vaccine induces efficient protective immunity during acute and chronic retroviral infection. Nanomedicine. 2014;10:1787-98 pubmed publisher
  472. Boyoglu Barnum S, Chirkova T, Todd S, Barnum T, Gaston K, Jorquera P, et al. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice. J Virol. 2014;88:10569-83 pubmed publisher
  473. Vogelzang A, Perdomo C, Zedler U, Kuhlmann S, Hurwitz R, Gengenbacher M, et al. Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guérin ?ureC::hly vaccine's superior protection against tuberculosis. J Infect Dis. 2014;210:1928-37 pubmed publisher
  474. Azzimonti B, Zavattaro E, Provasi M, Vidali M, Conca A, Catalano E, et al. Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio. Br J Dermatol. 2015;172:64-73 pubmed publisher
  475. Pastille E, Bardini K, Fleissner D, Adamczyk A, Frede A, Wadwa M, et al. Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer. Cancer Res. 2014;74:4258-69 pubmed publisher
  476. Chen Z, Ozbun L, Chong N, Wallecha A, Berzofsky J, Khleif S. Episomal expression of truncated listeriolysin O in LmddA-LLO-E7 vaccine enhances antitumor efficacy by preferentially inducing expansions of CD4+FoxP3- and CD8+ T cells. Cancer Immunol Res. 2014;2:911-22 pubmed publisher
  477. Nandi B, Pai C, Huang Q, Prabhala R, Munshi N, Gold J. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis. PLoS ONE. 2014;9:e97566 pubmed publisher
  478. Sreedharan R, Chen S, Miller M, Haribhai D, Williams C, Van Why S. Mice with an absent stress response are protected against ischemic renal injury. Kidney Int. 2014;86:515-24 pubmed publisher
  479. Smolarchuk C, Zhu L, Chan W, Anderson C. T cells generated in the absence of a thoracic thymus fail to establish homeostasis. Eur J Immunol. 2014;44:2263-73 pubmed publisher
  480. Breuer J, Schwab N, Schneider Hohendorf T, Marziniak M, Mohan H, Bhatia U, et al. Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Ann Neurol. 2014;75:739-58 pubmed publisher
  481. Pick J, Arra A, Lingel H, Hegel J, Huber M, Nishanth G, et al. CTLA-4 (CD152) enhances the Tc17 differentiation program. Eur J Immunol. 2014;44:2139-52 pubmed publisher
  482. Rossi G, Pengo G, Caldin M, Palumbo Piccionello A, Steiner J, Cohen N, et al. Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease. PLoS ONE. 2014;9:e94699 pubmed publisher
  483. Kuwahara M, Suzuki J, Tofukuji S, Yamada T, Kanoh M, Matsumoto A, et al. The Menin-Bach2 axis is critical for regulating CD4 T-cell senescence and cytokine homeostasis. Nat Commun. 2014;5:3555 pubmed publisher
  484. Cochain C, Chaudhari S, Koch M, Wiendl H, Eckstein H, Zernecke A. Programmed cell death-1 deficiency exacerbates T cell activation and atherogenesis despite expansion of regulatory T cells in atherosclerosis-prone mice. PLoS ONE. 2014;9:e93280 pubmed publisher
  485. Keswani T, Bhattacharyya A. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii. Exp Parasitol. 2014;141:82-92 pubmed publisher
  486. Samuelson E, Laird R, Papillion A, Tatum A, Princiotta M, Hayes S. Reduced B lymphoid kinase (Blk) expression enhances proinflammatory cytokine production and induces nephrosis in C57BL/6-lpr/lpr mice. PLoS ONE. 2014;9:e92054 pubmed publisher
  487. Berney Meyer L, Hung N, Slatter T, Schollum J, Kitching A, Walker R. Omeprazole-induced acute interstitial nephritis: a possible Th1-Th17-mediated injury?. Nephrology (Carlton). 2014;19:359-65 pubmed publisher
  488. Fu H, Kishore M, Gittens B, Wang G, Coe D, Komarowska I, et al. Self-recognition of the endothelium enables regulatory T-cell trafficking and defines the kinetics of immune regulation. Nat Commun. 2014;5:3436 pubmed publisher
  489. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed publisher
  490. Wolfs T, Kramer B, Thuijls G, Kemp M, Saito M, Willems M, et al. Chorioamnionitis-induced fetal gut injury is mediated by direct gut exposure of inflammatory mediators or by lung inflammation. Am J Physiol Gastrointest Liver Physiol. 2014;306:G382-93 pubmed publisher
  491. Mercadante A, Perobelli S, Alves A, Gonçalves Silva T, Mello W, Gomes Santos A, et al. Oral combined therapy with probiotics and alloantigen induces B cell-dependent long-lasting specific tolerance. J Immunol. 2014;192:1928-37 pubmed publisher
  492. Joedicke J, Dietze K, Zelinskyy G, Dittmer U. The phenotype and activation status of regulatory T cells during Friend retrovirus infection. Virol Sin. 2014;29:48-60 pubmed publisher
  493. Xia S, Wei J, Wang J, Sun H, Zheng W, Li Y, et al. A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells. J Leukoc Biol. 2014;95:733-742 pubmed
  494. Hu Y, Xiao H, Shi T, Oppenheim J, Chen X. Progranulin promotes tumour necrosis factor-induced proliferation of suppressive mouse CD4? Foxp3? regulatory T cells. Immunology. 2014;142:193-201 pubmed publisher
  495. Chatterjee S, Eby J, Al Khami A, Soloshchenko M, Kang H, Kaur N, et al. A quantitative increase in regulatory T cells controls development of vitiligo. J Invest Dermatol. 2014;134:1285-1294 pubmed publisher
  496. Cavnar M, Zeng S, Kim T, Sorenson E, Ocuin L, Balachandran V, et al. KIT oncogene inhibition drives intratumoral macrophage M2 polarization. J Exp Med. 2013;210:2873-86 pubmed publisher
  497. Murphy K, Erickson J, Johnson C, Seiler C, Bedi J, Hu P, et al. CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of glioma. J Immunol. 2014;192:224-33 pubmed publisher
  498. Lee P, Puppi M, Schluns K, Yu Lee L, Dong C, Lacorazza H. The transcription factor E74-like factor 4 suppresses differentiation of proliferating CD4+ T cells to the Th17 lineage. J Immunol. 2014;192:178-88 pubmed publisher
  499. Chopra M, Lang I, Salzmann S, Pachel C, Kraus S, Bäuerlein C, et al. Tumor necrosis factor induces tumor promoting and anti-tumoral effects on pancreatic cancer via TNFR1. PLoS ONE. 2013;8:e75737 pubmed publisher
  500. Yockey L, Demehri S, Turkoz M, Turkoz A, Ahern P, Jassim O, et al. The absence of a microbiota enhances TSLP expression in mice with defective skin barrier but does not affect the severity of their allergic inflammation. J Invest Dermatol. 2013;133:2714-2721 pubmed publisher
  501. Barron L, Smith A, El Kasmi K, Qualls J, Huang X, Cheever A, et al. Role of arginase 1 from myeloid cells in th2-dominated lung inflammation. PLoS ONE. 2013;8:e61961 pubmed publisher
  502. Billich A, Baumruker T, Beerli C, Bigaud M, Bruns C, Calzascia T, et al. Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis. PLoS ONE. 2013;8:e59630 pubmed publisher
  503. Redpath S, Van Der Werf N, Cervera A, MacDonald A, Gray D, Maizels R, et al. ICOS controls Foxp3(+) regulatory T-cell expansion, maintenance and IL-10 production during helminth infection. Eur J Immunol. 2013;43:705-15 pubmed publisher
  504. Khan A, Fu H, Tan L, Harper J, Beutelspacher S, Larkin D, et al. Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition. Eur J Immunol. 2013;43:734-46 pubmed publisher
  505. Weiss J, Bilate A, Gobert M, Ding Y, Curotto de Lafaille M, Parkhurst C, et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J Exp Med. 2012;209:1723-42, S1 pubmed
  506. Hwang S, Song K, Lesourne R, Lee J, Pinkhasov J, Li L, et al. Reduced TCR signaling potential impairs negative selection but does not result in autoimmune disease. J Exp Med. 2012;209:1781-95 pubmed
  507. Jin X, Uchiyama M, Zhang Q, Hirai T, Niimi M. Inchingorei-san (TJ-117) and Artemisiae Capillaris Herba Induced Prolonged Survival of Fully Mismatched Cardiac Allografts and Generated Regulatory Cells in Mice. Evid Based Complement Alternat Med. 2012;2012:689810 pubmed publisher
  508. Golias J, Schwarzer M, Wallner M, Kverka M, Kozakova H, Srůtková D, et al. Heat-induced structural changes affect OVA-antigen processing and reduce allergic response in mouse model of food allergy. PLoS ONE. 2012;7:e37156 pubmed publisher
  509. Feng T, Cong Y, Alexander K, Elson C. Regulation of Toll-like receptor 5 gene expression and function on mucosal dendritic cells. PLoS ONE. 2012;7:e35918 pubmed publisher
  510. Uchiyama M, Jin X, Zhang Q, Hirai T, Amano A, Bashuda H, et al. Auditory stimulation of opera music induced prolongation of murine cardiac allograft survival and maintained generation of regulatory CD4+CD25+ cells. J Cardiothorac Surg. 2012;7:26 pubmed publisher
  511. Loebbermann J, Schnoeller C, Thornton H, Durant L, Sweeney N, Schuijs M, et al. IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice. PLoS ONE. 2012;7:e32371 pubmed publisher
  512. Loebbermann J, Thornton H, Durant L, Sparwasser T, Webster K, Sprent J, et al. Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunol. 2012;5:161-72 pubmed publisher
  513. Wollenberg I, Agua Doce A, Hernandez A, Almeida C, Oliveira V, Faro J, et al. Regulation of the germinal center reaction by Foxp3+ follicular regulatory T cells. J Immunol. 2011;187:4553-60 pubmed publisher
  514. West N, Panet Raymond V, Truong P, Alexander C, Babinszky S, Milne K, et al. Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR). Breast Cancer (Auckl). 2011;5:105-15 pubmed publisher
  515. Qian B, Li J, Zhang H, Kitamura T, Zhang J, Campion L, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475:222-5 pubmed publisher
  516. Liu J, Zhang N, Li Q, Zhang W, Ke F, Leng Q, et al. Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice. PLoS ONE. 2011;6:e19495 pubmed publisher
  517. Goldstein J, Balderas R, Marodon G. Continuous activation of the CD122/STAT-5 signaling pathway during selection of antigen-specific regulatory T cells in the murine thymus. PLoS ONE. 2011;6:e19038 pubmed publisher
  518. Gadiot J, Hooijkaas A, Kaiser A, Van Tinteren H, van Boven H, Blank C. Overall survival and PD-L1 expression in metastasized malignant melanoma. Cancer. 2011;117:2192-201 pubmed publisher
  519. Wainwright D, Sengupta S, Han Y, Ulasov I, Lesniak M. The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human glioma. PLoS ONE. 2010;5:e15390 pubmed publisher
  520. Hubert S, Rissiek B, Klages K, Huehn J, Sparwasser T, Haag F, et al. Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway. J Exp Med. 2010;207:2561-8 pubmed publisher
  521. Mandal M, Marzouk A, Donnelly R, Ponzio N. Maternal immune stimulation during pregnancy affects adaptive immunity in offspring to promote development of TH17 cells. Brain Behav Immun. 2011;25:863-71 pubmed publisher
  522. Lin P, Sun L, Thibodeaux S, Ludwig S, Vadlamudi R, Hurez V, et al. B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses. J Immunol. 2010;185:2747-53 pubmed publisher
  523. Tanaka S, Maeda S, Hashimoto M, Fujimori C, Ito Y, Teradaira S, et al. Graded attenuation of TCR signaling elicits distinct autoimmune diseases by altering thymic T cell selection and regulatory T cell function. J Immunol. 2010;185:2295-305 pubmed publisher
  524. Cai S, Cao X, Hassan A, Fehniger T, Ley T. Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease. Blood. 2010;115:1669-77 pubmed publisher
  525. Blache C, Adriouch S, Calbo S, Drouot L, Dulauroy S, Arnoult C, et al. Cutting edge: CD4-independent development of functional FoxP3+ regulatory T cells. J Immunol. 2009;183:4182-6 pubmed publisher
  526. Zelinskyy G, Dietze K, Hüsecken Y, Schimmer S, Nair S, Werner T, et al. The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virus-specific cytotoxic T-cell response. Blood. 2009;114:3199-207 pubmed publisher
  527. Houot R, Goldstein M, Kohrt H, Myklebust J, Alizadeh A, Lin J, et al. Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion. Blood. 2009;114:3431-8 pubmed publisher
  528. Ellestad K, Tsutsui S, Noorbakhsh F, Warren K, Yong V, Pittman Q, et al. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells. J Immunol. 2009;183:298-309 pubmed publisher
  529. Abboud G, Staumont Sallé D, Kanda A, Roumier T, Deruytter N, Lavogiez C, et al. Fc(epsilon)RI and FcgammaRIII/CD16 differentially regulate atopic dermatitis in mice. J Immunol. 2009;182:6517-26 pubmed publisher
  530. Hamada H, Garcia Hernandez M, Reome J, Misra S, Strutt T, McKinstry K, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol. 2009;182:3469-81 pubmed publisher
  531. Sato K, Eizumi K, Fukaya T, Fujita S, Sato Y, Takagi H, et al. Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease. Blood. 2009;113:4780-9 pubmed publisher
  532. Ribeiro de Almeida C, Heath H, Krpic S, Dingjan G, van Hamburg J, Bergen I, et al. Critical role for the transcription regulator CCCTC-binding factor in the control of Th2 cytokine expression. J Immunol. 2009;182:999-1010 pubmed
  533. Saito K, Torii M, Ma N, Tsuchiya T, Wang L, Hori T, et al. Differential regulatory function of resting and preactivated allergen-specific CD4+ CD25+ regulatory T cells in Th2-type airway inflammation. J Immunol. 2008;181:6889-97 pubmed
  534. Milne K, Barnes R, Girardin A, Mawer M, Nesslinger N, Ng A, et al. Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer. PLoS ONE. 2008;3:e3409 pubmed publisher
  535. Casiraghi F, Azzollini N, Cassis P, Imberti B, Morigi M, Cugini D, et al. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol. 2008;181:3933-46 pubmed
  536. Reinwald S, Wiethe C, Westendorf A, Breloer M, Probst Kepper M, Fleischer B, et al. CD83 expression in CD4+ T cells modulates inflammation and autoimmunity. J Immunol. 2008;180:5890-7 pubmed
  537. Bommireddy R, Babcock G, Singh R, Doetschman T. TGFbeta1 deficiency does not affect the generation and maintenance of CD4+CD25+FOXP3+ putative Treg cells, but causes their numerical inadequacy and loss of regulatory function. Clin Immunol. 2008;127:206-13 pubmed publisher
  538. Barron L, Knoechel B, Lohr J, Abbas A. Cutting edge: contributions of apoptosis and anergy to systemic T cell tolerance. J Immunol. 2008;180:2762-6 pubmed
  539. Rana S, Byrne S, MacDonald L, Chan C, Halliday G. Ultraviolet B suppresses immunity by inhibiting effector and memory T cells. Am J Pathol. 2008;172:993-1004 pubmed publisher
  540. Ahonen C, Wasiuk A, Fuse S, Turk M, Ernstoff M, Suriawinata A, et al. Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines. Blood. 2008;111:3116-25 pubmed publisher
  541. Venanzi E, Gray D, Benoist C, Mathis D. Lymphotoxin pathway and Aire influences on thymic medullary epithelial cells are unconnected. J Immunol. 2007;179:5693-700 pubmed
  542. Cambos M, Belanger B, Jacques A, Roulet A, Scorza T. Natural regulatory (CD4+CD25+FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion. Int J Parasitol. 2008;38:229-38 pubmed
  543. Kang S, Lim H, Andrisani O, Broxmeyer H, Kim C. Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J Immunol. 2007;179:3724-33 pubmed
  544. Yamazaki S, Bonito A, Spisek R, Dhodapkar M, Inaba K, Steinman R. Dendritic cells are specialized accessory cells along with TGF- for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3 precursors. Blood. 2007;110:4293-302 pubmed
  545. Jiang L, Yang P, He H, Li B, Lin X, Hou S, et al. Increased expression of Foxp3 in splenic CD8+ T cells from mice with anterior chamber-associated immune deviation. Mol Vis. 2007;13:968-74 pubmed
  546. Walsh C, Smith P, Fallon P. Role for CTLA-4 but not CD25+ T cells during Schistosoma mansoni infection of mice. Parasite Immunol. 2007;29:293-308 pubmed
  547. Stephens G, Andersson J, Shevach E. Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses. J Immunol. 2007;178:6901-11 pubmed
  548. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110:1225-32 pubmed
  549. Nakae S, Iwakura Y, Suto H, Galli S. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol. 2007;81:1258-68 pubmed
  550. MacKenzie D, Schartner J, Lin J, Timmel A, Jennens Clough M, Fathman C, et al. GRAIL is up-regulated in CD4+ CD25+ T regulatory cells and is sufficient for conversion of T cells to a regulatory phenotype. J Biol Chem. 2007;282:9696-702 pubmed
  551. Erhardt A, Biburger M, Papadopoulos T, Tiegs G. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology. 2007;45:475-85 pubmed
  552. Wang Z, Davies J. CD8 blockade promotes the expansion of antigen-specific CD4+ FOXP3+ regulatory T cells in vivo. Int Immunopharmacol. 2007;7:249-65 pubmed
  553. Lohr J, Knoechel B, Wang J, Villarino A, Abbas A. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med. 2006;203:2785-91 pubmed
  554. Gebe J, Unrath K, Falk B, Ito K, Wen L, Daniels T, et al. Age-dependent loss of tolerance to an immunodominant epitope of glutamic acid decarboxylase in diabetic-prone RIP-B7/DR4 mice. Clin Immunol. 2006;121:294-304 pubmed
  555. Cassan C, Piaggio E, Zappulla J, Mars L, Couturier N, Bucciarelli F, et al. Pertussis toxin reduces the number of splenic Foxp3+ regulatory T cells. J Immunol. 2006;177:1552-60 pubmed
  556. Hansen W, Loser K, Westendorf A, Bruder D, Pfoertner S, Siewert C, et al. G protein-coupled receptor 83 overexpression in naive CD4+CD25- T cells leads to the induction of Foxp3+ regulatory T cells in vivo. J Immunol. 2006;177:209-15 pubmed
  557. Leithäuser F, Meinhardt Krajina T, Fink K, Wotschke B, Moller P, Reimann J. Foxp3-expressing CD103+ regulatory T cells accumulate in dendritic cell aggregates of the colonic mucosa in murine transfer colitis. Am J Pathol. 2006;168:1898-909 pubmed
  558. Sfondrini L, Rossini A, Besusso D, Merlo A, Tagliabue E, Menard S, et al. Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer. J Immunol. 2006;176:6624-30 pubmed
  559. Robertson S, Messer R, Carmody A, Hasenkrug K. In vitro suppression of CD8+ T cell function by Friend virus-induced regulatory T cells. J Immunol. 2006;176:3342-9 pubmed
  560. Wohlfert E, Gorelik L, Mittler R, Flavell R, Clark R. Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo. J Immunol. 2006;176:1316-20 pubmed